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Abstract 
 
Increasing evidence supports the developmental origins of health and disease (DOHaD) 
hypothesis, which posits that exposure to environmental factors (e.g. diet, chemicals, stress etc.) 
during sensitive periods of life (e.g. pre-conception, gestation, infancy, adolescence) alters 
disease susceptibility later in life by influencing developmental plasticity. As support for 
DOHaD accumulates, it has been proposed that developmental exposures alter later-life gene 
regulation and subsequent phenotype through changes in heritable epigenetic marks – e.g. DNA 
methylation. Both biological aging and environmental exposures are associated with changes in 
DNA methylation, and it has been shown that developmental exposures can alter the rate of 
epigenetic aging. Based on these existing data, we defined a new term – environmental 
deflection – that refers to an environment- or toxicant-mediated shift away from the baseline rate 
of epigenetic aging within an organism. 
For this project, longitudinal animal model and human cohort studies were used to 
investigate whether developmental exposure to specific environmental factors – bisphenol A 
(BPA), Western high-fat diet (WHFD), and physical activity – would lead to environmental 
deflection of the aging epigenome. In the animal model study, matched blood and tail samples 
were collected from congenic a/a Agouti mice perinatally exposed to BPA (50 µg/kg diet) and/or 
WHFD. Linear mixed effects models were used to test for environmental deflection of epigenetic 
aging by dietary exposures. In the same mice, we used two next-generation sequencing methods 
– enhanced reduced representation bisulfite sequencing (ERRBS) and hydroxymethylated DNA 
 xiii 
immunoprecipitation sequencing (HMeDIP-seq) – to determine the contributions of 5-
methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) to the aging epigenome. In the 
Healthy Families Project, a human cohort, we investigated the effects of physical activity and 
diet quality on age-related methylation in longitudinal blood samples. DNA methylation was 
measured at obesity-related genes in matched neonatal bloodspot and childhood blood samples 
(12-24 months old, 3-5 years old, 10-12 years old). In an effort to test the utility of neonatal 
blood DNA methylation as a biomarker of obesity risk during childhood, we also investigated 
whether childhood obesity likelihood was associated with neonatal and/or childhood DNA 
methylation at a number of obesity-related genes.  
In both the mouse and human studies, we showed significant, gene-specific age-related 
DNA methylation. In mice, WHFD, but not BPA exposure, deflected age-related Esr1 
methylation rates away from Control baseline. In the mouse blood sequencing data, we showed a 
locus-specific contribution of 5-hmC to age-related DNA methylation patterns in mice, and also 
demonstrated significant effects of BPA exposure on DNA hydroxymethylation in the gene 
bodies of imprinted loci. In the human cohort, environmental deflection modeling was limited by 
sample size, but there was some indication of deflection by childhood BMI z-score and physical 
activity levels. Neonatal bloodspot LINE-1 DNA methylation was significantly associated with 
obesity likelihood in preschool children, and childhood PPARA was also negatively associated 
with body mass index z-score. 
In this dissertation, we showed that both altered diet and physical activity have the 
potential to alter rates of epigenetic aging. Separately, we found that developmental BPA 
exposure stably alters DNA hydroxymethylation at murine imprinted genes, and that human 
neonatal bloodspot DNA methylation may be a useful biomarker for estimating childhood 
 xiv 
obesity risk. These results emphasize the importance of longitudinal study design in 
toxicoepigenetics research, and suggest that environmental factors play a key role in the 
developmental origins of adult disease.  
 
 1 
Chapter 1  
Introduction 
1.1 Rationale and Significance 
Obesity as a disease burden 
Over the past several decades, U.S. adult and childhood obesity rates have steadily 
increased, reaching 39.8% and 18.5% in 2015-2016, respectively (Hales et al. 2017). As a 
phenotype, obesity is associated with a number of chronic diseases, including hypertension, 
various cancers, heart disease, and type 2 diabetes (Dixon 2010). As a result of these negative 
health impacts, obesity is also a significant economic burden; a recent literature review estimated 
that the annual medical cost of treating obesity in the U.S. is $149.4 billion in 2014 dollars (Kim 
and Basu 2016). Public health efforts to improve metabolic health in the U.S. have not been 
successful, leading to an investment in research examining the biological underpinnings of the 
obese phenotype.  Recent research has shown that childhood obesity or a family history of 
obesity are the best predictors of adult obesity (Loos and Janssens 2017), indicating that genetics 
may play a central role in the etiology of obesity. However, a new literature review on this topic 
showed that BMI-associated genetic variants only explain 0.66-2.70% of BMI variation, 
suggesting that obesity risk is not reflected in the available genetic information (Loos and 
Janssens 2017). This inconsistency suggests that there is critical role of the environment – 
including gene-environment interactions – in shaping obesity risk. 
 
 2 
Public health significance 
As the rates of both childhood and adult obesity continue to increase across the world, 
researchers have struggled to identify precise biological mechanisms that explain obesity’s rapid 
rise. The primary goal of this research effort is to identify targets of therapeutic intervention that 
will either help reverse the rise in obesity or help mitigate the associated negative health impacts 
of obesity. Right now, therapeutic interventions are able to treat obesity’s negative health 
outcomes, but have not successfully prevented the rising tide of obesity. As such, investigations 
into the causes of obesity, as well as associated negative health effects, remain necessary. 
Mounting scientific evidence supports the developmental origins of health and disease (DOHaD) 
hypothesis, which posits that early-life exposures to environmental factors are linked to the 
development of disease later in life (Bateson et al. 2004; Heindel et al. 2015). One of the main 
biological mechanisms thought to regulate this process is the epigenome, which can be defined 
as mitotically heritable, physical changes to the genome that are unrelated to the dinucleotide 
sequence. The goal of this dissertation is to determine whether gene-environment interactions, as 
reflected by exposure-mediated epigenetic changes, are related to the obesity phenotype. Since 
epigenetic changes are reversible, they represent potential therapeutic targets in treating obesity, 
and could represent a new avenue to mitigate this growing public health problem.   
 
Developmental origins of health and disease 
In the early 1990s, British epidemiologist David Barker proposed a new hypothesis – that 
the intrauterine environment plays a causal role in the development of adult disease (Barker 
1995; Barker et al. 1990). This idea, which went on to be known as the Barker hypothesis, 
focused on the link between fetal undernutrition and offspring cardiovascular disease risk, 
thereby introducing the idea of prenatal biological programming. In recent years, this 
 3 
programming paradigm was expanded beyond fetal nutrition to include developmental chemical 
exposures, giving birth to the Developmental Origins of Health and Disease (DOHaD) 
hypothesis (Heindel et al. 2015). This hypothesis states that exposure to nutritional and 
environmental factors during prenatal and early postnatal periods alters susceptibility to chronic 
diseases, including obesity, by influencing developmental plasticity (Bateson et al. 2004; Heindel 
et al. 2015). Given its importance in chronic disease development, DOHaD has become a 
valuable conceptual framework for investigating the effects of environmental factors on disease 
outcomes. 
1.2 Epigenetics 
As support for DOHaD accumulates, it has been shown that developmental exposure to 
environmental factors can alter gene regulation and subsequent phenotype through changes in the 
epigenome (Waterland and Jirtle 2004; Waterland and Michels 2007). Epigenetics refers to the 
study of mitotically heritable and potentially reversible changes in gene expression unrelated to 
the DNA sequence. Epigenetic marks include chromatin remodeling modifications (e.g. histone 
tail trimethylation), non-coding RNA, and alterations to DNA itself (e.g. DNA methylation, 
DNA hydroxymethylation) (Bernal and Jirtle 2010; Egger et al. 2004). DNA methylation is a 
well-characterized epigenetic control mechanism, and is typically defined as the addition of a 
methyl group to the 5’-carbon of cytosine in a Cytosine-phospho-Guanine (CpG) dinucleotide – 
5-methylcytosine (5-mC). In general, DNA methylation is associated with decreased 
transcription factor binding at promoter/enhancer sites, as well as decreased gene transcription 
(Medvedeva et al. 2014). Previous work has documented distinct waves of demethylation and de 
novo methylation that occur during fetal development (Reik et al. 2001; Smallwood and Kelsey 
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2012), as well as evidence that these waves of epigenetic reprogramming help regulate 
primordial germ cell proliferation and differentiation (Messerschmidt et al. 2014).  
While epigenetic reprogramming events are typically tightly regulated, 5-mC levels have 
also been shown to change in response to environmental exposures during early development 
(Anderson et al. 2012; Bernal and Jirtle 2010; Manikkam et al. 2013), adolescence (Essex et al. 
2013), and even adulthood (Tellez-Plaza et al. 2014; Wright et al. 2010). Specifically, animal 
studies have shown that offspring DNA methylation is associated with developmental exposure 
to a variety of environmental factors, including lead (Pb) (Dosunmu et al. 2012), altered diet 
(Marco et al. 2014; Vucetic et al. 2010), vinclozolin (Guerrero-Bosagna et al. 2012), arsenic 
(Reichard and Puga 2010), bisphenol A (BPA) (Kim et al. 2014), trichloroethylene (TCE) 
(Gilbert et al. 2012), ethanol (EtOH)((Kaminen-Ahola et al. 2010; Laufer et al. 2013; Marjonen 
et al. 2015), diesel exhaust (DE) (Tachibana et al. 2015), and stress (Dong et al. 2015). While 
this dissertation focuses mainly on DNA methylation, there is also evidence that environmental 
factors may influence other epigenetic modifications including posttranslational histone tail 
modifications (Arita et al. 2012), overall chromatin state (Schick et al. 2015; Veazey et al. 2015), 
and DNA hydroxymethylation (Tammen et al. 2014). As a result, direct measurements of 
epigenetic marks like chromatin structure and DNA methylation have become hallmark tools in 
investigating gene-environment interactions. 
1.3 Age-Related Methylation and Epigenetic Drift: Two Types of Change over the 
Life Course 
While environmental health sciences studies have focused on the association between 
toxicological factors and the epigenome in cross-sectional studies and in utero exposure models, 
a number of molecular epidemiology and genomics studies have evaluated DNA methylation 
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status as a function of age in humans and animal models. The aging epigenome was first 
described thirty years ago, when early investigations showed that levels of CpG methylation in 
human fibroblast cells and pooled mouse tissues were inversely related to lifespan (Fairweather 
et al. 1987; Wilson et al. 1987). More recently, a large number of studies have demonstrated age-
dependent changes in DNA methylation, including twin studies (Fraga et al. 2005; Martino et al. 
2013), human cohort studies (Alisch et al. 2012; Heyn et al. 2012; Madrigano et al. 2012; 
Urdinguio et al. 2016; Wang et al. 2012), and animal model studies (Maegawa et al. 2014; Spiers 
et al. 2016). Among the classically defined epigenetic marks, DNA methylation is most often 
investigated in epigenetic aging studies because of its stability and the availability of high 
throughput quantification methods. Studies investigating the aging epigenome show some 
consistent patterns, including locus-specific increases in DNA methylation with age 
(Teschendorff et al. 2013), global decreases in DNA methylation with age (Issa 2014; 
Teschendorff et al. 2013), and bidirectional changes in DNA methylation variability over time 
(Jones et al. 2015; Shah et al. 2014). To describe the epigenomic changes that occur in 
conjunction with chronological age, the literature has settled on two terms – age-related 
methylation and epigenetic drift (Issa 2014; Jung and Pfeifer 2015).   
Age-related methylation is traditionally defined as predictable, direction-specific changes 
in DNA methylation levels that occur with normal aging (Jung and Pfeifer 2015). This concept is 
closely linked to the “epigenetic clock” proposed by Horvath et al. in 2013, which showed that 
biological age could be reliably predicted from DNA methylation levels at specific CpG sites 
across the genome (Horvath 2013). Results from the literature demonstrate that age-related 
methylation occurs both at specific gene regions (Jung and Pfeifer 2015) and on an epigenome-
wide scale (Heyn et al. 2012). Additionally, a recent review of the aging epigenome noted that 
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the directionality of age-related methylation – hypomethylation or hypermethylation – varies by 
gene region (Jones et al. 2015). Considered together, these results suggest that age-related 
methylation is a complex process that can vary by genomic context. Further supporting this idea, 
age-related methylation has been shown to vary by tissue type. Day et al. looked at methylation 
array data from four different human tissue types – blood, kidney, brain, and skeletal muscle – 
and found both tissue-independent and tissue-dependent methylation changes associated with age 
(Day et al. 2013).  These data indicate that age-related methylation is non-random, and may be 
biologically meaningful.  
In contrast to age-related methylation, epigenetic drift refers to stochastic, bidirectional 
changes in epigenetic (e.g. DNA methylation) variability with age (Jones et al. 2015). These 
changes, which may alter methylome plasticity, are thought to be a result of methylation 
maintenance failure during cellular replication (Fraga et al. 2005; Teschendorff et al. 2013). 
Unlike age-related methylation, epigenetic drift is not a predictable process; instead, it can be 
conceptualized as the direct result of random inefficiencies in biological machinery that occur 
with age (Jones et al. 2015; Shah et al. 2014).  As such, epigenetic drift is not expected to be 
consistent across individuals within a population, and cannot be used to predict age. 
Nevertheless, this concept is critical for describing the epigenetic discordance that arises in 
monozygotic twins as they age (Fraga et al. 2005), and can also help explain results from cross-
sectional studies that show increased epigenetic variability with advanced age (Talens et al. 
2012). Baseline levels of epigenetic drift are expected to occur regardless of specific 
environmental exposures, providing a background rate of increased variability that occurs in 
tandem with site-specific age-related methylation changes. Supporting this idea, a recent study 
found an interaction between epigenetic drift and age-related methylation at specific “epigenetic 
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clock” CpG sites, showing an increased effect of environmental or stochastic influences with 
increasing age (van Dongen et al. 2016). This suggests that the relative contribution of epigenetic 
drift to the aging epigenome (i.e. longitudinal DNA methylation) varies across the lifecourse. 
1.4 Bisphenol A 
Bisphenol A (BPA) is a commercial monomer used in the production of polycarbonate 
plastic and epoxy resins that is found in a variety of consumer products (e.g. metal can linings, 
receipt paper, etc.). As a result of its presence in common products, BPA has near ubiquitous 
human exposure across the world (Calafat et al. 2008). BPA is a known endocrine disruptor that 
can activate a variety of growth-related transcription factors, and has been shown to bind 
effectively to several nuclear receptors involved in cell maturation (Krüger et al. 2008; Singh and 
Li 2012; Sui et al. 2012). In addition, BPA exposure has been shown to affect methylation levels 
across the epigenome (Manikkam et al. 2013; Singh and Li 2012; Wolstenholme et al. 2011; 
Zhang et al. 2012), and in utero doses of BPA in mouse models have been shown to affect both 
global and gene promoter-specific methylation (Anderson et al. 2012; Singh and Li 2012; 
Susiarjo et al. 2013). Combined, these results indicate that BPA exposure could alter regulation 
of gene expression during development, thereby modifying risk for negative health outcomes. 
The effects of BPA exposure on epigenetic aging have not been previously studied, but based on 
BPA’s documented ability to alter the epigenome, we hypothesized that prenatal BPA exposure 
would alter rates of age-related methylation.  
1.5 Western High-Fat Diet 
Western High-Fat Diet (WHFD) is characterized by high saturated and omega-6 
polyunsaturated fatty acids, reduced omega-3 fatty acid intake, and increased salt and refined 
sugar intake (Myles 2014). The adoption of the modern Western diet has been implicated in the 
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rising levels of obesity, diabetes, and immunologic disorders seen in Western countries across 
the world (Hariharan et al. 2015; Myles 2014). Recent studies in mice indicate that Western diet 
is associated with short-term increases in oxidative stress and adiposity, and a gradual increase in 
body fat mass across generations (Heinonen et al. 2014; Massiera et al. 2010). Additional rodent 
studies indicate that high-fat-diet-induced obesity is associated with altered promoter DNA 
methylation at genes related to metabolism, including leptin (Lep) and peroxisome proliferator-
activated receptor-α (Ppara) (Ge et al. 2014; Milagro et al. 2009). Genome-wide epigenome 
studies have also found obesity- and nutrient-sensitive CpG sites throughout the epigenome, 
suggesting that adiposity or an altered diet can affect specific gene regulation (Parle-McDermott 
and Ozaki 2011; Xu et al. 2013). Based on these results, it is clear that diet represents an 
important modifier of DNA methylation, and that it has the potential to affect the epigenome 
throughout the life course. 
1.6 Physical Activity and DNA methylation 
The physiological benefits of physical activity, which has been shown to alter gene 
expression levels (Huang et al. 2010; Lesniewski et al. 2013; Lindholm et al. 2014), are well-
documented, but the precise mechanism controlling activity-induced changes in gene expression 
remains relatively elusive. Investigating this idea, several recent studies have shown that physical 
activity is associated with changes in the epigenome, including gene-specific DNA methylation 
(Barrès et al. 2012; Rönn et al. 2013). One such study demonstrated that acute physical exertion 
is associated with decreases in DNA methylation at promoters of skeletal muscle gene promoters 
(Barrès et al. 2012). A second recent study demonstrated that long-term endurance training, as 
opposed to short-term physical activity, is associated with significant changes in DNA 
methylation at enhancer regions across the genome (Lindholm et al. 2014), suggesting that long-
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term physical activity may alter gene regulation via the epigenome. Supporting this idea, a third 
recent study showed that maternal exercise prevents high-fat-diet-induced hypermethylation at 
the promoter of peroxisome proliferator-activated receptor γ coactivator-1α (Pgc-1α), a master 
regulator of metabolism (Laker et al. 2014). While it remains unclear how much physical activity 
is needed to establish these epigenetic effects, it is clear that both acute and long-term physical 
activity can affect the methylome. As such, physical activity could also be an important modifier 
of the aging epigenome. 
1.7 Environmental Deflection of the Aging Epigenome 
Of particular interest to the field of toxicology, recent reports indicate that environmental 
exposure to exogenous environmental factors (e.g. lead (Pb), altered diet) can alter the rate of 
either age-related methylation (Faulk et al. 2014) or epigenetic drift (Gilbert et al. 2016). These 
results indicate that an interaction between age and exposure exists, and that investigations into 
the effects of environmental exposure on DNA methylation should not be limited to cross-
sectional analyses. However, while these papers discuss a role of the environment in establishing 
rates of “epigenetic drift” and/or “age-related methylation,” they do not provide a specific 
mechanism by which the environment could shape the aging epigenome.      
In an effort to improve clarity and interpretation of epigenetic studies in both animal 
models and human cohorts, we introduced a new term for this mechanism – environmental 
deflection – that refers to an environment- or toxicant-mediated shift away from the baseline rate 
of age-related methylation or epigenetic drift within an organism (Kochmanski et al. 2017). By 
altering longitudinal patterns of epigenetic marks, environmental deflection may facilitate long-
term changes in gene regulation via specific environmental exposures, showing the greatest 
effects during sensitive periods of growth and development. As such, environmental deflection 
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may underlie the apparent delay between developmental exposure and biological effects later in 
life. This type of long-lived, toxicant-sensitive epigenetic mechanism may also help to explain 
the growing prevalence of chronic diseases in human populations, demonstrating that 
longitudinal measures of the epigenome should be considered when designing future 
toxicoepigenetic and epigenetic epidemiological studies.  
Evidence for environmental deflection  
As a byproduct of their identical genetic background, monozygotic twin pairs are ideal 
for investigating the role the environment plays in shaping the aging epigenome while 
controlling for genetic effects. In 2005, a landmark paper by Fraga et al. demonstrated 
divergence of DNA methylation status with age in separate identical twin populations (Fraga et 
al. 2005). While this study was not longitudinal, the results suggest that environment and 
lifestyle, not simply genetics, could be driving age-associated changes in human methylation 
status. Supporting this idea, a more recent report demonstrated that newborn monozygotic (MZ) 
twins exhibit distinct patterns of inter-individual DNA methylation variation, indicating that the 
environment plays a role in determining the neonatal methylome (Ollikainen et al. 2010). 
Building off these data, another paper found locus-specific increases in within-twin pair 
methylation discordance across the adult life course (18-49 years old), a pattern that was 
attributable to the individual’s unique environment at most investigated loci (Talens et al. 2012). 
Extending twin studies to an epigenome-wide scale, several newer studies have shown region-
specific hypermethylation with age in adult MZ twins (Bell et al. 2012), high levels of within-
pair DNA methylation variability in adolescent twins (Lévesque et al. 2014), and significant 
interaction between environmental effects and age at 32,234 CpG sites across the epigenome 
(van Dongen et al. 2016). Combined, the epigenome-wide twin studies support the idea that the 
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environment plays an integral role in shaping the epigenome throughout human aging. However, 
by their very nature, twin studies are not able to tease apart the separate effects of environmental 
factors on epigenetic drift and age-related methylation, and do not examine interactions between 
specific exposures and the aging epigenome.  
Supplementing the available twin studies, a handful of recent non-twin human cohort 
studies have examined environmental deflection of epigenetic drift or age-related methylation by 
toxicants and other lifestyle factors. Building off the smaller scale methylation array and global 
methylation results noted previously, a recent publication using the Illumina 450K BeadChip 
showed that smoking-associated CpG probes exhibit diminished epigenetic drift, suggesting an 
environmental deflection of the drift rate by smoking status (Shah et al. 2014). Additionally, 
another recent publication showed that increased body mass index (BMI) is associated with 
accelerated age-related methylation at 353 CpG sites in human liver samples, suggesting that 
nutritionally-induced oxidative stress and metabolic alterations may deflect the rate of age-
related methylation (Horvath et al. 2014). These results indicate that environmental deflection of 
both epigenetic drift and age-related methylation may occur on an epigenome-wide scale in 
human populations. 
A small number of recent animal model studies have investigated the effects of 
environmental exposures on epigenetic aging. One such study found that perinatal lead (Pb) 
exposure alters the rate of age-related methylation in the promoter of a murine imprinted gene, 
Igf2r, as well as a metastable epiallele, CabpIAP (Faulk et al. 2014).  Similarly, examining 
epigenetic drift, a second study in mice found a trichloroethylene-dependent increase in naïve 
CD4+ T cell methylation variance at several gene regions, indicating that epigenetic drift can be 
shifted away from baseline by a chemical exposure (Gilbert et al. 2016). Together, these prior 
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animal studies provide direct, exposure-specific evidence for environmental deflection of both 
age-related methylation and epigenetic drift.  
Conceptual model for environmental deflection 
In an effort to establish a clear conceptual framework for environmental deflection, we 
have utilized a visual bow and arrow metaphor that takes into account exposure timing and age-
related methylation (Figure 1-1). Time zero in our model represents the period of initial 
developmental epigenetic programming, the flight of the arrow represents the rate of age-related 
methylation, and deviations in the flight path represent environmental deflection. Figure 1-1A 
demonstrates how epigenetic status at a specific locus or global marker can change with age or 
be deflected by an environmental exposure away from age-related hyper- or hypomethylation. 
Respectively, these endpoints can be conceptualized as the arrow striking its target and the arrow 
missing the target by a significant amount. Meanwhile, Figure 1-1B shows environmental 
deflection of epigenetic drift for a population, with the yellow shaded area representing the 
normal range of DNA methylation variability for the population.  If a subset of the population 
(dotted circle) is exposed to specific toxicant exposures (vertical dotted arrows) during specific 
developmental time periods (vertical dotted arrows), the trajectory over time at labile genes 
could be deflected outside the normal range of variation, depicted by the dotted lines. When 
firing a real-life arrow, the greatest opportunity to affect the arrow’s flight occurs at release. 
Assuming environmental deflection works in a similar way – as suggested by developmental 
plasticity theory (Wells 2014) – the greatest opportunity to affect the normal trajectory of age-
related methylation and/or epigenetic drift (i.e. the arrow’s flight) is early in life (i.e. the release 
point). However, much like wind or another outside force can alter the path of an arrow after 
release, environmental deflection can also occur at other points throughout an organism’s life 
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course (Figure 1-1B). To test this conceptual model in real populations, longitudinal studies with 
adequate early life exposure data and repeated epigenetic assessments are recommended to 
identify epigenetic loci with deflected methylation measurements.  
1.8 DNA Hydroxymethylation 
While much of the available DNA methylation research has focused on 5-mC, recent 
studies have begun to investigate an oxidized form of the molecule, 5-hydroxymethylcytosine (5-
hmC). Previous work in mice and humans have demonstrated low, tissue-specific 5-hmC content 
that is highest in the brain, but also present in the liver, testes, placenta, colon, and blood, albeit 
in progressively lower levels (Nestor et al. 2012). While many studies have focused on the role 
of 5-hmC in DNA demethylation pathways (Ito et al. 2011; Shen and Zhang 2013), other 
genome-wide studies in humans and mice have shown that 5-hmC is enriched in gene bodies and 
enhancer regions, suggesting a role in transcriptional control (Johnson et al. 2016; Stroud et al. 
2011; Wu et al. 2011). Supporting this idea, additional work has shown that 5-hmC is recognized 
by a unique binding protein (Mbd3) (Yildirim et al. 2011), that 5-hmC may be maintained across 
DNA replication via a complex of the DNMT1, Tet, and UHRF1 proteins (Shen and Zhang 
2013), and that 5-hmC is enriched at imprinted loci in human tissues (Hernandez Mora et al. 
2017).  Based on the growing evidence that 5-hmC is a stable epigenetic mark with a unique 
function, a recent review of the literature concluded that 5-hmC is likely to play an important 
role in aging and age-related diseases (López et al. 2017). However, due to a lack of studies 
investigating the role of 5-hmC during normal aging, evidence to support this hypothesis remains 
scarce. In this dissertation, we tested whether 5-hmC contributes to the aging epigenome through 
direct, longitudinal measurements of epigenome-wide 5-hmC levels in murine blood samples. 
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1.9 Project Overview 
This project uses several environmental factors – chemical, diet, and physical activity – 
as tools to study the underlying mechanisms of epigenetic aging. The overarching hypotheses for 
this dissertation are as follows: 1. Developmental exposure to bisphenol A (BPA) will result 
in altered epigenetic aging, as measured by longitudinal DNA methylation and 
hydroxymethylation levels in multiple tissues; 2. The rate of epigenetic aging will be 
mitigated by beneficial environmental cues like exercise and exacerbated by the Western 
high-fat diet. To test these central hypotheses, Aim 1 of this project combines an animal model 
exposure study with target gene pyrosequencing to investigate the effects of developmental BPA 
exposure, WHFD, and physical activity on age-related methylation. Aim 2 uses next-generation 
sequencing techniques to examine the effects of BPA exposure on longitudinal epigenome-wide 
5-mC and 5-hmC levels from the same developmentally exposed mice. Finally, Aim 3 uses 
neonatal bloodspots and childhood blood samples to investigate age-related methylation in a 
childhood obesity cohort. By combining mouse and human data, this dissertation aims to shed 
light on the contribution of life-course epigenetics to development of the obese phenotype 
(Figure 1-2). 
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1.10 Figures and Tables 
 
Figure 1-1: Conceptual framework for environmental deflection of the aging epigenome. A) 
Environmental deflection of age-related methylation for an individual; deflection is represented 
by the altered flight of an arrow fired at a target. The gradient bar on the right shows how 
epigenetic status at a specific locus or global marker can change with age or be deflected by an 
environmental exposure away from age-related hyper- or hypomethylation. Respectively, these 
endpoints can be conceptualized as the arrow striking its target and the arrow missing the target 
by a significant amount.  B) Environmental deflection of epigenetic drift for a population; the 
vertical arrows represent specific exposures that may affect drift trajectory throughout life.  The 
yellow shaded area is the normal range of DNA methylation variability at a given time point for 
the population.  If a subset of the population (dotted circle) is exposed to a toxicant during the 
early developmental time period (large vertical dotted arrow), the epigenetic drift trajectory at 
labile genes could be deflected outside the normal range of variation, depicted by the dotted line. 
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Figure 1-2: A conceptual model summarizing the dissertation hypotheses. Questions from 
the three aims work together to examine the effects of environmental factors on epigenetic aging 
and obesity. The hypotheses of each aim are indicated by colors (Aim 1 = red, Aim 2 = purple, 
Aim 3 = blue) and numbers. Variables that were considered in statistical modeling are indicated 
within the boxes. 
 
  
 17 
1.11 References 
Alisch RS, Barwick BG, Chopra P, Myrick LK, Satten GA, Conneely KN, et al. 2012. Age-
associated DNA methylation in pediatric populations. Genome Res 22:623–632; 
doi:10.1101/gr.125187.111. 
 
Anderson OS, Nahar MS, Faulk C, Jones TR, Liao C, Kannan K, et al. 2012. Epigenetic 
responses following maternal dietary exposure to physiologically relevant levels of 
bisphenol A. Environ. Mol. Mutagen. 53:334–342; doi:10.1002/em.21692. 
 
Arita A, Shamy MY, Chervona Y, Clancy HA, Sun H, Hall MN, et al. 2012. The effect of 
exposure to carcinogenic metals on histone tail modifications and gene expression in human 
subjects. J Trace Elem Med Biol 26:174–178; doi:10.1016/j.jtemb.2012.03.012. 
 
Barker DJ. 1995. The fetal and infant origins of disease. Eur. J. Clin. Invest. 25: 457–63. 
 
Barker DJ, Bull AR, Osmond C, Simmonds SJ. 1990. Fetal and placental size and risk of 
hypertension in adult life. BMJ 301: 259–62. 
 
Barrès R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, et al. 2012. Acute exercise 
remodels promoter methylation in human skeletal muscle. Cell Metab 15:405–411; 
doi:10.1016/j.cmet.2012.01.001. 
 
Bateson P, Barker D, Clutton-Brock T, Deb D, D’Udine B, Foley RA, et al. 2004. 
Developmental plasticity and human health. Nature 430:419–421; doi:10.1038/nature02725. 
 
Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D, et al. 2012. Epigenome-wide scans 
identify differentially methylated regions for age and age-related phenotypes in a healthy 
ageing population. PLoS Genet 8:e1002629; doi:10.1371/journal.pgen.1002629. 
 
Bernal AJ, Jirtle RL. 2010. Epigenomic disruption: the effects of early developmental exposures. 
Birth Defects Res A Clin Mol Teratol 88:938–944; doi:10.1002/bdra.20685. 
 
Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008. Exposure of the U.S. population to 
bisphenol A and 4-tertiary-octylphenol: 2003-2004. Env. Heal. Perspect 116:39–44; 
doi:10.1289/ehp.10753. 
 
Day K, Waite LL, Thalacker-Mercer A, West A, Bamman MM, Brooks JD, et al. 2013. 
Differential DNA methylation with age displays both common and dynamic features across 
human tissues that are influenced by CpG landscape. Genome Biol 14:R102; 
doi:10.1186/gb-2013-14-9-r102. 
 
Dixon JB. 2010. The effect of obesity on health outcomes. Mol. Cell. Endocrinol. 316:104–108; 
doi:10.1016/j.mce.2009.07.008. 
 
Dong E, Dzitoyeva SG, Matrisciano F, Tueting P, Grayson DR, Guidotti A. 2015. Brain-derived 
 18 
neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype 
induced by prenatal stress in mice. Biol Psychiatry 77:589–596; 
doi:10.1016/j.biopsych.2014.08.012. 
 
Dosunmu R, Alashwal H, Zawia NH. 2012. Genome-wide expression and methylation profiling 
in the aged rodent brain due to early-life Pb exposure and its relevance to aging. Mech 
Ageing Dev 133:435–443; doi:10.1016/j.mad.2012.05.003. 
 
Egger G, Liang G, Aparicio A, Jones PA. 2004. Epigenetics in human disease and prospects for 
epigenetic therapy. Nature 429:457–463; doi:10.1038/nature02625. 
 
Essex MJ, Boyce WT, Hertzman C, Lam LL, Armstrong JM, Neumann SM, et al. 2013. 
Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA 
methylation in adolescence. Child Dev 84:58–75; doi:10.1111/j.1467-8624.2011.01641.x. 
 
Fairweather DS, Fox M, Margison GP. 1987. The in vitro lifespan of MRC-5 cells is shortened 
by 5-azacytidine-induced demethylation. Exp Cell Res 168: 153–159. 
 
Faulk C, Liu K, Barks A, Goodrich JM, Dolinoy DC. 2014. Longitudinal epigenetic drift in mice 
perinatally exposed to lead. Epigenetics 9:934–941; doi:10.4161/epi.29024. 
 
Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. 2005. Epigenetic 
differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 
102:10604–10609; doi:10.1073/pnas.0500398102. 
 
Ge ZJ, Luo SM, Lin F, Liang QX, Huang L, Wei YC, et al. 2014. DNA methylation in oocytes 
and liver of female mice and their offspring: effects of high-fat-diet-induced obesity. Env. 
Heal. Perspect 122:159–164; doi:10.1289/ehp.1307047. 
 
Gilbert KM, Blossom SJ, Erickson SW, Reisfeld B, Zurlinden TJ, Broadfoot B, et al. 2016. 
Chronic exposure to water pollutant trichloroethylene increased epigenetic drift in CD4(+) 
T cells. Epigenomics 8:633–649; doi:10.2217/epi-2015-0018. 
 
Gilbert KM, Nelson AR, Cooney CA, Reisfeld B, Blossom SJ. 2012. Epigenetic alterations may 
regulate temporary reversal of CD4(+) T cell activation caused by trichloroethylene 
exposure. Toxicol Sci 127:169–178; doi:10.1093/toxsci/kfs093. 
 
Guerrero-Bosagna C, Covert TR, Haque MM, Settles M, Nilsson EE, Anway MD, et al. 2012. 
Epigenetic transgenerational inheritance of vinclozolin induced mouse adult onset disease 
and associated sperm epigenome biomarkers. Reprod Toxicol 34:694–707; 
doi:10.1016/j.reprotox.2012.09.005. 
 
Hales CM, Carroll MD, Fryar CD, Ogden CL. 2017. Prevalence of Obesity Among Adults and 
Youth: United States, 2015–2016 Key findings Data from the National Health and Nutrition 
Examination Survey. NCHS Data Brief. 
 
 19 
Hariharan D, Vellanki K, Kramer H. 2015. The Western diet and chronic kidney disease. Curr 
Hypertens Rep 17:529; doi:10.1007/s11906-014-0529-6. 
 
Heindel JJ, Balbus J, Birnbaum L, Brune-Drisse MN, Grandjean P, Gray K, et al. 2015. 
Developmental Origins of Health and Disease: Integrating Environmental Influences. 
Endocrinology 156:3416–3421; doi:10.1210/EN.2015-1394. 
 
Heinonen I, Rinne P, Ruohonen ST, Ruohonen S, Ahotupa M, Savontaus E. 2014. The effects of 
equal caloric high fat and western diet on metabolic syndrome, oxidative stress and vascular 
endothelial function in mice. Acta Physiol 211:515–527; doi:10.1111/apha.12253. 
 
Hernandez Mora JR, Sanchez-Delgado M, Petazzi P, Moran S, Esteller M, Iglesias-Platas I, et al. 
2017. Profiling of oxBS-450K 5-hydroxymethylcytosine in human placenta and brain 
reveals enrichment at imprinted loci. Epigenetics 00–00; 
doi:10.1080/15592294.2017.1344803. 
 
Heyn H, Li N, Ferreira HJ, Moran S, Pisano DG, Gomez A, et al. 2012. Distinct DNA 
methylomes of newborns and centenarians. Proc Natl Acad Sci U S A 109:10522–10527; 
doi:10.1073/pnas.1120658109. 
 
Horvath S. 2013. DNA methylation age of human tissues and cell types. Genome Biol. 14:R115; 
doi:10.1186/gb-2013-14-10-r115. 
 
Horvath S, Erhart W, Brosch M, Ammerpohl O, von Schonfels W, Ahrens M, et al. 2014. 
Obesity accelerates epigenetic aging of human liver. Proc. Natl. Acad. Sci. 111:15538–
15543; doi:10.1073/pnas.1412759111. 
 
Huang P, Li S, Shao M, Qi Q, Zhao F, You J, et al. 2010. Calorie restriction and endurance 
exercise share potent anti-inflammatory function in adipose tissues in ameliorating diet-
induced obesity and insulin resistance in mice. Nutr Metab 7:59; doi:10.1186/1743-7075-7-
59. 
 
Issa JP. 2014. Aging and epigenetic drift: a vicious cycle. J Clin Invest 124:24–29; 
doi:10.1172/JCI69735. 
 
Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. 2011. Tet proteins can convert 5-
methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:1300–3; 
doi:10.1126/science.1210597. 
 
Johnson KC, Houseman EA, King JE, von Herrmann KM, Fadul CE, Christensen BC. 2016. 5-
Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in 
glioblastoma patients. Nat. Commun. 7:13177; doi:10.1038/ncomms13177. 
 
Jones MJ, Goodman SJ, Kobor MS. 2015. DNA methylation and healthy human aging. Aging 
Cell 14:924–932; doi:10.1111/acel.12349. 
 
 20 
Jung M, Pfeifer GP. 2015. Aging and DNA methylation. BMC Biol 13:7; doi:10.1186/s12915-
015-0118-4. 
 
Kaminen-Ahola N, Ahola A, Maga M, Mallitt KA, Fahey P, Cox TC, et al. 2010. Maternal 
ethanol consumption alters the epigenotype and the phenotype of offspring in a mouse 
model. PLoS Genet 6:e1000811; doi:10.1371/journal.pgen.1000811. 
 
Kim DD, Basu A. 2016. Estimating the Medical Care Costs of Obesity in the United States: 
Systematic Review, Meta-Analysis, and Empirical Analysis. Value Heal. 19:602–613; 
doi:10.1016/j.jval.2016.02.008. 
 
Kim JH, Sartor MA, Rozek LS, Faulk C, Anderson OS, Jones TR, et al. 2014. Perinatal 
bisphenol A exposure promotes dose-dependent alterations of the mouse methylome. BMC 
Genomics 15:30; doi:10.1186/1471-2164-15-30. 
 
Kochmanski J, Montrose L, Goodrich JM, Dolinoy DC. 2017. Environmental Deflection: The 
Impact of Toxicant Exposures on the Aging Epigenome. Toxicol. Sci. 156:kfx005; 
doi:10.1093/toxsci/kfx005. 
 
Krüger T, Long M, Bonefeld-Jørgensen EC. 2008. Plastic components affect the activation of the 
aryl hydrocarbon and the androgen receptor. Toxicology 246:112–123; 
doi:10.1016/j.tox.2007.12.028. 
 
Laker RC, Lillard TS, Okutsu M, Zhang M, Hoehn KL, Connelly JJ, et al. 2014. Exercise 
prevents maternal high-fat diet-induced hypermethylation of the Pgc-1α gene and age-
dependent metabolic dysfunction in the offspring. Diabetes 63:1605–1611; 
doi:10.2337/db13-1614. 
 
Laufer BI, Mantha K, Kleiber ML, Diehl EJ, Addison SM, Singh SM. 2013. Long-lasting 
alterations to DNA methylation and ncRNAs could underlie the effects of fetal alcohol 
exposure in mice. Dis Model Mech 6:977–992; doi:10.1242/dmm.010975. 
 
Lesniewski LA, Zigler ML, Durrant JR, Nowlan MJ, Folian BJ, Donato AJ, et al. 2013. Aging 
compounds western diet-associated large artery endothelial dysfunction in mice: prevention 
by voluntary aerobic exercise. Exp Gerontol 48:1218–1225; 
doi:10.1016/j.exger.2013.08.001. 
 
Lévesque ML, Casey KF, Szyf M, Ismaylova E, Ly V, Verner M-P, et al. 2014. Genome-wide 
DNA methylation variability in adolescent monozygotic twins followed since birth. 
Epigenetics 9:1410–21; doi:10.4161/15592294.2014.970060. 
 
Lindholm ME, Marabita F, Gomez-Cabrero D, Rundqvist H, Ekström TJ, Tegnér J, et al. 2014. 
An integrative analysis reveals coordinated reprogramming of the epigenome and the 
transcriptome in human skeletal muscle after training. Epigenetics 9:1557–1569; 
doi:10.4161/15592294.2014.982445. 
 
 21 
Loos RJF, Janssens ACJW. 2017. Predicting Polygenic Obesity Using Genetic Information. Cell 
Metab. 25:535–543; doi:10.1016/j.cmet.2017.02.013. 
 
López V, Fernández AF, Fraga MF. 2017. The role of 5-hydroxymethylcytosine in development, 
aging and age-related diseases. Ageing Res. Rev. 37:28–38; 
doi:10.1016/J.ARR.2017.05.002. 
 
Madrigano J, Baccarelli A, Mittleman MA, Sparrow D, Vokonas PS, Tarantini L, et al. 2012. 
Aging and epigenetics: longitudinal changes in gene-specific DNA methylation. Epigenetics 
7:63–70; doi:10.4161/epi.7.1.18749. 
 
Maegawa S, Gough SM, Watanabe-Okochi N, Lu Y, Zhang N, Castoro RJ, et al. 2014. Age-
related epigenetic drift in the pathogenesis of MDS and AML. Genome Res 24:580–591; 
doi:10.1101/gr.157529.113. 
 
Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner MK. 2013. Plastics derived endocrine 
disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of 
obesity, reproductive disease and sperm epimutations. PLoS One 8:e55387; 
doi:10.1371/journal.pone.0055387. 
 
Marco A, Kisliouk T, Tabachnik T, Meiri N, Weller A. 2014. Overweight and CpG methylation 
of the Pomc promoter in offspring of high-fat-diet-fed dams are not “reprogrammed” by 
regular chow diet in rats. FASEB J 28:4148–4157; doi:10.1096/fj.14-255620. 
 
Marjonen H, Sierra A, Nyman A, Rogojin V, Grӧhn O, Linden AM, et al. 2015. Early maternal 
alcohol consumption alters hippocampal DNA methylation, gene expression and volume in 
a mouse model. PLoS One 10:e0124931; doi:10.1371/journal.pone.0124931. 
 
Martino D, Loke YJ, Gordon L, Ollikainen M, Cruickshank MN, Saffery R, et al. 2013. 
Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months 
of age reveals rapid epigenetic change in early life and pair-specific effects of discordance. 
Genome Biol 14:R42; doi:10.1186/gb-2013-14-5-r42. 
 
Massiera F, Barbry P, Guesnet P, Joly A, Luquet S, Moreilhon-Brest C, et al. 2010. A Western-
like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. J 
Lipid Res 51:2352–2361; doi:10.1194/jlr.M006866. 
 
Medvedeva YA, Khamis AM, Kulakovskiy I V, Ba-Alawi W, Bhuyan MS, Kawaji H, et al. 
2014. Effects of cytosine methylation on transcription factor binding sites. BMC Genomics 
15:119; doi:10.1186/1471-2164-15-119. 
 
Messerschmidt DM, Knowles BB, Solter D. 2014. DNA methylation dynamics during epigenetic 
reprogramming in the germline and preimplantation embryos. Genes Dev 28:812–828; 
doi:10.1101/gad.234294.113. 
 
Milagro FI, Campión J, García-Díaz DF, Goyenechea E, Paternain L, Martínez JA. 2009. High 
 22 
fat diet-induced obesity modifies the methylation pattern of leptin promoter in rats. J 
Physiol Biochem 65: 1–9. 
 
Myles IA. 2014. Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J 
13:61; doi:10.1186/1475-2891-13-61. 
 
Nestor CE, Ottaviano R, Reddington J, Sproul D, Reinhardt D, Dunican D, et al. 2012. Tissue 
type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome 
Res. 22:467–77; doi:10.1101/gr.126417.111. 
 
Ollikainen M, Smith KR, Joo EJ, Ng HK, Andronikos R, Novakovic B, et al. 2010. DNA 
methylation analysis of multiple tissues from newborn twins reveals both genetic and 
intrauterine components to variation in the human neonatal epigenome. Hum Mol Genet 
19:4176–4188; doi:10.1093/hmg/ddq336. 
 
Parle-McDermott A, Ozaki M. 2011. The impact of nutrition on differential methylated regions 
of the genome. Adv Nutr 2:463–471; doi:10.3945/an.111.001008. 
 
Reichard JF, Puga A. 2010. Effects of arsenic exposure on DNA methylation and epigenetic 
gene regulation. Epigenomics 2:87–104; doi:10.2217/epi.09.45. 
 
Reik W, Dean W, Walter J. 2001. Epigenetic reprogramming in mammalian development. 
Science (80-. ). 293:1089–1093; doi:10.1126/science.1063443. 
 
Rönn T, Volkov P, Davegårdh C, Dayeh T, Hall E, Olsson AH, et al. 2013. A six months 
exercise intervention influences the genome-wide DNA methylation pattern in human 
adipose tissue. PLoS Genet 9:e1003572; doi:10.1371/journal.pgen.1003572. 
 
Schick S, Fournier D, Thakurela S, Sahu SK, Garding A, Tiwari VK. 2015. Dynamics of 
chromatin accessibility and epigenetic state in response to UV damage. J Cell Sci 
128:4380–4394; doi:10.1242/jcs.173633. 
 
Shah S, McRae AF, Marioni RE, Harris SE, Gibson J, Henders AK, et al. 2014. Genetic and 
environmental exposures constrain epigenetic drift over the human life course. Genome Res 
24:1725–1733; doi:10.1101/gr.176933.114. 
 
Shen L, Zhang Y. 2013. 5-Hydroxymethylcytosine: generation, fate, and genomic distribution. 
Curr. Opin. Cell Biol. 25:289–96; doi:10.1016/j.ceb.2013.02.017. 
 
Singh S, Li SS. 2012. Epigenetic effects of environmental chemicals bisphenol a and phthalates. 
Int J Mol Sci 13:10143–10153; doi:10.3390/ijms130810143. 
 
Smallwood SA, Kelsey G. 2012. De novo DNA methylation: a germ cell perspective. Trends 
Genet 28:33–42; doi:10.1016/j.tig.2011.09.004. 
 
Spiers H, Hannon E, Wells S, Williams B, Fernandes C, Mill J. 2016. Age-associated changes in 
 23 
DNA methylation across multiple tissues in an inbred mouse model. Mech Ageing Dev 
154:20–23; doi:10.1016/j.mad.2016.02.001. 
 
Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE. 2011. 5-Hydroxymethylcytosine is 
associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol 
12:R54; doi:10.1186/gb-2011-12-6-r54. 
 
Sui Y, Ai N, Park SH, Rios-Pilier J, Perkins JT, Welsh WJ, et al. 2012. Bisphenol A and its 
analogues activate human pregnane X receptor. Env. Heal. Perspect 120:399–405; 
doi:10.1289/ehp.1104426. 
 
Susiarjo M, Sasson I, Mesaros C, Bartolomei MS. 2013. Bisphenol A Exposure Disrupts 
Genomic Imprinting in the Mouse. G. Kelsey, ed PLoS Genet. 9:e1003401; 
doi:10.1371/journal.pgen.1003401. 
 
Tachibana K, Takayanagi K, Akimoto A, Ueda K, Shinkai Y, Umezawa M, et al. 2015. Prenatal 
diesel exhaust exposure disrupts the DNA methylation profile in the brain of mouse 
offspring. J Toxicol Sci 40:1–11; doi:10.2131/jts.40.1. 
 
Talens RP, Christensen K, Putter H, Willemsen G, Christiansen L, Kremer D, et al. 2012. 
Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on 
monozygotic twin pairs. Aging Cell 11:694–703; doi:10.1111/j.1474-9726.2012.00835.x. 
 
Tammen SA, Dolnikowski GG, Ausman LM, Liu Z, Kim KC, Friso S, et al. 2014. Aging alters 
hepatic DNA hydroxymethylation, as measured by liquid chromatography/mass 
spectrometry. J Cancer Prev 19:301–308; doi:10.15430/JCP.2014.19.2.301. 
 
Tellez-Plaza M, Tang WY, Shang Y, Umans JG, Francesconi KA, Goessler W, et al. 2014. 
Association of global DNA methylation and global DNA hydroxymethylation with metals 
and other exposures in human blood DNA samples. Env. Heal. Perspect 122:946–954; 
doi:10.1289/ehp.1306674. 
 
Teschendorff AE, West J, Beck S. 2013. Age-associated epigenetic drift: implications, and a case 
of epigenetic thrift? Hum Mol Genet 22:R7–R15; doi:10.1093/hmg/ddt375. 
 
Urdinguio RG, Torró MI, Bayón GF, Álvarez-Pitti J, Fernández AF, Redon P, et al. 2016. 
Longitudinal study of DNA methylation during the first 5 years of life. J. Transl. Med. 
14:160; doi:10.1186/s12967-016-0913-x. 
 
van Dongen J, Nivard MG, Willemsen G, Hottenga JJ, Helmer Q, Dolan C V, et al. 2016. 
Genetic and environmental influences interact with age and sex in shaping the human 
methylome. Nat Commun 7:11115; doi:10.1038/ncomms11115. 
 
Veazey KJ, Parnell SE, Miranda RC, Golding MC. 2015. Dose-dependent alcohol-induced 
alterations in chromatin structure persist beyond the window of exposure and correlate with 
fetal alcohol syndrome birth defects. Epigenetics Chromatin 8:39; doi:10.1186/s13072-015-
 24 
0031-7. 
 
Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM. 2010. Maternal high-fat diet alters 
methylation and gene expression of dopamine and opioid-related genes. Endocrinology 
151:4756–4764; doi:10.1210/en.2010-0505. 
 
Wang D, Liu X, Zhou Y, Xie H, Hong X, Tsai HJ, et al. 2012. Individual variation and 
longitudinal pattern of genome-wide DNA methylation from birth to the first two years of 
life. Epigenetics 7:594–605; doi:10.4161/epi.20117. 
 
Waterland RA, Jirtle RL. 2004. Early nutrition, epigenetic changes at transposons and imprinted 
genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20: 63–68. 
 
Waterland RA, Michels KB. 2007. Epigenetic epidemiology of the developmental origins 
hypothesis. Annu Rev Nutr 27:363–388; doi:10.1146/annurev.nutr.27.061406.093705. 
 
Wells JC. 2014. Adaptive variability in the duration of critical windows of plasticity: 
Implications for the programming of obesity. Evol Med Public Heal. 2014:109–121; 
doi:10.1093/emph/eou019. 
 
Wilson VL, Smith RA, Ma S, Cutler RG. 1987. Genomic 5-methyldeoxycytidine decreases with 
age. J Biol Chem 262: 9948–9951. 
 
Wolstenholme JT, Rissman EF, Connelly JJ. 2011. The role of Bisphenol A in shaping the brain, 
epigenome and behavior. Horm Behav 59:296–305; doi:10.1016/j.yhbeh.2010.10.001. 
 
Wright RO, Schwartz J, Wright RJ, Bollati V, Tarantini L, Park SK, et al. 2010. Biomarkers of 
lead exposure and DNA methylation within retrotransposons. Env. Heal. Perspect 118:790–
795; doi:10.1289/ehp.0901429. 
 
Wu H, D’Alessio AC, Ito S, Wang Z, Cui K, Zhao K, et al. 2011. Genome-wide analysis of 5-
hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in 
mouse embryonic stem cells. Genes Dev 25:679–684; doi:10.1101/gad.2036011. 
 
Xu X, Su S, Barnes VA, De Miguel C, Pollock J, Ownby D, et al. 2013. A genome-wide 
methylation study on obesity. Epigenetics 8:522–533; doi:10.4161/epi.24506. 
 
Yildirim O, Li R, Hung J-H, Chen PB, Dong X, Ee L-S, et al. 2011. Mbd3/NURD Complex 
Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem 
Cells. Cell 147:1498–1510; doi:10.1016/j.cell.2011.11.054. 
 
Zhang XF, Zhang LJ, Feng YN, Chen B, Feng YM, Liang GJ, et al. 2012. Bisphenol A exposure 
modifies DNA methylation of imprint genes in mouse fetal germ cells. Mol Biol Rep 
39:8621–8628; doi:10.1007/s11033-012-1716-7. 
 25 
Chapter 2 
Longitudinal Effects of Developmental Bisphenol A, Variable Diet, and 
Physical Activity on Age-related Methylation in Mice 
 
Abstract 
Environmental factors, including exogenous exposures and nutritional status, can affect DNA 
methylation across the epigenome, but effects of exposures on the aging epigenome remain 
unclear. Here, we tested the hypothesis that early-life exposure to bisphenol A (BPA), variable 
diet, and/or changes in physical activity result in altered age-related methylation, as measured 
longitudinally via target loci methylation in matched mouse tail (PND21, 10 months) and blood 
(2 months, 4 months, 10 months) samples. DNA methylation was quantified at two repetitive 
elements (LINE-1, IAP), two imprinted genes (Igf2, H19), and one non-imprinted gene (Esr1) in 
isogenic a/a Agouti mice developmentally exposed to Control, Control+BPA (50 µg/kg diet), 
Mediterranean high-fat diet (MHFD), Western high-fat diet (WHFD), Mediterranean+BPA, or 
Western+BPA diets. With age, tail tissue DNA methylation levels significantly (p<0.05) 
decreased at LINE-1, IAP, and H19, and significantly increased at Esr1. In blood, Esr1 DNA 
methylation increased significantly with age, but no other investigated loci showed significant 
age-related methylation. In the tail tissue, Igf2 demonstrated WHFD-specific changes in early-
life methylation (p=0.027), and IAP showed marginal negative environmental deflection in the 
Western (p=0.058) and Western+BPA (p=0.051) exposure groups. In blood, Esr1 showed 
significant negative environmental deflection by WHFD exposure in females (p=0.02). Physical 
activity, while not significant, showed an opposite, positive effect on age-related Esr1 
methylation in female blood, suggesting that it may abrogate the effects of WHFD on the aging 
epigenome. Overall, we demonstrated significant age-related DNA methylation in two matched 
mouse tissues, as well as significant effects of developmental nutritional exposures on age-
related methylation patterns. 
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2.1 Introduction 
The epigenome is a dynamic regulatory framework that utilizes epigenetic information to 
govern the response of cells, tissues, and entire organisms to environmental stressors. Epigenetic 
control mechanisms operate at several levels, including alterations to DNA itself (e.g. DNA 
methylation), chromatin remodeling (e.g. histone modifications), and non-coding RNA 
interactions (Bernal and Jirtle 2010; Egger et al. 2004).
 
DNA methylation, which is perhaps the 
best-studied epigenetic mark, is defined by the addition of a methyl group to the 5’-carbon of 
cytosine in a cytosine-phospho-guanine (CpG) dinucleotide. Recent evidence indicates that DNA 
methylation status changes as a function of age in both humans and animal models, and that this 
change is often gene- or tissue-specific (Florath et al. 2014; Issa 2014; Madrigano et al. 2012; 
Teschendorff et al. 2013). This process of altered DNA methylation across the life-course is has 
important implications for gene expression and disease onset throughout the life course (Issa 
2014). While this process occurs across all individuals, twin studies have shown that genetically 
identical individuals can have vast divergence in their epigenetic marks as they age (Fraga et al. 
2005). These results suggest that unique environmental exposures throughout life, rather than 
any inherent genetic predisposition, may lead to a modulation in the rate of age-related DNA 
methylation.  
Mounting evidence indicates that exposure to environmental factors during key 
developmental windows may alter gene regulation and phenotype through changes in epigenetic 
marks (Waterland and Jirtle 2004). As such, the epigenome represents a possible mechanism 
underlying the Developmental Origins of Health and Disease (DOHaD) hypothesis, which states 
that exposure to nutritional and environmental factors during prenatal and early postnatal periods 
alters susceptibility to chronic diseases by influencing developmental plasticity (Bateson et al. 
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2004). In general, methylation of DNA at specific promoter/enhancer sites is associated with 
decreased transcription factor binding, as well as decreased transcription (Medvedeva et al. 
2014). However, gene-specific DNA methyl marks do not accurately predict global 5-
methylcytosine levels, which are driven by CpG methylation of non-coding, repetitive DNA 
elements, including transposons, retrotransposons, and endogenous retroviruses (Nelson et al. 
2011; Yang et al. 2004). In contrast to the transcriptional effects seen at gene 
promoters/enhancers, altered methylation of repetitive elements has the potential to affect genetic 
stability through increased movement of repetitive elements around the genome (Rodriguez et al. 
2006; Ross et al. 2010; Suzuki et al. 2006).
 
Based on the differential regulatory effects of site-
specific and global methylation levels, it is important to measure both when investigating the 
biological effects of epigenetic aging. Recent data also indicate that early life exposure to 
environmental toxicants has the potential to alter age-related global and gene-specific 
methylation (Christensen et al. 2009; Huen et al. 2014).
 
Supporting this idea, we recently 
demonstrated that developmental lead (Pb) exposure in congenic mice altered DNA methylation 
levels at imprinted genes, and that exposure was associated with alterations in the rate of 
epigenetic drift throughout the life-course (Faulk et al. 2014).  
Endocrine disrupting chemicals (EDCs) are an important class of environmental factors 
that have been linked to the developmental origins of adult disease (Newbold et al. 2009). One 
such chemical, bisphenol A (BPA), is a commercial monomer that makes up polycarbonate 
plastic and epoxy resins. BPA is found in a variety of consumer products (e.g. metal can linings, 
receipt paper, etc.), and has near ubiquitous and continuous human exposure across the world 
(Calafat et al. 2008). BPA can directly bind estrogen receptor α, has been shown to activate a 
variety of growth-related transcription factors, and can also bind effectively to several nuclear 
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receptors involved in cell maturation (Krüger et al. 2008; Singh and Li 2012; Sui et al. 2012; 
Watson et al. 2007).
 
BPA exposure has also been shown to affect DNA methylation levels across 
the epigenome (Manikkam et al. 2013; Singh and Li 2012; Wolstenholme et al. 2011; Zhang et 
al. 2012). In utero doses of BPA in mouse models affect both global and gene promoter-specific 
methylation, indicating that BPA exposure could alter gene expression during development 
(Anderson et al. 2012; Kim et al. 2014; Singh and Li 2012). The effects of BPA exposure on 
age-related methylation in matched samples have not been previously studied, but based on 
BPA’s ability to alter the developing epigenome, BPA exposure has the potential to alter 
epigenetic aging.  
In addition to chemical exposure, maternal diet can also affect offspring DNA 
methylation levels (Tobi et al. 2018; Waterland and Jirtle 2003).
 The modern “Western High-Fat 
Diet” (WHFD) is characterized by high saturated and omega-6 polyunsaturated fatty acids, 
reduced omega-3 fatty acid intake, and increased salt and refined sugar intake (Myles 2014). 
Studies in animal models have shown that alterations in maternal diet, specifically levels of 
methyl donors, can alter gene-specific and global methylation in offspring, indicating that diet 
can induce long-lasting, inter-generational changes in methylation (Dolinoy et al. 2007; 
Hollingsworth et al. 2008; Niculescu et al. 2006). Genome-wide studies of the methylome have 
also noted nutrient-sensitive CpG sites throughout the epigenome, indicating that alterations in 
diet can affect DNA methylation at specific genomic sites (Parle-McDermott and Ozaki 2011). 
Based on these results, maternal diet represents an important mediator of the epigenome that has 
the potential to affect offspring methylation throughout the life course. 
Despite increasing investigation of diet- and toxicant-induced epigenetic changes, the 
role of physical activity in modulating the epigenome has been less extensively studied. Physical 
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activity is a lifestyle factor with well-documented positive health effects; in mice, exercise 
training has been shown to increase energy expenditure, offsetting the weight-gain induced by 
HFD (Sasaki et al. 2014). Physical activity-related energy expenditure (AEE), a measure of 
physical activity’s contribution to metabolic rate, can be calculated in mice using calorimetry 
data (Hills et al. 2014; Pontzer et al. 2016; Van Klinken et al. 2012). In addition to affecting 
energy expenditure, exercise/physical activity has also shown associations with gene promoter-
specific DNA methylation in mice (Kanzleiter et al. 2015; King-Himmelreich et al. 2016; 
Nguyen et al. 2016), suggesting that physical activity may also offset the epigenetic effects of 
HFD. Providing support for this idea, a recent study in mice demonstrated that maternal exercise 
attenuated HFD-induced Pgc-1α promoter hypermethylation in skeletal muscle of offspring 
(Laker et al. 2014). As such, physical activity is a lifestyle factor that has the potential to not 
only alter the aging epigenome, but also mitigate the epigenetic effects of HFD exposure.  
To investigate the potential combined effects of BPA exposure, Western high-fat diet, 
and physical activity on the epigenome, DNA methylation was measured in murine target loci 
regions -- Long Interspersed Nuclear Element-1 (LINE-1) repeats, Intracisternal A-Particle (IAP) 
repeats, Insulin-like growth factor 2 (Igf2) differentially methylated region (DMR) 2 (Faulk et al. 
2014; Waterland et al. 2006), H19 DMR (Faulk et al. 2014; Stouder et al. 2009), and the 
promoter region of Estrogen receptor α (Esr1) (Maegawa et al. 2010). These target gene regions 
fall into three classes – repetitive elements (LINE-1, IAP), imprinted genes (Igf2, H19), and a 
non-imprinted protein-coding gene (Esr1). Target region classes were chosen based on their 
potential to reflect global methylation levels, their use as frequent biomarkers in environmental 
epigenetic studies, and their involvement in growth and metabolism, respectively. 
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Long interspersed nuclear element-1 (LINE-1) is the most common transposable element 
in the mouse genome, representing more than 20% of the murine sequence (Sookdeo et al. 2013). 
LINE-1 elements are ancient retrotransposons that replicated in the genome over evolutionary 
time. Although most LINE-1 elements are no longer active, they have widespread distribution 
across the genome, making LINE-1 methylation a useful approximation of “global” methylation 
levels (Nelson et al. 2011; Yang et al. 2004). Intracisternal A-Particle (IAP) retrotransposons are 
murine, long terminal repeat (LTR)-type genetic elements that also utilize RNA intermediates to 
retrotranspose around the genome (Horie et al. 2007). With the exception of metastable epialleles 
like the well-studied viable yellow (A
vy
) IAP element (Dolinoy et al. 2007), most IAPs are 
tightly regulated, and have lost their ability to retrotranspose (Horie et al. 2007).
 
However, 
evidence indicates that aging can cause demethylation of IAP promoters, potentially reactivating 
their retrotransposition competency (Barbot et al. 2002; Horie et al. 2007). The IAP assay in this 
study utilizes a conserved IAP sequence to measure methylation across all IAP retrotransposons 
present in the murine genome, thereby providing a second, but more genetically “active” 
approximation of global methylation.  
Along with repetitive elements, several imprinted and non-imprinted genes were also 
investigated. Imprinted genes display parent-of-origin differential methylation and mono-allelic 
expression (Sasaki et al. 2000). The imprinted genes included in this study, Igf2 and H19, 
contain differentially methylated regions (DMRs) that exhibit variability in methylation 
associated with exposure to diet and/or EDCs (Hoyo et al. 2011; LaRocca et al. 2014; Lee et al. 
2014; McKay et al. 2011; Susiarjo et al. 2013; Waterland et al. 2006), making them valuable 
biomarkers of exposure-induced changes in methylation. In addition to the imprinted genes, we 
also examined methylation levels at a non-imprinted protein-coding gene – Esr1. Estrogen 
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receptor α is a transcription factor activated by estrogenic ligands, and it mediates estrogen’s 
involvement in the regulation of growth and development (Bondesson et al. 2015). Evidence 
indicates that methylation of the Esr1 exon 2 promoter is positively associated with age in 
unmatched samples of murine small intestine (Maegawa et al. 2010). This fact, combined with 
Esr1’s biological importance throughout life, makes it an ideal non-imprinted candidate gene for 
assessing the effects of developmental exposure on epigenetic aging.   
The described study examines longitudinal changes in absolute mean DNA methylation 
from paired postnatal day 21 (PND21) and 10 month old mouse tail tissue, as well as matched 2 
month, 4 month, and 10 month old blood samples. Matched tail and blood tissues were used due 
to availability early in life and at sacrifice, and to eliminate inter-individual confounding. This 
study investigates whether developmental exposure to BPA, altered diet, and/or physical activity 
levels affects the rate of age-related methylation at five selected genetic loci. We found tissue- 
and gene-specific changes in absolute mean DNA methylation with age at all measured loci. 
WHFD exposure had a significant modifying effect on the rate of age-related methylation at the 
non-imprinted Esr1 locus in both tail and blood samples. In the blood samples, the effect of 
WHFD exposure on age-related methylation was sex-specific, showing negative deflection only 
in female mice. Physical activity had a non-significant positive effect on age-related Esr1 
methylation in female blood. Exposure to WHFD also modified rates of age-related methylation 
at IAP repeats in tail and blood. Dietary BPA exposure did not have a significant effect on the 
rate of age-related methylation at any of the investigated loci in either tail or blood. This study 
demonstrates measurable, gene-specific age-related methylation, as well as diet-dependent 
alterations in the rate of epigenetic aging at a class of repetitive elements and a non-imprinted 
locus related to murine growth and development. 
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2.2 Results 
Litter parameters 
Developmental BPA and/or diet exposure did not significantly alter litter size, sex ratio, 
or a/a to A
vy
/a genotypic ratio (n=277). Percent survival was significantly lower in the 
Control+BPA exposed offspring (survival = 73%) compared to Control (survival = 91%, 
p=0.006) and Mediterranean+BPA (survival = 85%, p=0.007) exposure groups, but was not 
significantly different in other comparisons. A subset of a/a non-agouti wild type mouse pups 
(n=133) was selected for inclusion in longitudinal follow-up up to 10 months of age, which 
incorporated collection of matched tail tip and blood samples (Table 2-1). 
Exposure- and diet-dependent changes in cross-sectional DNA methylation 
For all exposure groups, no significant changes in cross-sectional tail DNA methylation 
were found in the LINE-1, IAP, and H19 loci across the measured time points. However, several 
significant differences in PND21 cross-sectional tail DNA methylation were identified at the 
Esr1 and Igf2 loci (Figure 2-1). The Esr1 locus demonstrated significant alterations to PND21 
tail methylation when compared to Control, Mediterranean, and Western diets (ANOVA, p = 
0.002). Specifically, mice exposed to Western diet showed significantly decreased Esr1 tail 
methylation compared to Control (Tukey’s test, p= 0.027) and Mediterranean (Tukey’s test, p = 
0.002), and the Western exposure group demonstrated a significant decrease in Esr1 tail 
methylation compared to the Western+BPA group (Student’s t-test, p=0.005). The Igf2 locus 
demonstrated significant alterations to PND21 tail methylation when comparing BPA, 
Mediterranean+BPA, and Western+BPA diets (ANOVA, p = 0.020). At PND21, tail Igf2 
methylation in the Western+BPA group was significantly higher than methylation in the BPA 
group (Tukey’s test, p=0.027); a similar, marginally significant increase in tail Igf2 methylation 
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was seen when comparing Western+BPA to Mediterranean+BPA (Tukey’s test, p=0.073). There 
were no significant differences in cross-sectional DNA methylation by exposure group in the 
blood samples. 
DNA methylation changes with age 
DNA methylation at the LINE-1 and IAP repetitive elements, as well as the Igf2, H19, 
and Esr1 genes, was quantified from paired PND21 and 10 month tail samples (Table 2-2). 
When adjusting for exposure group, sex, age:exposure, and age:sex, LINE-1, IAP, and the H19 
locus demonstrated significant decreases in methylation over time (- 0.94%, p=0.035; -1.32%, 
p=2.2E-06; -10.44%, p=6.22E-08; respectively). In contrast, the Igf2 and Esr1 genes 
demonstrated increased methylation over time; however, only the increase in the Esr1 gene was 
statistically significant (7.60% increase, p=1.44E-12) (Table 2-2).  
DNA methylation was also quantified from matched 2 month, 4 month, and 10 month 
blood samples. When adjusting for exposure group, sex, age:exposure, and log(AEE), only the 
Esr1 gene demonstrated significant changes over time (β=4.094, p=3.64E-14) (Table 2-2). 
Specifically, Esr1 showed a significant increase in mean blood DNA methylation from 2 to 10 
months of age. Furthermore, the included sex variable showed a significant relationship with 
mean Esr1 DNA methylation (β=8.24, p<2E-16), indicating that sex may be modifying the 
association between age and blood DNA methylation. 
Developmental exposures alter mean DNA methylation 
To examine the effects of exposure on DNA methylation, we first examined whether each 
exposure group had a direct, significant effect on mean tail DNA methylation compared to 
Control. LINE-1, IAP, and H19 showed no significant effects of developmental exposures on 
mean tail methylation (Table 2-3). At the Igf2 locus, BPA exposure had a marginally significant 
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negative effect on mean tail methylation compared to Control (β=-3.81, p=0.066); no other 
exposure groups had a significant effect on tail methylation at this gene. At the Esr1 gene, 
Western diet exposure had a significant negative effect on mean tail methylation compared to 
Control (β= -1.93, p=0.013); this was the only significant exposure effect for the Esr1 gene in 
tail tissue (Table 2-3).  
To follow up on the tail results, we also examined whether BPA and/or WHFD exposure 
had a significant effect on mean blood DNA methylation compared to Control. IAP, Igf2, H19, 
and Esr1 showed no significant effects of developmental exposures on mean blood methylation 
(Table 2-4). At the LINE-1 repetitive element, WHFD exposed mice showed a significant 
increase in mean blood methylation compared to Control (β=0.762, p=0.003); no other exposure 
groups showed a significant change in mean blood methylation at this repetitive element (Table 
2-4). 
Environmental deflection by exposure 
To further examine the potential effects of exposure on the rate of age-related 
methylation in tail tissue, an interaction term between age and categorical exposure was included 
in the linear mixed effects model for each gene (Table 2-3). The Igf2 and H19 genes showed no 
significant interaction between age and exposure group, indicating that the relationship between 
age and tail methylation was not affected by developmental exposures in those genes. On the 
other hand, at LINE-1 repetitive elements, developmental Western diet exposure had a 
marginally significant negative effect on the association between age and tail methylation 
compared to Control (β=-1.05, p=0.069). Similarly, for global IAP, both the Western and 
Western+BPA diets had marginally significant negative effects on tail age-related methylation 
relative to Control (β=-0.645, p=0.058; β=-0.0649, p=0.051). At the Esr1 gene, developmental 
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Mediterranean+BPA diet exposure had a marginally significant positive effect on tail age-related 
methylation when compared to Control (β=1.85, p=0.064). Directionality of the interaction 
between age and exposure was specific to each gene in tail tissue (Table 2-3, Figure 2-1).  
Given that gene regulation can vary by sex, two additional variables – sex and a sex:age 
interaction term – were included in the linear mixed model for each gene. Neither sex nor 
sex:age were significant terms in the mixed models for LINE-1 (p=0.395, p=0.644), IAP 
(p=0.476, 0.786), Igf2 (p=0.868, p=0.686), and H19 (p=0.294, p=0.639) in tail tissue. However, 
at the Esr1 gene, while the sex categorical variable did not demonstrate a significant effect on 
tail methylation, the sex:age interaction term was statistically significant (p=0.003), indicating 
effect modification of tail age-related methylation by sex.  
Following up on the tail results, age:exposure interaction terms were also included in 
mixed effects models for mouse blood methylation to test for environmental deflection of age-
related methylation. There was significant WHFD-induced environmental deflection of age-
related blood methylation at LINE-1 (p=0.01), IAP (p=0.04), and Esr1 (p=0.02) (Table 2-4). At 
these gene regions, WHFD exposed mice had higher % methylation at 2M and lower % 
methylation at 10M compared to control (Figure 2-2). The Igf2 and H19 gene loci demonstrated 
no significant environmental deflection of age-related methylation by exposure. 
In the linear mixed model for Esr1, the included sex variable showed a significant 
relationship with mean DNA methylation (β=8.24, p<2E-16), indicating that sex may be having 
a confounding effect of the association between age and blood DNA methylation. To further 
examine the effects of sex on this relationship, sex-stratified models of age-related methylation 
were run for the Esr1 gene region. These models showed that the effect of age and WHFD 
exposure on Esr1 promoter methylation varied by sex in mouse blood. Males showed a 
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significant increase in Esr1 methylation with age (β=4.22; p=0.004), but no significant effects of 
exposure. Meanwhile, females demonstrated both a significant increase in Esr1 methylation with 
age (β=2.11, p=0.001) and a significant negative age:WHFD interaction term (β= -1.67, p=0.02). 
Combined, these data show a WHFD-mediated decrease in the rate of age-related Esr1 
methylation in female mouse blood compared to Control (Figure 2-3). 
Environmental deflection by physical activity 
To characterize murine physical activity, spontaneous activity levels were measured 
using Comprehensive Lab Animal Monitoring System (CLAMS) cages, which used lasers to 
measure movement in all directions. CLAMS data was collected at 2, 4, and 8 months prior to 
blood draws. From the CLAMS data, we used penalized spline regression models to calculate 
activity-related energy expenditure (AEE) values. An age:log(AEE) interaction term was then 
included in linear mixed models for the Esr1 gene region, the only gene region in blood with 
significant age-related methylation. Since the relationship between age and Esr1 methylation was 
shown to vary by sex, the age:log(AEE) variable was included in sex stratified models. In the 
female model, the age:log(AEE) term was non-significant, but positive, showing opposite 
directionality to the significant negative age:WHFD coefficient (Table 2-5). This indicates that 
AEE may partially offset the significant negative WHFD-mediated environmental deflection in 
female mice, a result that is apparent in a plot of the female mixed model results (Figure 2-4). 
2.3 Discussion 
BPA exposure 
 We did not find any significant effects of developmental BPA exposure on either cross-
sectional DNA methylation or age-related methylation at the five investigated genetic loci. These 
results match our previous work, which showed that the same dose of BPA (50 µg/kg diet) did 
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not significantly alter LINE-1 repetitive element methylation in liver (Faulk et al. 2016) or Esr1 
methylation in liver (Weinhouse et al. 2015). However, separate studies in our lab have shown 
that BPA exposure can alter genome-wide and global methylation levels in mouse liver and tail, 
respectively (Anderson et al. 2012, Kim et al. 2014). Taken together, these contradictory results 
suggest that the epigenetic effects of BPA may be tissue-, dose-, and gene-specific. Therefore, 
the lack of significant BPA-related changes in DNA methylation in this study may simply reflect 
an absence of exposure effects in tail or blood at the selected dose or investigated loci. 
Age-related methylation 
The results from this study indicate that the epigenome is dynamic with age in mouse tail 
and blood tissues. In tail, age-associated changes in DNA methylation occurred at all measured 
genetic loci, with statistically significant changes present at Esr1, H19, LINE-1, and IAP repeats. 
In blood, only the Esr1 promoter region demonstrated statistically significant age-related 
methylation across the 10 month life-course. Consistent with other results in the literature, 
directionality of age-related methylation was specific to each gene (Christensen et al. 2009; Issa 
2014). In blood and tail tissues, the non-imprinted gene promoter, Esr1, demonstrated an 
increase in methylation with age, a result consistent with documented decreases in estrogen 
receptor α (ERα) expression during aging (Wilson and Westberry 2009). Meanwhile, repetitive 
element methylation decreased with age in tail, and the investigated imprinted genes either 
increased or decreased with age in tail depending upon the locus. These results are also 
consistent with previous reports (Issa 2014; Maegawa et al. 2014; Teschendorff et al. 2013), and 
indicate that epigenetic aging varies in a region-specific manner.  
The effect of age on Esr1 promoter methylation in blood was also sex-specific, with 
males showing a more pronounced effect of age compared to females. This may be a reflection 
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of sex-specific Estrogen receptor α (ERα) regulation during the aging process. Previous work in 
mouse cortex has shown that adult females have increased ERα protein levels, mRNA 
expression, and promoter methylation compared to males (Sharma and Thakur 2006; Wilson et 
al. 2011). As such, females may show decreased effects of age due to a sex-specific requirement 
for increased ERα expression into adulthood. 
The documented region-specific directionality of drift fits a growing hypothesis in the 
field – that age-related changes in methylation facilitate development of chronic disease (e.g. 
cancer) via increased genomic instability and altered regulation of genes related to growth and 
development (Decottignies and d’Adda di Fagagna 2011; Issa 2014; Teschendorff et al. 2010). 
Decreased DNA methylation of repetitive elements with age has the potential to increase 
genomic instability through increased transposition of repetitive elements around the genome 
and dysregulation of expression via cis-chromatin modifying effects (Rodriguez et al. 2006; Ross 
et al. 2010; Suzuki et al. 2006). Additionally, increased methylation of promoter regions in 
protein-coding genes is associated with dysregulated transcription (Medvedeva et al. 2014; 
Varley et al. 2013). Combined, these effects have the potential to produce an epigenetic 
environment that alters gene expression and may increase the risk of disease states commonly 
associated with aging.  
Environmental deflection 
Expanding on simply examining the effects of age, we also tested the hypothesis that 
developmental BPA exposure, high-fat diet, and/or physical activity-related energy expenditure 
would lead to environmental deflection of age-related methylation rates. In tail tissue, the 
age:WHFD interaction term demonstrated marginal significance at IAP repeats and the Esr1 
locus, but not at LINE-1, Igf2, or H19, suggesting that WHFD exposure may lead to 
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environmental deflection of epigenetic aging. Supporting this idea, the age:WHFD interaction 
term was also significant at the Esr1, IAP, and LINE-1 loci when modeling longitudinal blood 
methylation. At all three significant loci in blood, WHFD exposed mice had higher % 
methylation at 2 months and lower % methylation at 10 months, suggesting differential effects of 
developmental WHFD exposure at distinct life-stages. Although the exact mechanism remains 
undefined, the apparent delay between WHFD exposure and decreased DNA methylation could 
be the result of a two phase process: early-life epigenetic programming followed by 
compensatory changes in regulation of methylation machinery – e.g. Dnmt3a, Tet1. DNA 
methyltransferase 3a (Dnmt3a) is an enzyme that facilitates the de novo addition of methyl 
groups to CpG sites across the genome (Challen et al. 2011). Meanwhile, ten-eleven 
translocation methylcytosine dioxygenase 1 (Tet1) is a 5-methylcytosine (5-mC) dioxygenase 
that facilitates oxidation of 5-mC, thereby tagging methylated CpG sites for active DNA 
demethylation by base excision repair (BER) (Xu and Wong 2015). Asynchronous alterations in 
activity of these opposing enzymes may explain the life-stage-specific effects of developmental 
WHFD exposure. 
The two-phase effect of WHFD exposure on the murine epigenome may be the result of 
oxidative stress (OS) induction. Previous work has demonstrated that Western diet can induce 
OS in mice (Heinonen et al. 2014), and other work has shown that OS can alter DNA 
methylation (Yara et al. 2015). For example, research indicates that OS can induce DNA 
hypermethylation via targeted acceleration of the reaction between cytosine molecules and S-
adenyl-methionine (SAM), a methyl group donor (Yara et al. 2015). Research has also shown 
that oxidative conditions can activate Tet enzymes (Chia et al. 2011; Coulter et al. 2013; Zhao et 
al. 2014), suggesting that OS may affect active DNA demethylation. These bidirectional effects 
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of OS on the epigenome fit into a proposed two-phase model for the effects of WHFD on DNA 
methylation. In the first phase, WHFD-induced OS would increase DNA methylation on a short 
time scale though direct acceleration of the interaction between SAM and CpG sites across the 
genome. In the second phase, OS recruits Tet enzymes, leading to hypomethylation at specific 
promoter regions via targeted oxidation of 5-mC to 5-hydroxymethylcytosine (5-hmC). 5-hmC 
could then be lost throughout the life-course via active or passive demethylation pathways (Shen 
et al. 2014). While this model fits well with our results, 5-hydroxymethylcytosine (5-hmC) is not 
distinguishable from 5-mC in bisulfite-pyrosequencing data (Huang et al. 2010). As a result, 
there may be an early-life wave of OS-induced 5-mC oxidation to 5-hmC that is not captured in 
our targeted pyrosequencing data. Additional work is needed to fully characterize the role of OS 
in WHFD-induced environmental deflection of epigenetic aging in mice. 
In contrast to an oxidative stress or environmental mismatch model, the apparent delay 
between WHFD exposure and age-related hypomethylation may be the result of technical 
limitations in our methods. The Tet1 enzyme oxidizes 5-mC to 5-hydroxymethylcytosine (5-
hmC), but this oxidized form is not distinguishable from 5-mC in bisulfite-pyrosequencing data. 
As a result, active demethylation would only appear in bisulfite-pyrosequencing data once the 
oxidized methyl group has been targeted for repair and replaced with an unmethylated cytosine. 
This means may be an early-life wave of Tet-assisted 5-mC oxidation to 5-hmC that is not 
captured in our targeted pyrosequencing data. In addition to this technical issue, recent evidence 
has shown that 5-hmC is a stable epigenetic mark that has a complex role in both positive and 
negative regulation of transcription (Hahn et al. 2014; Wu et al. 2011). As such, the delay 
between exposure and Esr1 hypomethylation could be the result of early-life processing of 5-mC 
to 5-hmC followed by a gradual loss of 5-hmC during cellular replication.  
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In addition to WHFD-specific results, female blood also showed opposing effects of 
WHFD and AEE on longitudinal Esr1 methylation, suggesting a mitigating effect of life-long 
physical activity on age-related methylation in WHFD-exposed female mice. Supporting this 
idea, a recent study in mice showed that maternal exercise attenuated HFD-induced Pgc-1α 
promoter hypermethylation in skeletal muscle of offspring (Laker et al. 2014). Combined with 
our results, this suggests that physical activity – whether maternal or life-long – can offset high-
fat diet effects on the epigenome. In our study, the opposing effects of WHFD and physical 
activity on age-related methylation were less clear in male mice, indicating that environmental 
deflection of age-related Esr1 methylation may be sex-specific. This may be a reflection of sex-
specific regulation of the Esr1 gene, which is more highly expressed in female mice (Sharma and 
Thakur 2006). These blood data at the Esr1 locus demonstrate the importance of considering 
sex-specific epigenetic effects when studying environmental deflection of epigenetic aging. 
For IAP repeats in tail tissue, developmental exposure to the Western and Western+BPA 
diets was associated with a marginally significant decrease in the rate of age-related methylation. 
At this global locus, the magnitude of this effect did not differ between the Western and 
Western+BPA diets, suggesting that exposure to Western diet was driving the age:exposure 
interaction effect. Given that age-related demethylation of IAP promoters has the potential to 
reactivate retrotransposition competency (Barbot et al. 2002; Horie et al. 2007), Western HFD, 
by increasing the rate of age-related methylation loss at IAP elements, may also increase IAP 
retrotransposition events. This suggests a mechanism by which developmental WHFD influences 
genomic stability throughout an organism’s life.  
Although age-related methylation at IAP repetitive elements demonstrated environmental 
deflection by WHFD in tail tissue, this result was not seen in LINE-1. This suggests that separate 
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classes of repetitive elements exhibit distinct epigenetic responses to environmental factors. 
Therefore, when studying the effects of the environment on global DNA methylation – both in 
cross-section and across the life course – multiple classes of repetitive elements should be 
included in analysis.  
In tail tissue, sex did not significantly alter age-related methylation directionality at 
LINE-1, IAP, Igf2, or H19. However, sex did significantly alter age-related methylation at the 
Esr1 locus in both tail and blood. Specifically, as age increased from PND21 to 10 months in tail 
tissue, there was a significant increase in the effect of sex on methylation at the Esr1 gene. 
Across all exposures except Med+BPA in tail, male mice demonstrated lower average Esr1 
methylation at PND21, but higher average Esr1 methylation at 10 months. This trend, combined 
with a significant age:sex interaction term, suggests a sex-specific change in regulation of the 
Esr1 gene during aging. This idea was supported by sex-specific differences in Esr1 DNA 
methylation in blood. In blood tissue, males showed greater increases in Esr1 DNA methylation 
between 2 months and 10 months of age. Additionally, effects of WHFD on age-related 
methylation were sex-specific, with a significant environmental deflection only apparent in 
female mice exposed to developmental WHFD. These data corroborate the fact that the sexes 
utilize estrogen for very different processes during reproduction and growth, with females of 
reproductive age demonstrating higher average serum estrogen than males (Bondesson et al. 
2015). Therefore, as the animals reach reproductive age, sex-specific effect modification of age-
related Esr1 methylation may occur as a regulatory response to sexually dimorphic estrogen 
activity.  
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Cross-sectional epigenetic effects of exposures 
Given the environmental deflection by WHFD exposure in tail, we also tested the effects 
of developmental exposure on cross-sectional methylation at PND21 and 10 month tail samples. 
PND21 tail DNA methylation showed significant changes by exposure group at two candidate 
regions – Igf2 and Esr1. Igf2 encodes the Insulin-like growth factor 2 protein, an important 
regulator of cellular glucose transport during development (Fowden et al. 2006; O’Dell and Day 
1998).
 
The cross-sectional WHFD-mediated increase in early-life Igf2 methylation may be a 
biological response to an increased simple sugar load, indicating that developmental exposure to 
WHFD can affect early-life establishment of age-related methylation at a gene related to 
metabolism and growth. Similarly, at the Esr1 gene promoter, WHFD had a significant effect on 
mean methylation, with a decrease in methylation compared to Control at PND21. This suggests 
that developmental exposure to WHFD alters the epigenetic profile of the Esr1 locus during 
development, potentially predisposing animals to increased Esr1 transcription in anticipation of 
the Western diet’s altered nutritional profile. Given the directionality of this exposure effect, 
developmental WHFD exposure, which is high in fat and has been linked to obesity, may 
increase transcription of the Estrogen Receptor  (ER) early in life. Previous studies have 
shown that ER is involved in control of lipid metabolism (Foryst-Ludwig and Kintscher 2010), 
with ER knockout mice demonstrating increased adipose tissue deposition with aging (Cooke 
et al. 2001; Ohlsson et al. 2000). As a result, our results suggest that developmental exposure to 
WHFD could alter risk for obesity development via epigenetic misregulation of the Esr1 locus. 
When a mismatch occurs between the developmental and postnatal environment, there is 
potential for improper regulation of epigenetic marks and disease development (Bateson et al. 
2004; Waterland and Jirtle 2004). The significant effects of exposure on PND21 tail DNA 
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methylation at the Igf2 and Esr1 loci support this idea, indicating that developmental exposure to 
environmental factors may not only alter the rates of age-related methylation, but also the cross-
sectional establishment of DNA methylation at specific genetic loci during development.  
At the Igf2 locus, BPA exposure had a marginally significant effect on mean tail 
methylation, with Control+BPA exposed mice showing decreased Igf2 methylation compared to 
Control at both PND21 and 10 months. This result, which is not present in the Med+BPA or 
Western+BPA diets, indicates that BPA exposure alone may alter regulation of the Igf2 gene. A 
previous study demonstrated decreased Igf2 methylation and increased Igf2 expression in 
developing embryos as a result of early-life 10 mg/kg/day BPA exposure (Susiarjo et al. 2013). 
Given these past results, the marginally significant effects of 50 µg BPA/kg diet exposure on 
Igf2 methylation presented in this report may reflect BPA exposure-mediated alterations in Igf2 
expression, but further investigation is required. The LINE-1, IAP, and H19 loci did not 
demonstrate significant cross-sectional effects by BPA exposure, suggesting that these three 
genetic regions are not sensitive to developmental BPA exposure. 
Effects of mediterranean diet on survival 
Separate from the epigenetic effects, the Mediterranean+BPA diet group had significantly 
improved PND21 survival rate compared to the Control+BPA diet group. Previous studies have 
observed that nutritional supplementation counteracts negative epigenetic effects on the 
epigenome (Bernal et al. 2013; Dolinoy et al. 2007). Furthermore, in multiple longitudinal 
human birth cohort studies, maternal adherence to a Mediterranean diet was associated with 
reduced risk of intrauterine growth restriction, low birth weight and low placental weight (Chatzi 
et al. 2012; Timmermans et al. 2012). Mothers consuming a Mediterranean diet also had higher 
circulating folate and vitamin B12 concentrations (Timmermans et al. 2012). Folate and vitamin 
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B12 are critical nutrients in the regeneration of S-adenosyl methionine, a major participant in 
DNA methylation maintenance; this suggests adherence to the Mediterranean diet may impact 
fetal epigenetic reprogramming. Therefore, it is possible that the developmental Mediterranean 
diet is providing a protective effect on survival by offsetting BPA-induced changes to epigenetic 
marks and gene regulation. Future studies should investigate this toxicant-diet interaction more 
fully.  
Limitations and future directions 
This study demonstrates measurable WHFD-based modifications to the rate of age-
related methylation in murine tail and blood, but the potential biological effects of this 
environmental deflection remain unclear without concurrent, longitudinal measurements of gene 
expression. Longitudinal measures of gene expression would provide a validation of DNA 
methylation results, demonstrating whether age- and exposure-related alterations to the 
epigenome have measurable physiological effects. As such, future studies investigating the 
effects of early-life toxicant exposure on epigenetic aging could expand the interpretability of 
their results by examining the effects of exposure and age on longitudinal gene expression, 
and/or examining DNA methylation and expression levels in other biological tissues of interest 
including blood – which may be accessed at multiple time points – and target tissues such as 
liver and brain.  
By using matched tail and blood tissues in this longitudinal study, age-related 
methylation rates reflected defined changes within organisms in the study population rather than 
changes in time between two separate populations. This matched design, combined with the 
controlled developmental exposure, isolates the effects of exposure for each organism in the 
study population, allowing for a direct test of the hypothesis that environmental factors can 
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modify the rates of epigenetic aging. Despite the longitudinal design, an inherent limitation of 
this study is the inability of bisulfite sequencing to differentiate between 5-methylcyosine (5-
mC) and 5-hydroxymethylcytosine (5-hmC). Although hydroxymethylation is not expected to be 
a major epigenetic mark in tail or blood tissue, recent study showed that aging affects global 
hydroxymethylation in healthy hepatic tissue, with a general trend towards increasing 5-hmC 
levels in older mice (Tammen et al. 2014). This reported increase in global hepatic 5-hmC levels 
over time is at odds with the previously reported loss of global 5-mC in cancer cells (Issa 2014; 
Maegawa et al. 2014; Teschendorff et al. 2013), suggesting that these separate epigenetic marks 
may change in different ways during aging. As a result, future epigenetic aging studies must 
better characterize the effects of aging on 5-hmC levels at specific CpG sites in the genome, as 
well as across tissue types. 
2.4 Conclusion 
We measured longitudinal DNA methylation in tail and blood tissue collected from 
isogenic mice, and then quantified the magnitude of age-related methylation in these samples at 
five genetic loci – two repetitive elements, two imprinted genes, and one non-imprinted gene. 
The use of matched tissues from an isogenic mouse colony allowed for strict control of genetic, 
environmental, and dietary measures, as well as removal of potential confounding. This study 
demonstrates significant, gene-specific age-related methylation, supporting the growing 
hypothesis that epigenetic aging plays an important role in the link between aging and cancer 
(Decottignies and d’Adda di Fagagna 2011; Issa 2014; Teschendorff et al. 2010). In addition, we 
showed significant WHFD- and sex-dependent environmental deflection of both repetitive 
elements and a non-imprinted gene. These results indicate that developmental exposure to 
WHFD can affect the aging epigenome in a mouse model. WHFD-dependent changes in tail 
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DNA methylation were also evident in two investigated loci at PND21, demonstrating the effect 
of developmental exposure on early-life establishment of epigenetic marks. Finally, activity-
related energy expenditure was shown to attenuate the effects of WHFD on age-related 
methylation at the Esr1 locus in blood tissue. To improve the generalizability of these results, the 
dynamics of epigenetic aging at the studied gene regions should be further evaluated in human 
cohorts. 
2.5 Materials and Methods 
Mouse colony 
Mice were a/a offspring sourced from a genetically invariant A
vy
/a mouse colony 
maintained in the Dolinoy Lab via sibling mating and forced heterozygosity for more than 220 
generations (Waterland 2003). Within this colony, the Avy allele is passed through the 
heterozygous male line, which has a genetically constant background 93% identical to C57BL/6J 
strain (Waterland 2003; Weinhouse et al. 2014). Two weeks prior to mate-pairing with A
vy
/a 
males, six week old wild type a/a dams were placed on one of six experimental diet groups: (1) 
Control (modified AIN-93G), (2) Control + 50 µg BPA/kg diet, (3) Mediterranean HFD chow, 
(4) Mediterranean + 50 µg BPA/kg diet, (5) Western HFD chow, and (6) Western HFD + 50 µg 
BPA/kg diet (Figure 2-5). Dietary exposure was continued through pregnancy and lactation, at 
which point treatment group pups were shifted over to a modified AIN-93G Control diet 
containing 7% corn oil rather than 7% soybean oil (Harlan Teklad). The 50 µg/kg diet BPA 
exposure level was chosen based on previous studies, which demonstrated both increased global 
methylation and sex-specific phenotypic effects at 50 µg/kg BPA (Anderson et al. 2013, 2012). 
BPA (0.01 g) was mixed with sucrose (9.99 g) in glass containers to achieve a 0.1% BPA 
mixture. To achieve the 50 µg/kg BPA concentration, 0.1% BPA/sucrose mixture was included 
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at 0.05 g/kg diet in custom Control/HFD diets by the manufacturer (Harlan Teklad). Western 
HFD and Mediterranean HFD mixtures were designed based on the U.S. junk food diet and the 
human Cretan diet, respectively (Block et al. 1985a, 1985b; Kafatos et al. 2000; Trichopoulou et 
al. 1993). Protein was kept constant between the three base diets, but vitamin levels, lipid ratios, 
and carbohydrate types were altered to mimic human consumption (Table 2-6).   
Exposure and tissue collection 
At postnatal day 21 (PND21), offspring were tail tipped, and collected tail tissue was 
frozen at -80°C. For each exposure group, a subset of PND 21 a/a wild-type pups were 
maintained until 10 months of age – Control: n = 22, Control+BPA: n=19, Mediterranean (Med): 
n=23, Mediterranean+BPA: n=24, Western: n=22, Western+BPA: n=23 (Table 2-1). At 2, 4, and 
8 months of age, offspring were relocated to a new cage outfitted with an integrated open-circuit 
calorimetry system: Comprehensive Lab Animal Monitoring System (CLAMS, Columbus 
Instruments); in this context, a host of phenotypic measures were taken, including body weight, 
oxygen consumption, food intake, and physical activity. After three days in the CLAMS cages, 
mice were returned to their original cages. During the 2 and 4 month cage transfers, tail vein 
blood samples were collected from all mice. At 10 months of age, mice were sacrificed; tail and 
cardiac puncture blood samples were again collected. All animals in this study were stored in 
polycarbonate-free cages with ad libitum access to food and drinking water, and were maintained 
in accordance with Institute for Laboratory Animal Research (ILAR) guidelines (National 
Research Council (US) Committee for the Update of the Guide for the Care and Use of 
Laboratory Animals 2011). The study protocol was approved by the University of Michigan 
Committee on Use and Care of Animals (UCUCA). 
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DNA isolation  
Genomic DNA was isolated from PND21 tail tissue (≤3mm) using a phenol-chloroform-
isoamyl alcohol protocol (Sambrook and Russell 2006). Genomic DNA was isolated from 10 
month tail tissue (3 mm) using the Maxwell Mouse Tail DNA Purification Kit (Promega, Cat. 
#AS1120). Genomic DNA was isolated from 2, 4, and 10 month frozen blood using the Qiagen 
Allprep DNA/RNA Mini Kit (Qiagen, Cat. #80204). Yield and purity of all DNA was measured 
using a NanoDrop spectrophotometer, and then genomic DNA was bisulfite converted using the 
Zymo Research 96-well EZ-methylation kit (Zymo Research, Cat. #D5004). Briefly, bisulfite 
conversion was accomplished through the addition of sodium bisulfite to 0.5-1 µg of genomic 
DNA, thereby converting unmethylated cytosines to uracil. Bisulfite converted DNA was then 
amplified using polymerase chain reaction (PCR), which causes uracils to be replaced with 
thymines. Remaining cytosines in the amplified PCR product are thereby a direct, quantitative 
measure of DNA methylation (Grunau et al. 2001). PCR amplification was performed on 
bisulfite converted DNA using HotStarTaq master mix (Qiagen, Cat. #203443), RNAse-free 
water, forward primer (9 pmol), and biotinylated reverse primer (9 pmol). Total PCR volume 
was 30-35 µL per sample, and gel electrophoresis was used to verify PCR product identity.  
DNA methylation measurement 
Specific PCR amplification for regions of interest (Igf2, H19, Esr1, IAP, and LINE-1) 
was performed on bisulfite converted DNA with primers designed using the PyroMark Assay 
Design software 2.0 and mm9 mouse genome. DNA methylation levels were quantified using the 
PyroMark Q96 MD instrument (Qiagen). Pyrosequencing samples were run in duplicate, and the 
average of the duplicates provided the final methylation percentages. Sample duplicates with 
coefficient of variation (%CV) > 10% were discarded and re-run. Pyrosequencing assay 
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information, including primer sequences, chromosomal location, annealing temperature, and 
sequences to analyze are available in Table 2-7. In an effort to reduce plate-to-plate batch 
effects, matched samples were run on the same plate for all PCR amplification and 
pyrosequencing runs. All pyrosequencing plates included 0% and 100% bisulfite converted 
methylation controls, as well as a no template control, to ensure proper functioning of the 
instrument and to provide background standards of methylation for each gene. 
Data analysis 
 Matched tail tissue was collected at postnatal day 21 and 10 months of age from a total of 
133 a/a offspring (Table 2-1). The effect of developmental BPA/HFD exposure on sex ratio and 
litter survival rate was determined by Fisher’s exact test, with Control as the reference group. 
Litter number, sex ratio, and litter survival rate were compared between exposure groups using a 
combined statistical approach involving both 3-way ANOVAs and Independent Student’s T-
tests. This same approach was used to compare cross-sectional PND21 or 10 month methylation 
data by exposure group. Separate 3-way ANOVAs were performed to compare Control vs. 
Mediterranean vs. Western and Control+BPA vs. Med+BPA vs. Western+BPA exposure groups. 
Separate Student’s t-tests were performed to individually compare methylation between base 
diets and their associated BPA exposure diet (e.g. Control vs. Control+BPA). For all ANOVAs, 
Tukey’s post-hoc test was used to determine the significance of each group-to-group 
comparison.  
In addition to tail, matched blood samples were collected at 2, 4, and 10 months of age 
from a total of 86 a/a offspring across four exposure groups – Control: n = 22 (10 female, 12 
male), Control+BPA: n=19 (9 female, 10 male), Western: n=22 (11 female, 11 male), 
Western+BPA: n=23 (12 female, 11 male). Cross-sectional DNA methylation for each target 
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gene was compared between the Control, Western, Control+BPA, and Western+BPA exposure 
groups using ANOVA. For all ANOVAs, Tukey’s post-hoc test was used to determine the 
significance of each group-to-group comparison. Physical activity (PA) data on multiple axes of 
movement -- X ambulatory counts, X total counts, and Z total counts – were measured using 
CLAMS cages (Columbus Instruments). We summarized physical activity data in a single 
activity-related energy expenditure (AEE) variable. AEE was calculated from total energy 
expenditure (TEE; kcal/kg/hour) and resting metabolic rate (RMR; kcal/kg/hour) using the 
following formula: AEE = 0.9(TEE) – RMR (Hills et al. 2014; Pontzer et al. 2016; Van Klinken 
et al. 2012). The 0.9 multiplier was based on the thermic effect of food (TEF), which was 
assumed to be ~10% of TEE (Hills et al. 2014). RMR was calculated from CLAMS data using a 
three step protocol. First, physical activity data was preprocessed using an optimized power 
function based on the CLAMS 20 minute sampling interval (Van Klinken et al. 2012). Second, a 
penalized spline regression model was used to model the time-course relationship between 
Energy Expenditure and Physical Activity for each mouse. Third, intercepts from the TEE vs. 
PA models were used to represent the RMR for each mouse. The AEE variable was log-
transformed prior to its addition to regression models. 
Mixed effect linear models were used to compare absolute methylation levels over time 
by exposure group. Age, exposure group, and sex were included as explanatory variables in all 
models. Linear mixed models for each target region also included a random factor to account for 
matched, within-individual data, as well as a random factor to account for within-litter effects. 
Environmental deflection of age-related methylation was compared by exposure group via 
inclusion of an age*exposure interaction term in all mixed models. For tail tissue models, an 
age*sex interaction term was included in an effort to identify and/or control for potential 
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modifying effects of sex on age-methylation levels. For blood, age*sex and age*log(AEE) 
interaction terms were also considered in mixed models; these terms were only included in the 
final model for Esr1, where they demonstrated statistical significance. 
Mixed models for tail tissue were fit using the following format: Methylation ~ Age + 
Sex + Exposure + Age:Exposure + Age:Sex + [1│ID] + [1│Litter]. For blood, mixed models 
were fit using the following format: Methylation ~ Age + Sex + Exposure + log(AEE) + 
Age:Exposure + Age:Sex + Age:log(AEE) + [1│ID] + [1│Litter]. For all models, the 
methylation outcome variable was defined as mean methylation across all amplicon CpG sites 
for two passing replicates. The lme4 package within the statistical program R was used for all 
linear mixed models (R version 3.2.3, http://www.r-project.org). Alpha significance levels were 
set at p≤0.05 for all statistical comparisons.  
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2.8 Figures and Tables 
Developmental 
Exposure 
Group 
N 
(litter) 
Female Male 
Pups 
(#) 
Control 14 10 12 22 
Control+BPA 25 9 10 19 
Med HFD 20 11 12 23 
Western HFD 21 11 11 22 
Med+BPA 15 12 12 24 
Western+BPA 23 12 11 23 
Total 118 65 68 133 
Table 2-1: Litter parameters. A subset of n=133 mouse pups included in longitudinal follow-
up. All pups in the longitudinal subset were maintained until sacrifice at 10 months of age. 
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Age-Related Methylation in Tail 
Gene N 
PND21 % Methylation 
(SE) 
10M % 
Methylation 
(SE) 
Methylation 
by Age - Beta 
coefficient† 
 p-value 
LINE-1 260 65.05 (0.12) 63.50 (0.11) -0.943 0.035 
IAP 222 90.31 (0.13) 88.62 (0.13) -1.321 2.20E-06 
Igf2 249 34.39 (0.78) 37.87 (0.26) 3.275 0.112 
H19 257 58.87 (0.62) 49.31 (0.27) -10.436 6.22E-08 
Esr1 260 4.26 (0.37) 12.09 (0.26) 7.604 1.44E-12 
Age-Related Methylation in Blood 
Gene N 
2M % 
Methylation 
(SE) 
4M % 
Methylation 
(SE) 
10M % 
Methylation 
(SE) 
Methylation 
by Age - Beta 
coefficient† 
 p-value 
LINE-1 252 65.85 (0.10) 65.62 (0.10) 65.47 (0.10) 0.085 0.542 
IAP 252 92.64 (0.09) 92.80 (0.10) 92.62 (0.13) 0.167 0.244 
Igf2 245 46.45 (0.28) 47.07 (0.22) 47.05 (0.19) 0.218 0.469 
H19 237 42.79 (0.19) 42.87 (0.23) 43.00 (0.28)  -0.049 0.867 
Esr1 244 50.71 (0.73) 56.21 (0.62) 58.69 (0.40) 4.094 3.64E-14 
Table 2-2: Age-related DNA methylation in mouse tail and blood. Linear mixed effect 
models were used to compare absolute methylation levels over time. Age, exposure group, sex, 
and age:exposure were included as terms in all models. Log(AEE)variable was included for 
blood variables. Linear mixed models for each gene also included a paired factor to account for 
matched, within-individual data, as well as a random factor to account for within-litter effects. 
Separate models were run for each gene; beta coefficients and associated p-values for age 
predictor from each model are reported. BOLD = p<0.05; † = Beta coefficient for age predictor 
in linear mixed effects model. 
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Tail Age-related DNA Methylation by Exposure Group 
      DNA Methylation 
Relative Methylation by 
Exposure 
Environmental 
Deflection 
Gene 
Developmental 
Exposure Group 
N 
PND21 % 
Methylation 
(SD) 
10 Month % 
Methylation 
(SD) 
Methylation 
by Age Beta 
Coefficient† 
p-value 
Age : 
Exposure 
Interaction 
Beta 
Coefficient† 
p-value 
LINE-1 
Control 44 64.86 (1.14) 64.00 (1.40) (Reference) n/a (Reference) n/a 
Control+BPA 38 64.78 (2.18) 63.32 (1.32) -0.079 0.855 -0.596 0.316 
Med 44 64.81 (1.53) 63.83 (1.43) -0.040 0.925 -0.132 0.820 
Western 43 65.18 (1.03) 63.27 (1.13) 0.331 0.431 -1.052 0.069 
Med+BPA 47 65.08 (1.44) 63.41 (1.29) 0.232 0.568 -0.818 0.147 
Western+BPA 46 64.97 (1.25) 63.65 (1.09) 0.122 0.766 -0.450 0.426 
          
IAP 
Control 38 89.98 (1.37) 88.64 (1.60) (Reference) n/a (Reference) n/a 
Control+BPA 32 90.56 (1.02) 89.03 (1.19) 0.560 0.279 -0.358 0.299 
Med 38 89.86 (1.15) 88.29 (1.15) 0.783 0.169 -0.291 0.410 
Western 34 90.34 (1.37) 88.77 (1.37) 0.484 0.356 -0.645 0.058 
Med+BPA 42 90.74 (1.53) 88.70 (1.53) 0.206 0.689 -0.325 0.335 
Western+BPA 38 90.37 (1.38) 88.36 (1.38) 0.788 0.135 -0.649 0.051 
          
Igf2 
Control 43 33.64 (6.23) 38.07 (2.59) (Reference) n/a (Reference) n/a 
Control+BPA 37 30.65 (8.26) 37.59 (4.58) -3.811 0.066 3.355 0.221 
Med 41 
32.70 
(10.69) 
37.83 (2.05) -0.513 0.804 0.338 0.900 
Western 41 
37.43 
(11.04) 
36.99 (1.84) 2.846 0.163 -3.914 0.143 
Med+BPA 44 31.97 (8.02) 38.61 (1.81) -2.506 0.207 2.965 0.259 
Western+BPA 45 37.55 (8.26) 38.25 (3.34) 3.162 0.108 -2.888 0.268 
          
H19 
Control 38 59.77 (7.22) 48.93 (2.86) (Reference) n/a (Reference) n/a 
Control+BPA 31 58.77 (6.43) 49.61 (2.29) -0.830 0.650 1.588 0.521 
Med 42 58.43 (7.31) 49.51 (3.84) -1.956 0.249 2.601 0.266 
Western 42 59.75 (8.28) 50.07 (3.23) 0.426 0.806 0.814 0.730 
Med+BPA 42 58.43 (6.25) 48.55 (2.67) -1.047 0.532 0.688 0.766 
Western+BPA 37 58.02 (7.32) 49.28 (3.03) -2.334 0.173 2.776 0.236 
          
Esr1 
Control 43 5.03 (2.25) 11.90 (1.93) (Reference) n/a (Reference) n/a 
Control+BPA 38 4.45 (1.56) 12.07 (3.00) -0.587 0.458 0.758 0.468 
Med 45 4.53 (1.84) 12.07 (2.01) -0.523 0.489 0.669 0.504 
Western 42 3.08 (1.12) 11.48 (1.65) -1.933 0.013* 1.620 0.112 
Med+BPA 46 3.96 (1.72) 12.67 (4.95) -1.089 0.150 1.851 0.064 
Western+BPA 46 4.51 (1.97) 12.27 (3.14) -0.604 0.424 0.988 0.321 
                  
 56 
Table 2-3: Tail DNA methylation by exposure group. Average methylation by age group was 
compared across exposure groups using a linear mixed effects model. Age, exposure group, sex, 
age:exposure, and age:sex were included as terms in all models. Linear mixed models included a 
paired factor to account for matched, within-individual data, as well as a random factor to 
account for within-litter effects. Separate models were run for each gene; beta coefficients and 
associated p-values for the exposure categories from each model are reported. Environmental 
deflection of age-related methylation was tested across all exposure groups via inclusion of an 
age:exposure interaction term in the model. Control diet was used as the reference exposure in all 
comparisons. † = Beta coefficient for age predictor in Linear Mixed Model; BOLD = p<0.10; * 
= p<0.05 
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Blood Age-related DNA Methylation by Exposure Group 
  DNA Methylation 
Relative Methylation 
by Exposure 
Environmental 
Deflection 
Gene Exposure N 
2M % 
Methylation 
(SE) 
4M % 
Methylation 
(SE) 
10 Month % 
Methylation 
(SE) 
Methylation 
by Age Beta 
Coefficient† 
p-value 
Age : 
Exposure 
Interaction 
Beta 
Coefficient† 
p-value 
LINE-1 
Control 64 65.58 (0.24) 65.39 (0.20) 65.66 (0.17) (Reference) n/a (Reference) n/a 
BPA 57 65.89 (0.19) 65.44 (0.23) 65.52 (0.19) 0.365 0.172 -0.228 0.249 
Western 66 66.24 (0.18) 65.80 (0.17) 65.31 (0.26) 0.762 0.003* -0.493 0.010* 
Western 
+BPA 65 65.69 (0.16) 65.84 (0.23) 65.38 (0.19) 0.347 0.173 -0.181 0.343 
                    
 IAP 
Control 64 92.44 (0.18) 92.69 (0.12) 92.78 (0.20) (Reference) n/a (Reference) n/a 
BPA 57 92.60 (0.19) 92.95 (0.15) 92.75 (0.32) 0.228 0.430 -0.099 0.626 
Western 66 92.71 (0.14) 92.84 (0.26) 92.27 (0.22) 0.367 0.307 -0.395 0.046* 
Western 
+BPA 65 92.77 (0.17) 92.73 (0.21) 92.71 (0.29) 0.299 0.185 -0.199 0.312 
                    
Igf2 
Control 63 46.50 (0.35) 46.91 (0.39) 46.92 (0.41) (Reference) n/a (Reference) n/a 
BPA 55 46.43 (0.50) 47.10 (0.48) 48.17 (0.65) -0.270 0.676 0.636 0.138 
Western 65 46.58 (0.33) 46.97 (0.47) 46.49 (0.51) 0.165 0.785 -0.323 0.429 
Western 
+BPA 62 46.29 (0.42) 47.32 (0.44) 46.69 (0.59) -0.004 0.994 -0.033 0.937 
                    
H19 
Control 60 43.16 (0.39) 42.96 (0.44) 43.06 (0.46) (Reference) n/a (Reference) n/a 
BPA 56 42.44 (0.36) 42.01 (0.51) 42.25 (0.72) -0.739 0.256 -0.095 0.816 
Western 62 42.31 (0.27) 42.47 (0.36) 42.89 (0.56) -0.747 0.235 0.261 0.513 
Western 
+BPA 59 43.32 (0.50) 43.93 (0.43) 43.76 (0.52) 0.307 0.631 0.264 0.518 
                    
Esr1 
Control 61 50.62 (0.90) 56.36 (1.34) 59.18 (1.46) (Reference) n/a (Reference) n/a 
BPA 55 50.25 (0.84) 56.30 (1.35) 59.58 (1.34) -0.327 0.732 0.503 0.480 
Western 63 51.48 (0.80) 56.21 (1.11) 56.64 (1.57) 1.417 0.114 -1.489 0.029* 
Western 
+BPA 65 50.41 (0.68) 56.00 (1.27) 59.47 (1.42) 0.139 0.876 0.389 0.565 
                    
Table 2-4: Blood DNA methylation by exposure group. Average methylation by age group 
was compared across exposure groups using a linear mixed effects model. Age, exposure group, 
age:exposure, and log(AEE) were included as terms in all models. Linear mixed models included 
id and litter random factors to account for intra-individual and within-litter effects. Separate 
models were run for each gene; beta coefficients and associated p-values for the exposure 
categories from each model are reported. Environmental deflection of age-related methylation 
was tested across all exposure groups via inclusion of an age:exposure interaction term in the 
model. Control diet was used as the reference exposure in all comparisons. † = Beta coefficient 
for age predictor in Linear Mixed Model; BOLD = p<0.10; * = p<0.05. 
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Male Esr1 Age-related Methylation in Blood Female Esr1 Age-related Methylation in Blood 
Variable Estimate SE DF p-value Variable Estimate SE DF p-value 
(Intercept) 53.41 0.79 109.7 <2E-16 (Intercept) 48.11 0.84 76.5 <2E-16 
Age 4.22 1.42 115.7 0.004 Age 2.11 0.62 93.8 0.001 
BPA -0.01 1.17 109.8 0.990 BPA -0.76 1.25 79.8 0.544 
WHFD 0.88 1.12 109.2 0.434 WHFD 1.70 1.15 76.2 0.144 
WHFD + 
BPA -0.28 1.12 109.1 0.801 
WHFD + 
BPA 0.28 1.13 76.3 0.807 
log(AEE) -2.97 1.98 85.7 0.137 log(AEE) -2.91 3.29 109.0 0.379 
Age:BPA 0.17 0.86 81.9 0.846 Age:BPA 1.06 0.76 74.3 0.167 
Age:WHF
D -0.83 0.84 81.9 0.324 Age:WHFD -1.67 0.70 71.4 0.020 
Age:WHF
D + BPA 0.80 0.88 85.7 0.362 
Age:WHFD 
+ BPA 0.74 0.70 72.1 0.293 
Age:log(A
EE) 1.59 1.22 116.0 0.193 
Age:log(AE
E) 1.40 1.65 89.6 0.399 
Table 2-5: Age-related Esr1 methylation stratified by sex. Beta estimates/coefficients for the 
Esr1 linear mixed models stratified by sex. Age is a significant predictor in both models, but 
only female mice show significant negative environmental deflection by WHFD. Age:log(AEE) 
has a positive, non-significant coefficient in both male and female models.  
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Nutrient Content in 3 Base Diets 
Diet Nutrients Control Mediterranean Western 
Kcal/g 3.98 4.53 4.72 
%Calories 
from Fat 16% 42% 40% 
PUFE : SFA : 
MUFA 1 : 0.2 : 0.5 1 : 1.3 : 5.6 1 : 1.9 : 1.6 
Protein 
(casein) 20 19 19 
Carb Content 
(g/100 g 
chow) 
  
  
Cornstarch 40 23 14 
Sucrose 10 9.2 25.5 
Cellulose 5 8 2 
Vitamin A 
(IU) 4000 8000 4000 
Vitamin C 
(mg) 0 500 0 
Vitamin D 
(IU) 1000 1000 400 
Vitamin E 
(IU) 75 75 25 
Folic Acid 
(mg) 2 4 1 
Sodium (mg) 1039 1039 7000 
Potassium 
(mg) 3600 8000 3600 
Magnesium 
(mg) 513 850 513 
Table 2-6: Comparison of nutrient content by diet. Three base diets were included as 
developmental exposures in this study – Control, Mediterranean HFD, and Western HFD. For all 
three base diets, protein was kept constant, but vitamin levels, lipid ratios, and carbohydrate 
types were altered to mimic human consumption. BPA was added to each diet to produce three 
additional developmental dietary exposure groups – Control+BPA, Med+BPA, and 
Western+BPA. Apart from BPA addition, nutrient content was not altered from the base diet 
levels in these three groups. 
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Primer/ 
Sequence to 
Analyze 
Igf2
1 
H19
1 
LINE-1 IAP Esr1
2 
Location 
chr7:149839707
–149839926 
strand = reverse 
chr7:149767589-
149767843 
Repetitive 
Element 
Repetitive 
Element 
chr10:4712147-
4712203 
Forward PCR 
Primer 
TTTTTTAATA 
TGATATTTGG 
AGATAGTT 
GGGGGGTTAT 
AAATGTTATT 
AGGGGGGTA
GG 
AAGGGGTTTG
TGTTTTAGAT
TAGG 
GTGTTATTTTT
TGATTGGTTGT
AGTTT 
TTTGGAAGT
TGTAGTTTTT
GGTTAGT 
Reverse PCR 
Primer 
biotin-
CCACATAATT
TAATTCACTA
ATAATT ACTA 
biotin-
AACCCCTAAC 
CTCATAAAAC 
CCATAACTAT 
AAAATCA 
biotin-
AACTCCCCAC
CAAATCCTAA
AACCTCTA 
biotin-
ACCAAAAATA
TCTTATAACTA
CTTATACT 
biotin-
ACAAAACAC
AAATAACCC
AACTC 
Sequencing 
Primer 
AATATGATAT
TT 
GGCGATAGTT 
GTGTAAAGAT 
TAGGGTTGT 
AGTTTGTTTT
TTTATGTATT
ATAGT 
ATTTTTTGATT
GGTTGTAGTTT
A 
GGAGAGGAG
TATGTAAAG 
Sequence to 
Analyze 
YGYGGGAYG
T  
TTGYGTAGAG 
GTTTGTTTGT 
TTTTTTGYGT 
GTTYGTYGGG 
GTYGT 
GYGGTYAGTG 
AAGTTTYGTA 
TATYG 
TTTAGGTTTY 
GYGYGATTGG 
ATTGGGGTAG 
AYGTTGTGTT 
TTATTTATTA 
GAGGTTT 
TYGGTYGAGT 
TGAYGTTAYG 
GGGAAAGTAG 
AGTATAAGTA 
GTTA 
TTGGAGAAT
T 
YGGGAGYGT
T 
TGGGTGYGT
T 
TTTTGGAGTT 
GGGTTATTT
G TGTTTT 
Amplicon 
Length (bp) 
220 255 132 87 131 
Annealing 
Temperature 
(°C) 
56 55 61 56 55 
Number of 
Cycles 
50 40 44 45 40 
Number of 
CpG Sites 
8 4 4 4 3 
Table 2-7: Pyrosequencing assay PCR conditions. Information for each assay, including 
genomic location, primer sequences (5’-3’), sequence to analyze, amplicon length, annealing 
temperature, number of cycles, and number of CpG sites measured. 
1
Assays from Faulk et al. 
2014; 
2
Assay adapted from Maegawa et al. 2010. 
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Figure 2-1: Methylation drift by exposure group. Visualization of age-related methylation 
over time at five target loci. LINE-1, H19, and IAP demonstrated a negative association between 
age and % methylation, while Esr1 and Igf2 demonstrated a positive association between age and 
% methylation. * = age:exposure interaction term p-value <0.10 for at least one exposure group 
in linear mixed model. † = ANOVA/t-test p-value <0.05 for cross-sectional comparison by 
exposure group. 
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Figure 2-2: Environmental deflection of age-related methylation by exposure group. 
Visualization of environmental deflection by exposure at five target loci. LINE-1, IAP, and Esr1 
demonstrated significant negative deflection of age-related methylation in Western-exposed mice 
compared to control. Igf2 and H19 did not display environmental deflection by WHFD. * = 
age:exposure interaction term p-value <0.05 for WHFD exposure group in linear mixed model. 
 63 
 
Figure 2-3: Age-related Esr1 DNA methylation split by exposure and sex. Spaghetti plot of 
age-related Esr1 methylation as it varies by both exposure and sex. WHFD-exposed female mice 
had a decreased rate of age-related methylation compared to control (p=0.026). No other group 
showed a significant interaction between age and DNA methylation. 
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Figure 2-4: Age-related Esr1 methylation for female mice. Slope estimates of the relationship 
between age and methylation for female mice. Slope estimates are separated based on exposure 
to Western diet and/or AEE. Slope estimates are based on beta values from the Esr1 linear mixed 
model for female mice. In the legend, “aging” refers to the baseline rate of age-related 
methylation, which is conceptualized as the beta estimate for the age term in the model when 
AEE and/or WHFD exposure are not considered. The other terms in the legend represent the 
effect of exposure and/or physical activity beta estimates on the baseline rate of age-related 
methylation. AEE and WHFD had opposing effects on Esr1 methylation rate in female mouse 
blood. 
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Figure 2-5: Diagram of exposure timing. F0 dams were assigned to one of six dietary 
BPA/HFD exposure groups two weeks prior to mating. Exposure continued throughout 
conception, gestation, and through lactation until weaning at post-natal day 21 (PND21). After 
weaning, offspring were transferred to an ad libitum Control diet, which continued until sacrifice 
at 10 months of age. Matched tail tips were collected at both PND21 and 10 months, and 
matched blood samples were collected at 2, 4, and 10 months. CLAMS data was collected during 
animal phenotyping at 2, 4, and 8 months of age. 
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Chapter 3  
Longitudinal Effects of Developmental Bisphenol A Exposure on Epigenome-
wide DNA Hydroxymethylation at Imprinted Loci in Mouse Blood 
 
 
Abstract 
Epigenetic machinery plays an important role in genomic imprinting, a developmental process 
that establishes parent-of-origin-specific monoallelic gene expression. While a number of studies 
have investigated the role of 5-methylcytosine in imprinting control, the contribution of 5-
hydroxymethylcytosine (5-hmC) to this epigenetic phenomenon remains unclear. Using matched 
mouse blood samples (2, 4, and 10 months of age), we examined the effects of perinatal 
bisphenol A (BPA) exposure (50 µg/kg diet) on longitudinal 5-hmC patterns at imprinted 
regions. We also tested the hypothesis that 5-hmC would show defined patterns at imprinted 
genes that persist across the life course. Genome-wide 5-hmC content was measured using 
hydroxymethylated DNA immunoprecipitation sequencing (HMeDIP-seq). Modeling of 
differential hydroxymethylation by BPA exposure was performed using a pipeline of 
bioinformatics tools, including the csaw R package.Based on BPA exposure, we identified 5,950 
differentially hydroxymethylated regions (DHMRs), including 12 DHMRs that were annotated 
to murine imprinted genes – Gnas, Grb10, Plagl1, Klf14, Pde10a, Snrpn, Airn, Cmah, Ppp1r9a, 
Kcnq1, Phactr2, and Pde4d. When visualized, these imprinted gene DHMRs showed clear, 
consistent patterns of differential 5-hmC by developmental BPA exposure that persisted 
throughout adulthood. These data show long-term establishment of 5-hmC marks at imprinted 
loci during development. Further, the effect of perinatal BPA exposure on 5-hmC at specific 
imprinted loci indicates that developmental exposure to environmental toxicants may alter long-
term imprinted gene regulation via an epigenetic mechanism. 
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3.1 Introduction 
DNA methylation is an epigenetic mark that typically occurs at cytosines (5-
methylctyosine; 5-mC) in cytosine-phosphate-guanine (CpG) dinucleotides. Research has shown 
that 5-mC plays a role in X chromosome inactivation (Cotton et al. 2015), regulation of gene 
transcription (Medvedeva et al. 2014), and genomic imprinting (Bartolomei and Ferguson-Smith 
2011). In addition to 5-mC, recent studies have shown that the oxidized form of 5-mC – 5-
hydroxymethylcyotisine (5-hmC) – is a stable epigenetic mark present in a variety of mammalian 
tissues (Globisch et al. 2010; Hahn et al. 2014; Wu et al. 2011). Active processing of 5-mC to 5-
hmC occurs via a Ten-eleven translocation (TET) methylcytosine dioxygenase-mediated 
oxidative pathway (Shen et al. 2014), and previous studies show that exposure-induced oxidative 
stress can alter both TET enzyme expression (Coulter et al. 2013) and global 5-hmC content 
(Delatte et al. 2015). In addition to these characteristics, 5-hmC has a complex role as both a 
positive and negative regulator of transcription (Hahn et al. 2014; Wu et al. 2011), suggesting it 
may represent an important secondary genomic regulator in the methylome.  
During early embryonic development, DNA methylation undergoes a distinct wave of 
demethylation and de novo methylation (Reik et al. 2001; Smallwood and Kelsey 2012), 
processes that assist in the regulation of stem cell proliferation and differentiation 
(Messerschmidt et al. 2014). After differentiation, there is a second phase of DNA methylation 
reprogramming that occurs to establish a baseline methylome in primordial germ cells prior to 
birth (Smallwood and Kelsey 2012). Given these multiple waves of reprogramming during 
development, DNA methylation has been proposed as a mechanism driving the developmental 
origins of health and disease (DOHaD) hypothesis. DOHaD posits that exposure to 
environmental factors (e.g. diet, chemicals, etc.) during sensitive periods of development 
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influences developmental plasticity, thereby altering disease susceptibility later in life (Bateson 
et al. 2004; Heindel et al. 2015; Jirtle and Skinner 2007). Of particular interest in the DOHaD 
field is genomic imprinting, an epigenetic phenomenon by which parent-of-origin-specific 
monoallelic gene expression is established during development (Bartolomei and Ferguson-Smith 
2011; Das et al. 2009). Genomic imprinting is critical for proper placental maturation, embryonic 
growth and development, and it also plays important roles in post-natal development – especially 
in parent-offspring interactions (e.g. milk suckling, maternal care) (Plasschaert and Bartolomei 
2014). A vast amount of research on genomic imprinting has shown that differential DNA 
methylation at imprinting control regions (ICRs) plays an important role in establishing genomic 
imprinting during development, and that these regions are not demethylated during post-
fertilization reprogramming (Arnaud 2010; Kelsey and Feil 2012; Kim et al. 2017; Pidsley et al. 
2012; Smallwood and Kelsey 2012). Given that imprinted gene expression is controlled via 
developmentally programmed epigenetic marks, imprinted genes have been investigated as 
potential targets of developmental environmental exposures in both human and rodent studies 
(Haycock and Ramsay 2009; Heijmans et al. 2008; Nye et al. 2015; Susiarjo et al. 2013).  
However, virtually all of the existing studies on genomic imprinting relied upon sodium 
bisulfite treatment for generation of DNA methylation levels from biological samples. While 
bisulfite treatment is a useful quantitative tool for measuring the methylome, it also has an 
inherent weakness – it does not distinguish between 5-mC and 5-hmC. This is because both 5-
mC and 5-hmC are resistant to sodium bisulfite-induced cytosine deamination (Huang et al. 
2010). This means that bisulfite treatment-based measurements of the “methylome” actually 
represent combined 5-mC+5-hmC levels. In recent years, methods to specifically measure 5-
hmC, including hydroxymethylated DNA immunoprecipitation sequencing (HMeDIP-seq) (Tan 
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et al. 2013), have been developed. Despite these recent advances, however, little work has been 
done to identify the role of 5-hmC in genomic imprinting. One recent study showed enrichment 
of 5-hmC in imprinted regions in human brain and placenta (Hernandez Mora et al. 2017), but no 
study has yet investigated the contribution of 5-hmC to imprinting control in animal models. 
Furthermore, existing animal studies have not investigated effects of the environment on 5-hmC 
levels at imprinted genes. 
Developmental exposure to a number of environmental factors, including endocrine 
disrupting chemicals (EDCs), has been linked to changes in DNA methylation. Bisphenol A 
(BPA) is a commercial EDC that is found in a variety of consumer products (e.g. receipt paper, 
metal can linings, etc.) and has near ubiquitous human exposure across the world (Calafat et al. 
2008). BPA can activate growth-related transcription factors, bind nuclear receptors involved in 
cell growth and maturation, and also alter DNA methylation levels across the epigenome (Krüger 
et al. 2008; Manikkam et al. 2013; Singh and Li 2012; Sui et al. 2012; Watson et al. 2007; 
Wolstenholme et al. 2011; Zhang et al. 2012). Developmental BPA exposure in mouse models 
has been shown to alter the methylome (Anderson et al. 2012; Kim et al. 2014; Singh and Li 
2012), including specific effects on DNA methylation at imprinted loci (Susiarjo et al. 2013). 
Despite these results, however, it remains unclear whether developmental BPA exposure can 
specifically affect DNA hydroxymethylation. 
Here, we used the HMeDIP-seq method to measure epigenome-wide 5-hmC from  
longitudinal mouse blood samples in an effort to examine DNA hydroxymethylation at imprinted 
loci throughout murine adulthood. HMeDIP-seq is an antibody-based high-throughput 
sequencing method that measures the genome-wide distribution of 5-hmC. While this method 
has some inherent antibody inefficiency and fails to provide base-pair resolution sequencing 
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data, it does provide cost-effective amplification of high frequency, low signal 5-hmC marks 
within gene bodies (Skvortsova et al. 2017; Tan et al. 2013). Given the discovery nature of this 
study and the lack of a priori knowledge regarding 5-hmC levels in mouse blood, HMeDIP-seq 
was chosen to measure genome-wide 5-hmC from longitudinal blood samples. From this data, 
we tested the hypothesis that perinatal BPA exposure alters longitudinal 5-hmC content at 
imprinted genes. We also tested the hypothesis that imprinted genes would show defined 5-hmC 
peaks that persist across the life course. Our results confirm these hypotheses, showing both 
BPA-related differential hydroxymethylation and persistent 5-hmC patterning at imprinted 
genes. 
3.2 Materials and Methods 
Study animals and blood collection 
Mice included in longitudinal analysis were a/a offspring sourced from a genetically 
invariant viable yellow agouti A
vy
/a mouse colony maintained by sibling mating and forced 
heterozygosity for more than 220 generations (Waterland and Jirtle 2003). Within this colony, 
the A
vy
 allele is passed through the heterozygous male line, which has a genetically constant 
background 93% identical to C57BL/6J strain (Waterland and Jirtle 2003; Weinhouse et al. 
2014). Two weeks prior to mate-pairing with A
vy
/a males, eight to ten-week-old wild type a/a 
dams were placed on one of two experimental diet groups: (1) Control (modified, phytoestrogen-
free 7% corn oil AIN-93G), (2) Control + 50 µg BPA/kg diet (Figure 3-1) (Anderson et al. 2012; 
Weinhouse et al. 2014). BPA dose was chosen based on a previous dosing study from our lab 
that showed intake of 50 ug BPA/kg diet produced on average 2.02 ng BPA/g liver (Anderson et 
al. 2012). This exposure level is within the range of human exposure levels measured in human 
fetal liver samples (range: non-detect to 96.8 ng BPA/g liver) (Anderson et al. 2012). Dietary 
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exposure was continued through pregnancy and lactation, at which point BPA-exposed offspring 
(total n=19; n=6 used for these analyses) were weaned to the modified AIN-93G Control diet and 
followed along with Control offspring (total n=22; n=6 used for these analyses) until 10 months 
of age. All diets were provided by Envigo (Indianapolis, IN). At 2 months and 4 months of age, 
tail vein blood samples were collected from all mice (Figure 3-1). At 10 months of age, mice 
were sacrificed, and blood samples were again collected, this time using cardiac puncture. Six 
mouse blood samples from each exposure group were selected for inclusion in next-generation 
sequencing analyses. In accordance with methods established by the NIEHS TaRGET II 
consortium (Wang et al. 2018), we selected male (n=3) and female (n=3) blood samples 
collected from six separate litters. All animals were stored in polycarbonate-free cages with ad 
libitum access to food and drinking water, and were maintained in accordance with Institute for 
Laboratory Animal Research (ILAR) guidelines (National Research Council (US) Committee for 
the Update of the Guide for the Care and Use of Laboratory Animals 2011). The study protocol 
was approved by the University of Michigan Committee on Use and Care of Animals (UCUCA 
PRO00004797). 
DNA and RNA isolation 
To allow for matched analyses of DNA hydroxymethylation and gene expression from 
the same set of mice (n=6), genomic DNA and RNA were co-isolated from 2, 4, and 10 month 
frozen blood using the Qiagen Allprep DNA/RNA/miRNA Universal Kit (Qiagen, Cat. #80224). 
Yield and purity of all DNA and RNA was measured using a NanoDrop spectrophotometer. All 
samples were stored at -80°C prior to DNA and RNA isolations.  
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Real-time quantitative PCR (RT-qPCR) 
 The Bio-Rad iScript cDNA Synthesis Kit (Cat. #1708890) was used to reverse transcribe 
complementary DNA (cDNA) from 250 ng of RNA for each sample. In preparation for RT-
qPCR, cDNA samples were diluted 1:2.5 in RNase-free water, then mixed with 10 µM 
forward/reverse primers, nuclease-free water, and Bio-Rad iQ SYBR Green Supermix (Cat. 
#1708880). RT-qPCR was then performed using a Bio-rad CFX96 Real-Time System C1000 
Thermal Cycler (Bio-Rad; Hercules, CA). The pre-programmed 2-step PCR+melt curve protocol 
was used for all qPCR reactions – 95°C for 3 minutes, [95°C for 10 seconds, 55°C for 30 
seconds, plate read] x40, 95°C for 10 seconds. The melt curve for each plate was 65°C-95°C; 
0.5°C increment for 5 seconds, with plate read at each temperature. RT-qPCR analyses were 
performed for the Gnas genes in triplicate for each cDNA sample. Three housekeeping genes – 
Actb, 18S, and Gapdh – were included as internal controls in all RT-qPCR runs. In addition to 
housekeeping genes, an inter-plate calibrator control of brain cDNA was included for calculation 
of relative gene expression across multiple plates. Expression levels were calculated following 
the 2
−ΔΔCt
 method (Livak and Schmittgen 2001). RT-qPCR primers for the Gnas and Gapdh 
genes (Table 3-1) were designed using the online Genscript Real-time PCR Primer Design 
software (https://www.genscript.com/tools/real-time-pcr-tagman-primer-design-tool). The β-
actin and 18S gene primer pairs were sourced from the literature (Dolinoy et al. 2010; La Salle et 
al. 2004). Primer pair specificity for all designed primers was checked using the NCBI Primer-
BLAST online tool (https://www.ncbi.nlm.nih.gov/tools/ primer-blast/).  
Next-generation sequencing of 5-hmC 
Epigenome-wide DNA hydroxymethylation was quantified in blood from mice using 
hydroxymethylated DNA immunoprecipitation sequencing (HMeDIP-seq) (Tan et al. 2013). 
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Unlike other some other methods, HMeDIP-seq is an antibody-based approach that does not 
provide base-pair resolution data. This method is also subject to the inherent bias of a multi-step, 
immunoprecipitation-based sequencing method, including potential for antibody binding 
inefficiency, as well as library preparation bias, read mapping bias, or PCR amplification bias 
(Meyer and Liu 2014). Despite these weaknesses, HMeDIP-seq is a cost-effective method to 
measure genome-wide 5-hmC, including at regions of high frequency weak 5-hmC signal (Tan et 
al. 2013). Sequencing data were generated by Dr. Claudia Lalancette at the University of 
Michigan Epigenomics Core Facility for a subset of control (n=6) and BPA-exposed (n=6) mice 
(Figure 3-2). Blood samples from the six mice (3 male, 3 female) in each exposure group were 
sequenced at three time points across the life-course (2, 4, and 10 months of age), for a total 
sequencing data sample size of 36 samples. The six mice for each exposure group were selected 
from different litters to minimize litter effects. Sample quality and quantitation were assessed 
using the Agilent TapeStation genomic DNA kit (Agilent, Cat. #G2991AA) and Qubit broad 
range dsDNA (Invitrogen, Cat. #Q32850), respectively. Indexed adapters and PCR primers were 
synthesized by Integrated DNA Technologies (IDT). Enzymes used for library preparation were 
sourced from New England BioLabs (NEB).  
A total of 1μg of genomic DNA (gDNA) was sheared by adaptive focused acoustics, 
using the Covaris S220 (Covaris, Cat. #4465653). This sheared DNA was next blunt-ended and 
phosphorylated. A single adenine nucleotide was then added to the 3’end of the fragments in 
preparation for ligation of adapter duplex with a thymine overhang. The ligated fragments were 
cleaned using Qiagen’s MinElute PCR purification columns (Qiagen, Cat. #28004). DNA 
standards for HMeDIP (Diagenode 5-hmC, 5-mC & cytosine DNA standard pack for HMeDIP, 
Cat. #AF-107-0040) were added to each sample before denaturation. Resuspension was then 
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performed in ice-cold immunoprecipitation buffer (10 mM Sodium Phosphate pH 7.0, 140 mM 
NaCl, 0.05% Triton X-100). A 10% volume (input) was retrieved before 2ug of a 5-hmC-
specific antibody (Active Motif, Cat # 39791) was added for immunoprecipitation overnight at 
4°C with rotation. Dynabeads Protein-G (Invitrogen, Cat. #10003D) was used to pull-down 5-
hmC-enriched fragments. The 5-hmC-enriched DNA fragments (IP) were then released from the 
antibody by digestion with Proteinase K (Ambion, Cat. #AM2548). After cleanup with AMPure 
XP beads (Beckman Coulter, Prod.# A63880), the percent input enrichment (%input) in the IP 
was evaluated by qPCR, using hydroxymethylated, methylated, and unmethylated primers for 
spike-ins. Samples with high % input for the 5-hmC spike-in – typical inclusion threshold was 
>80% – were then PCR amplified for the final library production, cleaned using AMPure XP 
beads, and quantified using the Qubit assay (Invitrogen, Cat. #Q32850) and TapeStation High 
Sensitivity D1000 kit (Agilent, Cat. #G2991AA). Single-end, 50 base pair reads were obtained 
for each library by sequencing on the HiSeq 4000 system (Illumina). Each HMeDIP-seq sample 
was run on a single sequencing lane. 
Bioinformatics pipeline for differential 5-hmC 
HMeDIP-seq data for all control and BPA-exposed mice were compared using a suite of 
bioinformatics tools (Figure 3-2). First, the Sartor lab mint pipeline was used for data quality 
control (FastQC and MultiQC), adapter trimming (trim_galore), and alignment (bowtie2) 
(Cavalcante et al. 2017). Based on previous research, we required a minimum overlap of 6bp and 
minimum quality score of 20 for adapter and quality trimming, respectively (Akalin et al. 2012). 
Although the default minimum overlap in trim_galore is 1 bp, we selected a less stringent 
minimum overlap of 6 bp in an effort to include all legitimate genomic sequences and improve 
read depth. Despite these benefits, the less stringent minimum overlap length increases the 
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possibility for adapter contamination in our data (Krueger 2017). The quality score cut-off is the 
default in trim_galore, and is based on previous research showing an optimal tradeoff between 
correct read mapping and read survival at quality scores between 20 and 30 (Del Fabbro et al. 
2013). Default parameters were used for bowtie2.  
After data quality check, trimming, and alignment, the csaw package was used to test for 
differential 5-hmC by BPA exposure (Lun and Smyth 2016). Aligned HMeDIP-seq data were 
read into R using the windowCounts function in csaw. When reading in the data, extension was 
set to 52, window width was set to 100, and sex chromosomes were removed. The data were then 
filtered twice – by count ( average count >5) and by local enrichment using the filterWindows 
function (type= “local”) – to remove regions of negligible binding. After filtering, normalization 
factors were calculated for each sample using the normOffsets function on binned data 
(width=10000). Normalization factors were linked to filtered data using the asDGEList function, 
and then the estimateDisp function was used to generate dispersion factors based on a 
multifactorial design matrix. The glmQLFit function was used to fit a model (model design = 
model.matrix(~ exposure + age + age:exposure + mouse_ID + sex)) for differential 5-hmC 
binding; an empirical Bayesian method used to stabilize the QL dispersion estimates. Contrast 
statements were used to extract modeling results for the variable of interest – BPA exposure. To 
correct for multiple testing, filtered data was clustered using a window length of 500 bp; the 
combineTests function was then used to compute a combined p-value for each cluster. Multiple 
testing correction was performed using the Benjamini-Hochberg method (Benjamini and 
Hochberg 1995, 1997). Differential hydroxymethylated region (DHMR) length cutoff was set at 
≥100 bp; significance was set at FDR < 0.10.  
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After testing for differential hydroxymethylation using csaw, the annotatr R package was 
used to annotate all DHMRs to the mm10 genome (Cavalcante and Sartor 2017). The 
annotate_regions function was used to generate genomic annotations, which include 
classifications by region class (e.g. intron, exon, promoter, etc.) and annotated gene IDs. A list of 
mouse imprinted loci was then sourced from the MouseBook online database (Williamson et al. 
2013). All available imprinted genes were manually cross-checked with the generated list of 
BPA-related DHMR annotated gene IDs.  
Sequencing data visualization 
 5-hmC peaks were visualized using the csaw and GViz R packages (Hahne and Ivanek 
2016; Lun and Smyth 2016). Using csaw, data was first read into R as a GRanges object using 
the extractReads function. Next, the GeneRegionTrack in the Gviz R package was used to define 
regions of interest for visualization. Separate blue and red genome tracks were used to represent 
the forward and reverse strand reads, respectively. The plotTracks function was then used to plot 
5-hmC peaks for these regions. Reads-per-million was used for the y-axis in all graphs, and scale 
was adjusted to individual region coverage.  
BPA-related DHMRs at imprinted loci were visualized using the GViz R package to 
determine directionality and magnitude of differential 5-hmC. Plots generated in R (R version 
3.4.0) were formatted for publication in Adobe Illustrator CS6 (version 16.0.5). 
Pathway analysis 
Pathway analysis for DHMRs was performed using ChIP-enrich (Welch et al. 2014). 
Within the ChIP-enrich online interface (http://chip-enrich.med.umich.edu/), the gene set filter 
was set to 2000, peak threshold was set to 1, and adjustment for mappability of gene locus 
regions was set to false. The genome used for pathway analyses was mm10, and the ChIP-enrich 
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method was used for enrichment testing. DHMRs were split into hypo- and hyper-
hydroxymethylated regions prior to separate analyses. Only regions <5kb from TSS were 
included in ChIP-enrich analysis. All pathway analyses included GO terms and KEGG pathways. 
After correcting for multiple testing, only pathways with FDR<0.05 were considered significant. 
3.3 Results 
Epigenome-wide differential 5-hmC 
Using the csaw R package, multivariate models were constructed to test for differential 5-
hmC by perinatal BPA exposure (50 µg/kg diet). Based on the csaw models, we identified 5950 
differentially hydroxymethylated regions (DHMRs) by BPA exposure (Table 1). Comparing the 
directionality of DHMRs by BPA exposure, we found more hypo-hydroxymethylated regions 
(n=4247; 71.4%) than hyper-hydroxymethylated regions (n=1559; 26.2%) (Table 1). We also 
identified a small fraction of BPA-related DHMRs (n=144; 2.4%) that showed both hypo- and 
hyper-hydroxymethylation. Taken together, these epigenome-wide results show that the 
directionality of differential hydroxymethylation varies by region, with a skew toward decreased 
5-hmC by BPA exposure. 
BPA-related DHMRs at imprinted genes 
 Previous research has shown effects of developmental exposures on DNA methylation at 
imprinted loci (Gallou-Kabani et al. 2010; Susiarjo et al. 2013), but it remains unclear whether 
exposures can also alter DNA hydroxymethylation at imprinted genes. Further complicating this 
question, despite recent research in humans showing enrichment of 5-hmC at imprinted loci 
(Hernandez Mora et al. 2017), the distribution and potential function of 5-hmC at murine 
imprinted genes remains unknown. In an effort to broadly identify BPA-sensitive regions of 5-
hmC at imprinted loci, we cross-checked the BPA-related DHMR annotations with a database of 
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known murine imprinted genes (Williamson et al. 2013). In total, 12 of the 151 known imprinted 
genes had annotated BPA-related DHMRs (Table 3-3). Five of these twelve genes had increased 
5-hmC peaks by BPA exposure – Grb10, Pde10a, Pde4d, Plagl1, and Gnas. The remaining 
seven imprinted loci – Ppp1r9a, Phactr2, Klf14, Kcnq1, Cmah, Airn, and Snrpn – had decreased 
5-hmC peaks by BPA exposure. The number of CpG sites within these DHMRs varied by 
region, with five of the DHMRs showing zero CpG sites (Table 3-4). In an effort to confirm the 
DHMRs, we visualized the five most significant imprinted gene DHMRs and one DHMR at the 
well-characterized Snrpn gene, showing marked changes in 5-hmC peaks by BPA exposure that 
persisted across all of the three matched sample ages (Figure 3-3). We also showed striking 
changes in 5-hmC peaks at the remaining six imprinted gene DHMRs, despite their decreased 
significance (Figure 3-4). In an effort to determine whether this was a shared trait at imprinted 
genes, we visualized 5-hmC peaks at Igf2 and H19, two well-characterized imprinted genes that 
did not have any annotated DHMRs with FDR < 0.1. Despite their lack of significant DHMRs, 
Igf2 and H19 still had specific 5-hmC peaks that showed non-significant changes by BPA 
exposure (Figure 3-5). Combined, these data suggest that perinatal BPA exposure alters the 
establishment of 5-hmC marks at specific regions of imprinted genes. 
In examining the imprinted loci visually, two of the DHMRs – Plagl1 and Gnas – had 5-
hmC peaks that were cut-off by the DHMR boundaries, suggesting larger scale 5-hmC patterns 
at these genes. To provide a complete picture for these two loci, 5-hmC peaks across the entire 
gene were visualized. Both Plagl1 and Gnas had widespread 5-hmC peaks along the entire gene-
coding region, with only the annotated DHMRs showing apparent modifications by BPA 
exposure (Figure 3-6). Of note, 5-hmC peaks across these two genes were consistent between 
mice and across time, a pattern that was also observed at the Igf2 and H19 imprinted genes 
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(Figure 3-5). Together, these data show that imprinted genes have predictable 5-hmC peaks 
along the length of their gene bodies.  
RT-qPCR gene expression data 
 To follow up on the DHMR annotated to the Gnas gene, we performed RT-qPCR on 
RNA from matched mouse blood samples to examine longitudinal mRNA expression. At the 
Gnas locus, there was a significant increase in mean mRNA expression from 2 to 10 months of 
age in mice exposed to BPA (p=0.05) (Figure 3-7). This increase was not significant in control 
samples. Additionally, mean Gnas expression was significantly lower in control mice than BPA-
exposed blood at 10 months of age (p=0.01), a result that reflects a result that reflects the 
increased Gnas 5-hmC peak found in BPA-exposed blood.  
Pathway analysis for DHMRs 
ChIP-enrich pathway analysis was performed on separate lists of hyper- and hypo-
methylated DHMRs. In an effort to maximize biological relevance and limit number of 
comparisons, DHMR datasets were restricted to regions <5kb from the transcription start site. 
After correction for multiple testing, a small number of GO terms were enriched in hypo- and 
hyper-hydroxymethylated DHMRs (Table 3-5). Of note, enriched pathways showed no overlap 
between hyper- and hypo-hydroxymethylated DHMRs. In the BPA-related hypo-
hydroxymethylated DHMRs, the only two significantly enriched pathways were hippocampus 
development and spinal cord association neuron differentiation. In the BPA-related hyper-
hydroxymethylated DHMRs, the two most significant enriched pathways were L-ascorbic acid 
binding and oxidoreductase activity. These pathway analysis results indicate that only a few GO 
terms were enriched in the significant DHMRs, and that enrichment was specific to directionality 
of BPA-related DHMRs. 
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3.4 Discussion 
Epigenome-wide differential 5-hmC 
We found statistically significant effects of perinatal BPA exposure on DNA 
hydroxymethylation across the epigenome. While the exact mechanism driving this relationship 
is unclear, it is possible that BPA-related DHMRs are a result of BPA-induced oxidative stress 
(OS) (Gassman 2017). Based on the available literature, free BPA is thought to induce OS via 
enzymatic formation of BPA phenoxyl radicals (Sakuma et al. 2010), which can then be further 
processed to other reactive oxygen species (ROS), including superoxides and peroxides (Babu et 
al. 2013). In addition to potential ROS-induced cytotoxicity (Gassman 2017), the prooxidant 
activity of BPA also has the potential to modify 5-hmC across the epigenome. Research has 
shown that Tet enzyme activity is activated under oxidative conditions (Chia et al. 2011; Coulter 
et al. 2013; Zhao et al. 2014), indicating that active processing of 5-mC to 5-hmC may be 
affected by ROS production. Further supporting this idea, recent research has shown that OS-
inducing exogenous factors – buthionine sulfoximine and PM2.5 fine particulate matter – can alter 
DNA hydroxymethylation levels (Delatte et al. 2015; Wei et al. 2017). These prior results 
support the hypothesis that BPA exposure could be triggering changes in 5-hmC via induction of 
oxidative stress. This idea should be further explored in future studies examining the effects of 
endocrine disrupting chemicals on 5-hmC levels across the epigenome. 
BPA-related DHMRs at imprinted genes  
In addition to examining the effects of BPA on broad-scale DNA hydroxymethylation, 
we also specifically investigated whether BPA exposure altered 5-hmC content at murine 
imprinted genes. Of the 151 interrogated imprinted loci, twelve (7.95%) had annotated DHMRs 
(Table 3-3). As a broad scale comparison, out of the estimated 24,360 known protein-coding 
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genes in mice (Blake et al. 2017), 1,616 unique gene IDs had annotated DHMRs (6.63%). These 
results indicate that imprinted genes show slight enrichment for DHMRs compared to all known 
genes combined. Although none of the twelve imprinted gene BPA-related DHMRs overlapped 
with known imprinting control regions (ICRs) (Figure 3-8), expanded visualization of Gnas and 
Plagl1 showed widespread hydroxyl across imprinted gene regions. The directionality and 
magnitude of the imprinted gene DHMRs was also gene-specific. Of note, five of the imprinted 
gene DHMRs had zero CpG sites (Table 3-4), a result that could be driven by several possible 
scenarios: 1. DNA hydroxymethylation at non-canonical methylation contexts (i.e. CHG sites, 
where H = A, C, or T); 2. Inexact DHMR definitions due to inherent lack of specificity in 
pulldown method (HMeDIP-seq); 3. False positives in our data. Supporting the first option, 
recent work in mice has shown intragenic enrichment of non-CpG methylation at particular 
domains in clusters of genes related to embryonic development (He et al. 2017). Further fitting 
with this idea, eight of the twelve imprinted gene DHMRs had at least ten CHG sites within their 
chromosomal ranges (Table 3-4). Nevertheless, it remains difficult to distinguish between the 
three outlined scenarios using the data available in this project. The most significant imprinted 
gene DHMR was annotated to the Gnas locus, which encodes the G-protein alpha subunit 
protein, a key component of G-protein coupled signal transduction (Plagge and Kelsey 2006). 
Gnas is an imprinted gene that has a complex expression pattern, four alternative promoters, a 
number of isoforms, and may be involved in energy homeostasis (Peters and Williamson 2007; 
Plagge and Kelsey 2006). Given the complexity of transcriptional control at this locus, the 
identified intronic Gnas DHMR may represent a long-range regulatory region. This hypothesis is 
supported by research demonstrating that 5-hmC is enriched at enhancers (Ehrlich and Ehrlich 
2014; Stroud et al. 2011; Sun et al. 2013; Wen et al. 2014), regulatory regions that can be quite 
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distant from the gene promoters they activate (Pennacchio et al. 2013; Shlyueva et al. 2014). 
Based on this idea of distant regulatory regions, we hypothesized that the documented increase in 
intronic Gnas 5-hmC would show a corresponding BPA-related change in Gnas expression. 
Using RT-qPCR, we found increased Gnas expression by BPA exposure across all three time 
points, with the magnitude of this increase reaching significance at 10 months of age (Figure 3-
7). Given the complex regulation of this locus, the age-specific effect of BPA exposure on Gnas 
expression may be a result of changes in alternative splicing, which is dynamic during the aging 
process (Li et al. 2017). During aging, Gnas splicing could shift toward specific isoforms that are 
controlled by 5-hmC at the BPA-related DHMR, leading to a late adulthood effect of 
developmental BPA exposure. Future functional work should explore this idea, as well as test for 
potential effects of BPA exposure at the human GNAS locus. 
In addition to Gnas, three other imprinted genes – Grb10, Plagl1, and Pde10a – showed 
significant increases in 5-hmC by BPA exposure. The first of these additional hyper-
hydroxymethylated genes, Grb10, encodes the growth factor receptor-bound protein 10 (Grb10). 
Grb10 is involved in a number of biological processes, including cellular proliferation, apoptosis, 
and metabolism (Holt and Siddle 2005; Kabir and Kazi 2014; Plasschaert and Bartolomei 2015; 
Riedel 2004). Grb10 is maternally expressed in most tissues, but it is paternally expressed in the 
brain; this complex imprinting pattern is established through tissue-specific alternate promoters 
(Sanz et al. 2008). The tissue-specific maternal and paternal expression patterns of Grb10 have 
been linked to fetal growth and adult social behavior in mice, respectively (Garfield et al. 2011). 
This complex expression patterning is thought to be controlled via epigenetic modifications 
(Sanz et al. 2008). Like Gnas, the Grb10 DHMR is intronic, meaning any functional effects of 
differential 5-hmC at this region would have to be through long-distance contacts. The second 
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additional gene, Plagl1, encodes the pleomorphic adenoma of the salivary gland gene like 1 
(Plagl1) protein. Plagl1 is a zinc finger transcription factor that regulates other imprinted loci 
involved in embryonic growth, including H19 and Igf2 (Varrault et al. 2006, 2017). As such, 
BPA-related alterations in 5-hmC at Plagl1 have the potential to affect an entire network of 
imprinted genes. Like Gnas and Grb10, Plagl1 has several alternative transcripts in mouse that 
are controlled by alternate promoters (Iglesias-Platas et al. 2013). The Plagl1 DHMR overlaps 
Exon 8 in some Plagl1 isoforms, but not others, suggesting that this region may play a role in 
alternative splicing for this gene. The third additional hyper-hydroxymethylated imprinted gene, 
Pde10a, encodes phosphodiesterase 10A (Pde10a). Pde10a is a member of the cyclic nucleotide 
phosphodiesterases (PDEs), a family of enzymes that regulate intracellular levels of cyclic AMP 
(cAMP) and cyclic GMP (cGMP), endogenous molecules involved in signal transduction 
(Bender and Beavo 2006; Soderling et al. 1999). Pde10a shows its highest expression levels in 
the brain, with minimal expression in peripheral tissues (Bender and Beavo 2006; Soderling et al. 
1999). Recent research shows that pharmaceutical inhibition of Pde10a leads to increased energy 
expenditure, decreased food intake, reduced adiposity, and improved insulin sensitivity in mice 
with high-fat diet-induced obesity (Nawrocki et al. 2014). As such, altered regulation of the 
Pde10a gene has the potential to modify murine energy homeostasis. While we found a Pde10a 
DHMR in blood tissue, where expression is minimal, our developmental BPA exposure occurred 
throughout tissue differentiation, so it is possible that the BPA-related DHMR annotated to 
Pde10a is present in multiple tissues, including the brain.  
 We also visualized two hypo-hydroxymethylated DHMRs annotated to imprinted genes – 
Klf14 and Snrpn. The first of these genes, Klf14, encodes the maternally-expressed Krüppel-like 
factor 14 (Klf14), a member of the Cys2/His2 zinc-finger transcription factors (Small et al. 2011; 
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Wang et al. 2017). Research shows that KLF14 acts as master regulator of adipose gene 
expression in humans (Small et al. 2011), and may be involved in metabolic disease risk. In 
addition, recent results in mice suggest that Klf14 may interact with peroxisome proliferator-
activated receptor-γ coactivator 1α (PGC-1α), a transcription coactivator that regulates a number 
of metabolic pathways, including hepatic gluconeogenesis (Wang et al. 2017). Based on these 
prior studies, changes in 5-hmC at Klf14 have the potential to not only alter murine energy 
homeostasis, but also modify risk of metabolic disorders. The second imprinted gene to show 
BPA-related decrease in 5-hmC was Snrpn, a paternally expressed gene that encodes the SmN 
protein, a key component of the spliceosome in the brain (Shemer et al. 1997). Snrpn has 
multiple alternate promoters and splice variants, is directly related to neurological function, and 
is located in the human Prader-Willi + Angelman syndrome (PWS/AS) imprinted domain (Wu et 
al. 2012). The PWS/AS imprinted domain is highly complex, containing a large number of C/D 
box small nucleolar RNAs (snoRNAs) and two imprinting control (IC) regions – PWS-IC and 
AS-IC (Wu et al. 2012). Research suggests the snoRNAs play a role in the etiology of the murine 
PWS phenotype (Relkovic and Isles 2013; Skryabin et al. 2007), which is often characterized by 
weight gain, decreased activity, and impaired attention (Relkovic and Isles 2013). Here, we 
identified a BPA-related hypo-hydroxymethylated region in an intron of Snrpn. While the 
functional relevance of this region remains unknown, previous work has shown that 
developmental BPA exposure alters DNA methylation at SNRPN/Snrpn (Faulk et al. 2015; 
Susiarjo et al. 2013), providing support for the idea that BPA can affect the epigenome at this 
locus. Additionally, the human SNRPN domain is enriched for 5-hmC across the expressed allele 
in brain tissue, indicating that 5-hmC may have a functional role in control of SNRPN gene 
expression (Hernandez Mora et al. 2017). Therefore, it is possible that BPA-related changes in 
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Snrpn 5-hmC could alter gene transcription, thereby modifying risk for PWS, a neurobehavioral 
disorder.  
 Remarkably, BPA-related DHMRs at the described imprinted loci persisted throughout 
adulthood despite BPA exposure ending at postnatal day 21 (PND21). These data indicate that 
perinatal exposure to BPA can have long-lasting effects on 5-hmC. Given the complex role of 5-
hmC in regulating transcription activation (Hahn et al. 2014; Wu et al. 2011), the identified 
BPA-related DHMRs may reflect programmed changes in gene regulation. Supporting this idea, 
a number of recent studies have shown that 5-hmC is a stable epigenetic mark that has an 
important role in gene regulation (reviewed in (López et al. 2017)). Building on the existing data, 
our results show differential 5-hmC at imprinted genes with complex regulatory patterns, 
indicating that 5-hmC marks at these genes may play a role in establishment of alternative 
splicing in response to BPA exposure. Though limited, our RNA expression data support this 
idea, showing that BPA exposure has long-term functional consequences at the imprinted Gnas 
locus. Based on these results, a new hypothesis has emerged – that differential 5-hmC at 
imprinted genes could be an important mechanism driving the developmental origins of adult 
disease.  
In addition to the BPA-specific DHMRs, our data separately show that widespread 5-
hmC peaks are established across entire imprinted genes during development, and that these 
patterns persist throughout life. This was apparent at genes with annotated DHMRs – Gnas and 
Plagl1 – and well-characterized genes without annotated DHMRs – Igf2 and H19. These results 
match recent research in humans, which showed 5-hmC enrichment at the H19-IGF2 locus in 
brain and at GNAS A/B in placenta (Hernandez Mora et al. 2017). Combined, the available data 
indicate that 5-hmC may be involved in imprinting control. As technologies for measuring 
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genome-wide 5-hmC continue to advance, efforts should be made to further examine the 
regulatory role of 5-hmC in genomic imprinting. 
Pathway analysis 
GO terms showed specific enrichment based on directionality of differential 
hydroxymethylation. This suggests that BPA exposure is associated with both up- and down-
regulation of several biological processes. In the BPA-related hypo-hydroxymethylated DHMRs, 
the only two significantly enriched pathways were hippocampus development and spinal cord 
association neuron differentiation. While it is difficult to interpret these pathways from blood 
samples, 5-hmC has its highest levels in brain tissue, where it is suspected to play a role in 
neuron development (Kinde et al. 2015). As such, it’s possible that these enriched pathways 
reflect a pre-differentiation effect of developmental BPA exposure on 5-hmC in stem cells. 
Previous work has shown that epigenetic marks at imprinted genes are maintained during post-
fertilization reprogramming (Plasschaert and Bartolomei 2014), suggesting that the epigenetic 
effects of developmental exposure could be maintained at imprinted loci during cellular 
differentiation. Building on this idea, our results indicate that 5-hmC establishment at imprinted 
genes could be involved in regulating neural plasticity. Additional work in pre-differentiated 
cells and brain tissue could help determine whether BPA actually alters neuronal differentiation 
via 5-hmC.  
Limitations 
Little is known about the stability of 5-hmC at imprinted loci across blood cell type 
proportions, but previous studies have shown that epigenetic marks can vary across blood cell 
types (Houseman et al. 2012; Skinner 2016). As such, it is possible that the documented effects 
of BPA on genome-wide 5-hmC in blood are simply a reflection of shifts in blood cell type 
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proportions. Counter to this idea, however, previous studies have shown that DNA methylation is 
often conserved across different cell types at imprinted loci (Skinner 2016; Talens et al. 2010), 
suggesting that investigating differential methylation from whole blood should still be valid at 
imprinted genes. While this evidence supports the validity our BPA-related DHMRs at imprinted 
loci, the dynamics of 5-hmC at these imprinted genes across blood cell types remains to be 
elucidated. To further explore the idea that altered 5-hmC in blood impacts imprinted gene 
regulation, future studies should also investigate allele-specific expression in individual cell 
types using new single-cell RNA-seq methods (Santoni et al. 2017). Despite lingering blood cell 
type questions, the use of matched blood samples allowed for direct measurement of 5-hmC 
from the same mice over time, reducing the potential confounding of inter-individual variability. 
Additionally, matched blood samples provide greater translatability to human epigenetics 
studies, which typically rely on peripheral blood samples.  
Due to low RNA yields from the longitudinal blood samples, it was not possible to 
examine gene expression at all identified imprinted loci with annotated DHMRs. RNA yields 
were diminished due to the small amount of blood collected during in vivo tail vein collection at 
2 and 4 months of age. Despite the low amounts of blood RNA available, the use of longitudinal 
samples allowed for direct measurement of expression at the Gnas imprinted locus from the 
same longitudinal samples used for HMeDIP-seq data generation. As such, BPA-related changes 
in Gnas expression directly coincide with BPA-related alterations in DNA hydroxymethylation 
at this locus. 
DNA hydroxymethylation has only recently become recognized as an important 
consideration in the field of genomic imprinting, meaning its role in imprinting control is poorly 
defined. As a result, the exact functional effects of the BPA-related changes shown in this paper 
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remain undetermined. So far, the available research suggests that 5-hmC can have very different 
regulatory effects depending upon its genomic context, so the relationship between BPA-related 
DHMRs and gene expression could vary in a gene-specific manner. Similarly, the phenotypic 
effects of BPA-related DHMRs remain unclear without additional measures of murine biology 
throughout the life-course. Despite these limitations in interpretation, we identified a large 
number of BPA-related DHMRs, indicating that DNA hydroxymethylation is sensitive to 
environmental factors during development.  
3.5 Conclusions 
We measured 5-hmC in matched blood samples collected from isogenic mice at 2, 4, and 
10 months of age, and then examined the effects of BPA on the longitudinal DNA 
hydroxymethylation. Across the epigenome, we identified a number of exposure-related 
DHMRs, suggesting that perinatal BPA exposure can alter this DNA modification throughout 
life. At twelve imprinted loci, including the Gnas locus, developmental BPA exposure 
significantly altered 5-hmC peaks in blood across all three measured ages. Echoing this result, 
we showed that BPA exposure modified Gnas expression throughout murine adulthood. These 
results suggest that BPA-related increases in Gnas hydroxymethylation may have long-lasting 
effects on gene expression at this complex imprinted locus, possibly through shifts in alternative 
splicing. In addition to BPA-related DHMRs, we also found stable patterns of 5-hmC along a 
number of imprinted loci, including Igf2 and H19. Combined, our data indicate that 5-hmC may 
play an important regulatory role in imprinting control, and that establishment of DNA 
hydroxymethylation at imprinted loci may be sensitive to developmental BPA exposure. Future 
studies should examine the contribution of DNA hydroxymethylation to the methylome at 
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imprinted loci, as well as the impact of additional environmental exposures on this recently 
rediscovered epigenetic mark.  
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3.7 Figures and Tables 
 
Gene Full Name 
GenBank 
Number 
Strand Primers (5' to 3') Tm (°C) Amplicon Size 
Gapdh 
Glyceraldehyde 
3-phosphate 
dehydrogenase 
NM_008084.3 
FWD 
GCCTGCTTCACCACC
TTCTT 
59.96 
98 
RVS 
CATGGCCTTCCGTGT
TCCTA 
59.07 
Gnas 
GNAS (guanine 
nucleotide 
binding 
protein, alpha 
stimulating) 
complex locus 
NM_201618.2 
FWD 
CTGCCATCATCTTCG
TGGTG 
58.99 
193 
RVS 
GATTTGCCAGCGAG
GACTTT 
58.83 
Table 3-1: RT-qPCR primers for self-designed gene assays. Forward and reverse primer 
sequences for the Gapdh and Gnas RT-qPCR assays are listed, along with melting temperatures 
and amplicon size. All assays were designed using the online Genscript Real-time PCR Primer 
Design software (https://www.genscript.com/tools/real-time-pcr-tagman-primer-design-tool). 
 
 
 
 
 
 
 
Δ5-hmC BPA-related 
DHMRs* 
Hyper-hydroxymethylated 1559 
Hypo-hydroxymethylated 4247 
Both 144 
Total 5950 
Table 3-2: Differential 5-hmC in mouse blood by BPA exposure. The csaw R package was 
used to examine the effect of BPA exposure (50 µg/kg diet) on 5-hmC content across the 
epigenome. Models included a paired mouse ID variable to account for within-individual effects, 
as well as a sex variable. Directionality of DHMRs (relative to control) is indicated in separate 
rows. *DHMR-calling significance threshold was set at FDR < 0.10. 
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Chr Start End Gene ID 
Gene 
Name 
Locatio
n 
Direction 
with BPA 
exposure 
csaw 
score 
FDR 
chr2 174315451 174315750 14683 Gnas intronic + 113.4 <0.001 
chr11 12004801 12005100 14783 Grb10 intronic + 70.5 <0.001 
chr10 13130651 13131050 22634 Plagl1 exonic + 60.7 <0.001 
chr6 30957751 30958050 619665 Klf14 exonic - 55.9 <0.001 
chr17 8746901 8747050 23984 Pde10a intronic + 50.1 <0.001 
chr17 12828001 12828550 104103 Airn intronic - 16.2 0.02 
chr13 24335001 24335150 12763 Cmah intronic - 13.1 0.05 
chr7 60207401 60207600 20646 Snrpn intronic - 13.0 0.05 
chr6 5079501 5079850 243725 Ppp1r9a intronic - 12.8 0.05 
chr7 143348051 143348350 16535 Kcnq1 intronic - 11.5 0.07 
chr10 13402051 13402250 215789 Phactr2 intronic - 11.3 0.07 
chr13 108963951 108964200 238871 Pde4d intronic + 10.1 0.10 
Table 3-3: Imprinted genetic loci with BPA-related DHMR. List of imprinted loci with annotated, significant (FDR<0.10) DHMRs 
generated from csaw modeling results. The first four columns show the chromosomal location and entrez gene ID for each annotated 
imprinted gene. A transformed FDR is used for the csaw score, such that score = -10*log10(FDR); higher score indicates a larger 
degree of significance (lower FDR value). Additionally, direction of effect by BPA exposure is shown, with a (+) indicating increased 
5-hmC with BPA exposure, and a (-) indicating decreased 5-hmC with BPA exposure. 
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Gene 
Name 
Location Chr Start End CpG Sites CHG Sites 
Gnas intronic chr2 174315451 174315750 0 21 
Grb10 intronic chr11 12004801 12005100 0 13 
Plagl1 exonic chr10 13130651 13131050 0 17 
Klf14 exonic chr6 30957751 30958050 23 11 
Pde10a intronic chr17 8746901 8747050 1 10 
Airn intronic chr17 12828001 12828550 4 25 
Cmah intronic chr13 24335001 24335150 0 3 
Snrpn intronic chr7 60207401 60207600 0 0 
Ppp1r9a intronic chr6 5079501 5079850 1 31 
Kcnq1 intronic chr7 143348051 143348350 5 13 
Phactr2 intronic chr10 13402051 13402250 1 1 
Pde4d intronic chr13 108963951 108964200 1 5 
Table 3-4: Number of CpG and CHG sites at imprinted gene DHMRs. The number of CpG 
and CHG sites contained within the twelve BPA-related imprinted gene DHMRs were quantified 
using the mm10 reference genome (https://www.ncbi.nlm.nih.gov/nuccore). The number of CpG 
sites varied by region, with five of the DHMRs showing zero CpG sites. This unexpected result 
may be the byproduct of several possible scenarios: 1. DNA hydroxymethylation at non-
canonical methylation contexts (i.e. CHG sites); 2. Inexact DHMR definitions due to inherent 
lack of specificity in pulldown method (HMeDIP-seq); 3. False positives in our data. CpG and 
CHG sites were counted from the exact chromosomal range that was defined as a BPA-related 
DHMR. 
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Hypo-hydroxymethylated BPA-related  DHMR  Pathways 
Pathway Type Description FDR Genes 
Gene Ontology 
Biological 
Process 
hippocampus 
development 
0.007896 
12568, 
12570, 
19280, 
22062, 
22416 
 
Gene Ontology 
Biological 
Process 
spinal cord association 
neuron differentiation 
0.013765 
18505, 
21349, 
22416 
  
  
 
  
 
Hyper-hydroxymethylated BPA-related DHMR Pathways 
Pathway Type Description FDR Gene IDs 
Gene Ontology 
Molecular 
Function 
L-ascorbic acid binding 0.006355 
18484, 
320452 
Gene Ontology 
Molecular 
Function 
oxidoreductase activity, 
acting on paired donors, 
with incorporation or 
reduction of molecular 
oxygen 
0.006355 
13105, 
18484, 
232174, 
320452, 
60527 
Gene Ontology 
Cellular 
Component 
nucleolar part 0.02366 
12578, 
68147 
Gene Ontology 
Biological 
Process 
positive regulation of 
establishment of protein 
localization to plasma 
membrane 
0.028313 
56212, 
76686 
Gene Ontology 
Molecular 
Function 
isoprenoid binding 0.041794 
225467, 
232174 
Table 3-5: Enriched BPA-related DHMR pathways. Pathway analysis for DHMRs was 
performed using the ChIP-enrich analysis tool (http://chip-enrich.med.umich.edu/). Within the 
ChIP-enrich tool, the gene set filter was set to 2000, peak threshold was set to 1, and adjustment 
for mappability of gene locus regions was set to false. The genome used for pathway analyses 
was mm10, and the ChIP-enrich method was used for enrichment testing. DHMRs were split into 
hypo- and hyper-methylated regions prior to separate analyses. Only regions <5kb from TSS 
were included in ChIP-enrich analysis. All pathway analyses included GO terms and KEGG 
pathways. After correcting for multiple testing, only pathways with FDR<0.05 were considered 
significant. Significant pathways for hypo- and hyper-methylated DHMRs are listed in separate 
tables; there was no overlap between significant pathways for these separate analyses. None of 
the significant pathways included any imprinted genes. 
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Figure 3-1: Exposure paradigm and blood collection time points to measure longitudinal 5-
hmC patterns. Two weeks prior to mate-pairing with Avy/a males, six week old wild type a/a 
dams were placed on one of two experimental diet groups: (1) Control (modified AIN-93G), (2) 
Control + 50 µg BPA/kg diet. Exposure continued through pregnancy and lactation, ending for 
offspring at PND21. Matched blood samples were collected from wildtype a/a offspring at 2 
months, 4 months, and 10 months of age. 
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Figure 3-2: Sequencing data collection and analysis workflow. Genomic DNA was isolated 
from matched wild type a/a offspring blood samples at 2 months, 4 months, and 10 months of 
age. DNA was isolated from a subset of control (n=6 per age group) and BPA-exposed (n=6 per 
age group) mice, then processed in preparation for HMeDIP-seq. All processed samples were 
amplified and sequenced on an Illumina HiSeq 4000 sequencer using single-end, 50 nt reads. 
BPA-related differentially hydroxymethylated regions (DHMRs) were identified and annotated 
using a bioinformatics pipeline. Annotated DHMRs were then visualized in the genome browser. 
One target gene region – Gnas – was then validated using RT-qPCR on available RNA from the 
blood samples. 
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Figure 3-3: Differential imprinted gene 5-hmC peaks by BPA exposure. 5-hmC coverage was visualized at six imprinted loci with 
significant BPA-related DHMRs. 5-hmC peaks are shown for matched 2 month, 4 month, and 10 month blood samples, as indicated 
by y-axis labels. Blue and red peaks represent forward and reverse strand 5-hmC enrichment, respectively. All six DHMRs showed 
stable, longitudinal changes in 5-hmC peaks based on perinatal BPA exposure (50 µg/kg diet). A) Gnas showed BPA-related 
enrichment of 5-hmC in an intronic region. B) Grb10 also showed BPA-related enrichment of 5-hmC in an intronic region. C) Plagl1 
showed BPA-related enrichment of 5-hmC in an exonic region. D) Klf14 showed BPA-related depletion of 5-hmC in an exonic region. 
E) Pde10a showed subtle BPA-related enrichment of 5-hmC in an intronic region. F) Snrpn showed subtle BPA-related depletion of 
5-hmC in an intronic region. The degree of 5-hmC enrichment or depletion by perinatal BPA exposure varied by imprinted locus, 
indicating that BPA has a variable effect on 5-hmC establishment at imprinted genes during development. 
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Figure 3-4: Additional differential imprinted gene 5-hmC peaks by BPA exposure. 5-hmC 
coverage was visualized at an additional six imprinted loci with significant BPA-related 
DHMRs. These six DHMRs also showed stable, longitudinal changes in 5-hmC peaks based on 
perinatal BPA exposure (50 µg/kg diet). A) Airn showed BPA-related depletion of 5-hmC across 
an intronic region. B) Cmah showed BPA-related depletion of 5-hmC in an intronic region. C) 
Ppp1r9a showed BPA-related depletion of 5-hmC in an intronic region. D) Kcnq1 showed subtle 
BPA-related depletion of 5-hmC in an intronic region. E) Phactr2 showed BPA-related depletion 
of 5-hmC in an intronic region. F) Pde4d showed BPA-related enrichment of 5-hmC in an 
intronic region. The degree of 5-hmC enrichment or depletion by perinatal BPA exposure varied 
by imprinted locus. 
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Figure 3-5: 5-hmC peaks at the Igf2/H19 imprinted loci. Based on results at the Plagl1 locus, which is a regulator of Igf2 and H19, 
longitudinal 5-hmC patterns across the Igf2 and H19 imprinted genes were also visualized. 5-hmC peaks at both loci appear stable 
across individuals and adulthood stage in longitudinal mouse blood (2, 4, and 10 months old). Regions of non-significant BPA-related 
differential 5-hmC are indicated in red boxes for both genes. Specifically, Igf2 shows BPA-related hypo-hydroxymethylation, and H19 
shows BPA-related hyper-hysdroxymethylation. Despite not being detected as significant DHMRs in csaw, these BPA-related changes 
in 5-hmC were stable at all three measured time points.
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Figure 3-6: Genomic context of Gnas and Plagl1 DHMRs. The DHMRs annotated to the Gnas and Plagl1 genes were visualized in 
the context of their respective imprinted genes using the csaw and Gviz R packages. 5-hmC peaks across the complete Gnas and 
Plagl1 imprinted loci are presented, showing distinct 5-hmC peaks along the length of both genes. 5-hmC peaks are shown for 
matched 2 month, 4 month, and 10 month blood samples, as indicated by y-axis labels. Black boxes indicate significant DHMRs that 
were identified using csaw differential hydroxymethylation models. Blue and red peaks represent forward and reverse strand 5-hmC 
enrichment, respectively. Green boxes below UCSC gene tracks represent CpG islands. 
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Figure 3-7: Gnas expression by BPA exposure and age. Based on BPA-related DHMR 
annotated to the Gnas gene, RT-qPCR was used to investigate longitudinal blood Gnas mRNA 
expression levels. Three housekeeping genes – Actb, 18S, and Gapdh – were included as internal 
controls in all RT-qPCR runs. In addition to housekeeping genes, an inter-plate calibrator control 
of brain cDNA was included for calculation of relative gene expression across multiple plates; all 
expression values are shown relative to this inter-plate calibrator. Expression levels were 
calculated following the 2
−ΔΔCt
 method. 
a
Mean Gnas expression in BPA-exposed mouse blood 
showed a significant increase between 2 and 10 months of age (p=0.05); this pattern was not 
found in control samples. 
b
Mean Gnas expression was significantly lower in control blood than 
BPA-exposed blood at 10 months of age (p=0.01). 
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Figure 3-8: Organization of the Gnas, Grb10, Plagl1, Klf14, Pde10a, and Snrpn imprinted loci. The thick black mid-line 
represents the gene sequence. Maternally expressed exons are indicated by black boxes, and paternally expressed exons are indicated 
by grey boxes. Exon locations for each gene are relative, but not to scale. Exon 1 of the Gnas gene is both maternally and paternally 
expressed, and is therefore indicated by a white box. Arrows show directionality and start sites for transcription. Parental origin-
specific expression patterns are represented by location of arrow above or below middle line, and context-specific expression is 
indicated by dotted arrows. Filled and empty circles represent methylated or unmethylated alleles, respectively. Imprinting control 
regions (ICRs) are indicated by dotted line boxes, and BPA-related DHMRs are indicated by boxes bordered by dotted vertical lines. 
None of the identified BPA-related DHMRs are located in known imprinting control regions. 
1
Adapted from (Tibbit et al. 2015).
 
2
Adapted from (Hikichi et al. 2003).
 3
(Iglesias-Platas et al. 2012; Smith et al. 2002).
 4
Adapted from (Parker-Katiraee et al. 2007).
 
5
(Wang et al. 2011).
 6
(Sanli and Feil 2015; Shemer et al. 1997). 
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Chapter 4  
Age-related Epigenome-wide DNA Methylation and Hydroxymethylation in 
Longitudinal Mouse Blood 
 
 
Abstract 
DNA methylation status at cytosine-phosphate-guanine (CpG) dinucleotides changes as a 
function of age in humans and animal models, a process that may contribute to chronic disease 
development. Recent studies have begun to investigate the role of an oxidized form of DNA 
methylation – 5-hydroxymethylcyotisine (5-hmC) – in the epigenome, but its role in age-related 
DNA methylation remains unclear. We tested the hypothesis that 5-hmC changes with age, but in 
a direction opposite to 5-methylctosine (5-mC), thereby playing a distinct role in epigenetic 
aging. To characterize whether epigenetic aging is driven by changes in 5-mC or 5-hmC, DNA 
modifications were measured in longitudinal blood samples (2, 4, and 10 months of age) from 
isogenic mice. Genome-wide 5-mC and 5-hmC levels were measured using two sequencing 
methods – enhanced reduced representation bisulfite sequencing (ERRBS) and 
hydroxymethylated DNA immunoprecipitation sequencing (HMeDIP-seq). Examining the 
epigenome by age, we identified 38,300 unique differentially methylated CpGs (DMCs) and 
8,613 differentially hydroxymethylated regions (DHMRs). Comparing age-related DMCs and 
DHMRs, 1,854 annotated genes showed both differential 5-mC and 5-hmC, including one gene – 
Nfic – at five CpGs in the exact same chromosomal region. At this shared region, 5-mC and 5-
hmC levels both decreased with age. Reflecting these age-related epigenetic changes, Nfic RNA 
expression in blood decreased with age, suggesting that age-related regulation of this gene may 
be driven by 5-hmC, not canonical DNA methylation. Combined, our genome-wide results show 
age-related differential 5-mC and 5-hmC, as well as some indication that changes in 5-hmC may 
drive age-related DNA methylation and gene expression. 
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4.1 Introduction 
Epigenetics refers to the study of heritable and potentially reversible changes in gene 
expression unrelated to the DNA sequence. Epigenetic marks include alterations to DNA itself 
(e.g. DNA methylation), chromatin modifications (e.g. histone tail trimethylation), and non-
coding RNAs (Bernal and Jirtle 2010; Egger et al. 2004). DNA methylation, which is the focus 
of this study, is typically defined as the addition of a methyl group to the 5’-carbon of cytosine in 
a Cytosine-phosphate-Guanine (CpG) dinucleotide; in simpler terms, it is termed 5-
methylctyosine (5-mC). Previous work has shown that increased promoter DNA methylation is 
associated with decreased transcription factor binding and decreased gene transcription 
(Medvedeva et al. 2014). During development, the methylome undergoes discrete waves of 
demethylation and de novo methylation (Reik et al. 2001; Smallwood and Kelsey 2012), 
processes that help regulate both somatic cell differentiation and primordial germ cell 
proliferation (Messerschmidt et al. 2014). 
Despite their establishment during development and maintenance through cellular 
replication, DNA methylation levels demonstrate clear changes with age. Predictable, 
unidirectional changes in DNA methylation that occur with age are referred to as “age-related 
methylation” (Jung and Pfeifer 2015; Kochmanski et al. 2017). Separate from these predictable 
changes, there are also stochastic, bidirectional alterations in epigenetic variability that occur 
with age; these are referred to as “epigenetic drift” (Jones et al. 2015; Kochmanski et al. 2017). 
Combined, these two processes represent “epigenetic aging,” a phenotype of age-associated 
changes in the epigenome. These age-related changes in DNA methylation have important 
implications for transcriptional control and protein expression throughout life, and may underlie 
later-life disease development. 
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Separate from 5-mC, recent studies have begun to investigate the role of an oxidized 
form of DNA methylation – 5-hydroxymethylcyotisine (5-hmC) – in the epigenome. 
Hydroxylation of 5-mC to 5-hmC occurs via the Ten-eleven translocation (TET) dioxygenase 
enzymes, and 5-hmC is an intermediate on the active demethylation pathway (Shen et al. 2014). 
Beyond its role in demethylation, however, recent evidence suggests that 5-hmC is a secondary 
epigenetic mark that has a complex role as a regulator of transcription (Hahn et al. 2014; Wu et 
al. 2011). Previous studies have shown that 5-hmC is specifically recognized by DNA-binding 
proteins (Mellén et al. 2012; Spruijt et al. 2013), and that 5-hmC enrichment varies by tissue and 
genic region in mouse and human tissues (Globisch et al. 2010; Hernandez Mora et al. 2017; 
Nestor et al. 2012; Wen et al. 2014). Despite the increased interest in 5-hmC as an epigenetic 
mark, traditional bisulfite treatment sequencing methods do not distinguish between 5-mC and 5-
hmC (Huang et al. 2010), so it remains unclear whether 5-hmC contributes to epigenetic aging. 
Here, we tested the hypothesis that 5-hmC would change with age, but in a direction opposite to 
5-mC, thereby playing a distinct role in the aging epigenome. 
4.2 Results 
ERRBS – epigenome-wide differential 5-mC+5-hmC 
Enhanced reduced representation bisulfite sequencing (ERRBS) is a bisulfite treatment-
based sequencing method that measures epigenome-wide 5-mC and 5-hmC at the same time. 
Despite this, to remain consistent with previous studies, we refer to all ERRBS data using the 
catch-all terms “methylation” or “5-mC.” Using the DSS R package, multifactorial models were 
used to test for differential methylation by age in matched ERRBS data from blood samples 
collected at three time points – 2 months old (n=6), 4 months old (n=6), and 10 months old (n=6) 
(Figure 4-1). In total, we identified 20 differentially methylated regions (DMRs) and 28196 
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differentially methylated CpGs (DMCs) by age (Table 4-1). Comparing the directionality of 
DMRs by age, we found slightly more hypomethylated DMRs (n=11; 55.0%) than 
hypermethylated DMRs (n=9; 45.0%). Conversely, we found more hypermethylated DMCs 
(n=17460; 61.9%) than hypomethylated DMCs (n=10736; 38.1%) by age (Table 4-1). Using the 
annotatr R package, all DMRs and DMCs were annotated to the mm10 genome. Comparing to a 
random distribution generated from the ERRBS libraries, age-related DMCs showed variable 
patterns of enrichment and depletion depending on the genomic annotation. Of note, age-related 
DMCs were enriched at promoters, CpG islands, CpG shores, CpG shelves, promoters, 5’ UTRs, 
and exons, but were depleted at interCGI regions. (Figure 4-2).  
HMeDIP-Seq – epigenome-wide differential 5-hmC 
Unlike ERRBS, HMeDIP-seq is an immunoprecipitation-based method that measures 
only 5-hmC; therefore, we refer to HMeDIP-seq data as “hydroxymethylation” or “5-hmC.” For 
the HMeDIP-seq data, multivariate models were constructed in the csaw R package to test for 
differential 5-hmC by age. Based on the csaw models, we identified 8613 DHMRs by age (Table 
4-1). Comparing the directionality of DHMRs by age, almost all DHMRs were hypo-
hydroxymethylated (n=8446; 98.1%) compared to hyper-hydroxymethylated (n=160; 1.9%). We 
also identified a small fraction of age-related DHMRs that showed both hypo- and hyper-
hydroxymethylation (n=7; 0.001%). Using the annotatr R package, age-related DHMRs were 
annotated to the mm10 genome. Comparing to a random distribution, age-related DHMRs 
showed moderate enrichment at CpG shores, CpG shelves, promoters, 3’-UTRs, 5’-UTRs, 
exons, and introns, as well as mild depletion at interCGI regions and CpG islands (Figure 4-2). 
On a broad scale, our data showed decreased epigenome-wide 5-hmC with age. 
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Comparison of epigenome-wide differential 5-mC and 5-hmC 
 Due to inherent bias in the ERRBS method, the measured 5-mC levels have incomplete 
coverage across the genome, making direct comparison to the genome-wide HMeDIP-seq data 
imperfect. Despite this limitation, we used the bedtools intersect function to directly compare 
annotated DMRs/DMCs and DHMRs by chromosomal location across the epigenome. For age-
related DMCs and DHMRs, we found 65 CpGs that intersected by chromosomal location 
(Figure 4-3). However, when comparing age-related DMRs and DHMRs, we found zero regions 
matched by chromosomal location. For the age-related DMC and DHMR overlap sites, there 
were 40 unique annotated gene IDs. Of these 40 genes, three had multiple DMCs that overlapped 
a DHMR – Fbln1, Ldlrad3I, and Nfic. At the Nfic locus, we identified five age-related DMCs 
overlapping a single DHMR. These five sites are located in a CpG shelf 2588-2639 bp upstream 
of the Nfic gene (Figure 4-4).  
 Building on our previous research in mouse tail and blood samples from this colony 
(Kochmanski et al. 2016, 2018), we checked for age-related DMRs, DHMRs, and DMCs 
annotated to the Esr1 gene. While we did not find any age-related DHMRs or DMRs annotated 
to the Esr1 gene, it did have seven annotated age-related DMCs (Table 4-2). Examining the age-
related Esr1 DMCs, four of the sites had increased methylation with age, including two CpGs 
annotated to the promoter region. The other three age-related Esr1 DMCs -- one exonic and two 
intronic – showed decreased methylation with age. Given the large number of DMCs annotated 
to Esr1, we interrogated the HMeDIP-seq data at the Esr1 gene, pulling out a large region that 
contained all annotated DMCs. On this broad scale, we did not see any obvious differences in 5-
hmC by age, but we did find stable 5-hmC peaks across the Esr1 genic region (Figure 4-5). This 
suggests that 5-hmC levels at the Esr1 locus are stable during adulthood in mouse blood. 
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RT-qPCR expression data 
 To further investigate the functional effects of age-related epigenetic results at the Nfic 
and Esr1 genes, we performed RT-qPCR using RNA from the same matched mouse blood 
samples (primers available in Table 4-3). We found a significant decrease in Nfic expression 
between 2 and 10 months of age in blood samples (p=0.04), but no significant change in Esr1 
expression with age (Figure 4-6). The significant decrease in Nfic expression with age echoes 
the observed age-related decrease in 5-hmC upstream of the Nfic gene. Conversely, the lack of 
an observed difference in Esr1 expression with age is consistent with the stable 5-hmC levels at 
Esr1 across adulthood. 
Pathway analysis 
ChIP-enrich pathway analysis was performed on separate lists of hyper- and hypo-
methylated age-related DMCs and DHMRs. DMC and DHMR datasets were both restricted to 
sites and regions <5kb from the transcription start site. Due to the large number of significant 
CpGs, DMC datasets were further limited to sites annotated to a gene promoter. After correction 
for multiple testing, a number of molecular function and biological process GO terms were 
enriched in hypo- and hyper-methylated age-related DMCs and DHMRs. Of note, enriched 
pathways showed very little overlap between hypo- and hypermethylated sites or regions, 
showing specific enrichment based on directionality of differential methylation or 
hydroxymethylation. DHMR pathways were particularly discordant, showing no overlap 
between hyper- and hypo-methylated regions for age-related DHMRs. The hypo-
hydroxymethylated DHMRs showed enrichment for T cell activation pathways, while hyper-
hydroxymethylated DHMRs showed enrichment for B cell activation pathways. Unlike the 
discordance found in the DHMRs, there was some overlap in enriched pathways between hyper- 
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and hypo-methylated DMCs. Specifically, for the age-related DMCs, both hyper- and hypo-
methylated sites showed enrichment for development of primary sexual characteristics.  
4.3 Discussion 
The results from this study indicate that both 5-mC and 5-hmC are dynamic with age in 
mouse blood. We identified statistically significant age-related DNA methylation and 
hydroxymethylation on an epigenome-wide scale, indicating that both epigenetic marks are 
altered during murine aging. To our knowledge, this is the first study to examine age-related 5-
hmC levels in a longitudinal model. Given the lack of available research on this topic, the 
biological effects of age-related changes in DNA hydroxymethylation remain poorly 
characterized. However, we found moderate enrichment of age-related DHMRs at CpG shores, 
CpG shelves, promoters, 5’-UTRs, exons, introns, and 3’-UTRs compared to a random 
distribution (Figure 4-2). While this enrichment of DHMRs at specific genomic locations was 
subtle, DHMRs also showed a clear bias toward hypo-hydroxymethylation with age (Table 4-1), 
a pattern supported by human studies showing decreased 5-hmC levels in blood with age 
(Truong et al. 2015; Xiong et al. 2015). Combined, these data suggest that age-related changes in 
5-hmC are non-random, and that DNA hydroxymethylation could play an important role in the 
aging process. Future studies should examine whether longitudinal 5-hmC levels can be used to 
accurately predict biological age, as has been shown in DNA methylation (Horvath 2013).  
Contrary to our original hypothesis, there was little overlap between sites or regions of 
age-related methylation and regions of age-related hydroxymethylation. It’s possible that this 
lack of overlap reflects differences in the effects of aging on 5-hmC and 5-mC, with age-related 
changes in these separate epigenetic marks occurring at disparate genomic regions. This idea is 
supported by recent evidence showing that 5-hmC is a stable epigenetic mark with its own 
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distinct genomic distribution (Hahn et al. 2014; López et al. 2017; Stroud et al. 2011). 
Alternatively, this lack of overlap could be due to the limited genomic coverage of the ERRBS 
method; a more complete comparison of 5-mC and 5-hmC could be achieved using whole-
genome bisulfite sequencing. Using the available data, only 65 age-related DMCs overlapped the 
annotated DHMRs by chromosomal location. After annotating these 65 CpG sites to the mm10 
genome, we identified one gene – Nfic – with five age-related DMCs overlapping a single 
DHMR. These five sites are 2588-2639 bp upstream of the Nfic gene, a locus that encodes the 
nuclear factor I-C (NFI-C) protein (Figure 4-4). NFI-C is a member of the nuclear factor I (NFI) 
transcription factors, a class of proteins involved in stem cell differentiation and maintenance 
during development and adulthood, respectively (Harris et al. 2015). While NFI proteins are 
expressed in most adult tissues (Chaudhry et al. 1997; Gronostajski 2000), the limited available 
research on NFI-C shows that it plays an important role in hepatocyte proliferation during liver 
regeneration (Edelmann et al. 2015) and odontoblast and osteoblast differentiation (Lee et al. 
2014; Roh and Park 2017). As a result, age-related changes in Nfic regulation could have 
important consequences on tissue maintenance with age. This idea is supported by the fact that 
Nfic
-/-
 mice exhibit an age-related osteoporosis-like phenotype (Lee et al. 2014). In our 
longitudinal data, we found simultaneous age-related decreases in combined 5-mC+5-hmC levels 
(ERRBS) and 5-hmC peaks (HMeDIP-seq) upstream of the Nfic gene. This overlap suggests that 
age-related decreases in DNA methylation at this region may be at least partially driven by 
decreases in 5-hmC levels. Given that 5-hmC has shown localization to enhancers and positive 
associations with gene expression (Ehrlich and Ehrlich 2014; Greco et al. 2016; Sérandour et al. 
2012; Wen et al. 2014), we predicted that Nfic expression would decrease with age in 
concordance with 5-hmC levels. Matching our expectation, Nfic expression decreased with age 
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in blood (Figure 4-6), supporting the idea that 5-hmC, not 5-mC, may be driving age-related 
changes in the methylome upstream of the Nfic gene. This result, while only from a single gene, 
highlights the importance of considering 5-hmC when examining age-related methylation 
patterns. Without measuring 5-hmC, the documented age-related decreases in 5-mC and Nfic 
expression would have been difficult to reconcile with the classic view that DNA methylation is 
a repressive epigenetic mark. As a result, it is important for future studies investigating 
epigenetic aging to consider the contribution of DNA hydroxymethylation. 
In a previous study, we found age-related DNA methylation changes at the Esr1 gene 
promoter (chr10:4712147-4712203) in matched mouse tail and blood tissues (Kochmanski et al. 
2016, 2018). To follow up on these results, we interrogated our sequencing data for age-related 
DMCs annotated to the Esr1 locus. In total, we found seven age-related DMCs annotated to 
Esr1; four of these sites had increased methylation with age, including two CpGs in the promoter 
region (Table 4-2). This result matches our prior results, which showed increased promoter Esr1 
methylation with age in murine tail and blood (Kochmanski et al. 2016, 2018). Upon locating the 
seven DMCs annotated to Esr1, we also examined the HMeDIP-seq data at the Esr1 gene, 
visualizing a region containing all of the annotated Esr1 DMCs. We did not find any significant 
differences in Esr1 5-hmC by age; instead, there were a number of 5-hmC peaks along the Esr1 
gene body that were stable across individuals and time (Figure 4-5). This suggests that 5-hmC 
content at the Esr1 locus is tightly regulated, and may not contribute to the documented age-
related methylation patterns at this locus. 
Enriched age-related GO terms were discordant between hypo- and hypermethylated sites 
and regions, showing specific enrichment based on directionality of differential methylation or 
hydroxymethylation. This suggests that age is associated with up- or down-regulation of various 
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biological processes. In the age-related DHMRs, hypo-hydroxymethylated regions showed 
enrichment for T cell activation pathways and hyper-hydroxymethylated regions showed 
enrichment for B cell activation pathways. Reports have shown age-related changes in T cell and 
B cell function and generation (Cancro et al. 2009; Moro-García et al. 2013), so these differences 
in enriched pathways may reflect distinct epigenetic changes that occur in T cell and B cell 
populations with age. Related to this idea, it is possible that many of the age-related enriched 
pathways are actually a result of shifting blood cell populations, not defined changes in 
biological regulation. This possibility should be further investigated in additional longitudinal 
studies of the mouse and/or human blood epigenome. 
DNA methylation and hydroxymethylation levels vary by tissue (Globisch et al. 2010; 
Lokk et al. 2014; Maegawa et al. 2010), so it remains to be seen whether the documented 
epigenetic aging in blood would be consistent in other murine tissues – e.g. liver, kidney, brain. 
Despite this uncertainty, blood samples have some distinct advantages over other murine target 
tissues. First, we were able to collect blood samples from the same mice over time, allowing for 
direct measurement of intra-individual age-related methylation during adulthood. Second, the use 
of tail vein puncture at 2 and 4 months of age meant that blood collection was minimally 
invasive and did not disrupt mouse health. Third, the use of blood allows for greater 
translatability to human epigenetics studies, which often use peripheral blood samples collected 
in the field or clinic. For these reasons, we chose to use blood samples as our tissue of interest; 
however, future studies should examine whether our results carry over to other target tissues. 
As stated previously, the number of significant age-related DMRs identified in the 
ERRBS data was relatively small compared to the number of age -related DMCs. This result is 
likely the byproduct of two combined factors – inherent limitations of the ERRBS method and 
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our variable of interest (aging). ERRBS is not a whole-genome sequencing method, rather 
relying on MspI (C^CGG) restriction enzyme digestion to enrich for GC-rich regions prior to 
amplification and sequencing (Garrett-Bakelman et al. 2015). CpG-dense regions are often found 
in regulatory regions (e.g. promoters), and may be under tight biological control, limiting 5-mC 
variability. Additionally, these well-regulated regions may not be sensitive to a variable like age, 
which shows lower magnitude epigenetic effects than distinct disease states like cancer. 
Supporting this idea, previous literature shows that age-related methylation occurs at high rates 
in repetitive elements and intragenic regions (Zampieri et al. 2015), genetic locations that are not 
well covered by ERRBS. The genomic bias inherent in ERRBS data may also partially explain 
the low number of overlapping DMCs and DHMRs in our data. Specifically, we noted a number 
of DHMRs that did not have coverage in ERRBS data, a constraint that weakened our 
comparative analyses. 
In addition to coverage inconsistencies, data from the two sequencing methods were also 
analyzed using different statistical methods. For the ERRBS data, an analysis pipeline was 
created based on the DSS R package, which uses a Bayesian hierarchical model to estimate and 
shrink gene- or CpG site-specific dispersions, then detects differential expression/methylation 
using a Wald statistical test. This is appropriate for the ERRBS data, which provides read 
coverage for discrete CpG sites. Meanwhile, for the HMeDIP-seq data, we used the csaw R 
package, which uses sliding windows to identify differences in binding patterns for 5-
hydroxymethylcytosine across the genome. This is appropriate for the HMeDIP-seq data 
structure because it provides read coverage across regions. While these analysis methods are 
appropriate for their respective sequencing data types, their differences in resolutions and 
statistical methods make it difficult to directly compare called DMRs/DMCs and DHMRs. To 
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avoid these limitations, future studies could use similar methods – e.g. whole genome bisulfite 
sequencing (WGBS) and oxidative bisulfite sequencing (oxBS-seq) – to measure epigenome-
wide site-specific 5-mC and 5-hmC. While expensive, WGBS provides genomic coverage far 
greater than ERRBS (Ziller et al. 2014), and simultaneous oxBS-seq sequencing would allow for 
a direct comparison of 5-mC and 5-hmC at the base pair level (Booth et al. 2013). In this way, it 
would be possible to probe for additional genomic regions where epigenetic aging is driven by 
changes in 5-hmC. 
4.4 Conclusion 
We measured DNA methylation and hydroxymethylation in matched blood samples 
collected from isogenic mice at 2, 4, and 10 months of age, then examined the effects of age on 
the longitudinal methylome. The use of matched blood allows for greater translatability to 
bioavailable specimens in human populations. On an epigenome-wide scale, we identified a 
number of age-related DMCs, DMRs, and DHMRs, suggesting that age alters both 5-mC and 5-
hmC levels throughout the murine life course. Examining the age-related DMCs and DHMRs, 
we found a small number of DMC/DHMR overlap regions, including one upstream of the Nfic 
gene. At this region, both 5-mC and 5-hmC decreased with age, patterns that were reflected in 
decreased Nfic mRNA expression. This result suggests that age-related methylation patterns at 
some genes can be at least partially driven by changes in DNA hydroxymethylation, an 
important consideration for future epigenetic aging studies.  
4.5 Materials and Methods 
Study animals and blood collection 
Mice included in longitudinal analyses (n=6) were a/a offspring sourced from a 
genetically invariant A
vy
/a mouse colony maintained by sibling mating and forced heterozygosity 
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for more than 220 generations (Waterland and Jirtle 2003). Within this colony, the A
vy
 allele is 
passed through the heterozygous male line, which has a genetically constant background 93% 
identical to C57BL/6J strain (Waterland and Jirtle 2003; Weinhouse et al. 2014). At 2 months 
and 4 months of age, tail vein blood samples were collected from all mice (Figure 4-1). At 10 
months of age, mice were sacrificed, and blood samples were collected using cardiac puncture. 
All animals were stored in polycarbonate-free cages with ad libitum access to food and drinking 
water, and were maintained in accordance with Institute for Laboratory Animal Research (ILAR) 
guidelines (National Research Council (US) Committee for the Update of the Guide for the Care 
and Use of Laboratory Animals 2011). Mice were fed a modified AIN-93G standard chow with 
7% corn oil substituted for 7% soybean oil (Harlan Teklad). The study protocol was approved by 
the University of Michigan Committee on Use and Care of Animals (UCUCA).  
DNA and RNA isolation 
Genomic DNA and RNA were isolated from matched 2 month (n=6), 4 month (n=6), and 
10 month (n=6) frozen blood using the Qiagen Allprep DNA/RNA/miRNA Universal Kit 
(Qiagen, Cat. #80224). All isolates were stored at -80°C.  
Next-generation sequencing of 5-mC and 5-hmC 
Epigenome-wide DNA hydroxymethylation and methylation levels were quantified in 
blood from mouse blood using two sequencing methods -- hydroxymethylated DNA 
immunoprecipitation sequencing (HMeDIP-seq) and enhanced reduced representation bisulfite 
sequencing (ERRBS) (Garrett-Bakelman et al. 2015; Tan et al. 2013). Standard bisulfite 
sequencing methods, including ERRBS, do not distinguish between 5-mC and 5-hmC, so 
HMeDIP-seq data was generated in parallel to ERRBS to specifically measure epigenome-wide 
5-hmC. Sequencing data were generated for a subset of colony mice (n=6) with longitudinal 
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blood collection (Figure 4-1). Blood samples from the six mice (3 male, 3 female) were 
sequenced at three time points across the life-course (2, 4, and 10 months of age), giving a total 
sequencing data sample size of 18 samples for each method. The six mice included in 
longitudinal analyses were selected from different litters to minimize potential batch effects.  
ERRBS was performed at the University of Michigan Epigenomics Core as described 
(Akalin et al. 2012; Garrett-Bakelman et al. 2015). Briefly, 75 ng of genomic DNA was digested 
using MspI, a restriction enzyme that preferentially cuts CG-rich sites. The digested DNA was 
then purified using phenol:chloroform extraction and ethanol precipitation in the presence of 
glycogen, before blunt-ending and phosphorylation. A single adenine nucleotide was next added 
to the 3’end of the fragments in preparation for ligation of adapter duplex with a thymine 
overhang. The ligated fragments were cleaned, and processed for size selection on agarose gel. 
Selected fragments were treated with sodium bisulfite to convert unmethylated cytosines to 
uracils, which are then replaced with thymines during PCR amplification. After cleanup with 
AMPure XP beads (Beckman Coulter, Prod.# A63880), libraries were quantified using the 
Agilent TapeStation genomic DNA kit (Agilent, Cat. #G2991AA) and Qubit broad range dsDNA 
(Invitrogen, Cat. #Q32850). Single-end, 50 base pair reads were obtained for each library by 
sequencing on the HiSeq 4000 system (Illumina). ERRBS samples were multiplexed, with three 
samples per sequencing lane. 
For HMeDIP-seq, a total of 1μg of genomic DNA (gDNA) was sheared by adaptive 
focused acoustics, using the Covaris S220 (Covaris, Cat. #4465653). This sheared DNA was 
next blunt-ended and phosphorylated. A single adenine nucleotide was then added to the 3’end 
of the fragments in preparation for ligation of adapter duplex with a thymine overhang. The 
ligated fragments were cleaned using Qiagen’s MinElute PCR purification columns (Qiagen, 
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Cat. #28004). DNA standards for HMeDIP (Diagenode 5-hmC, 5-mC & cytosine DNA standard 
pack for HMeDIP, Cat. #AF-107-0040) were added to each sample before denaturation. 
Resuspension was then performed in ice-cold immunoprecipitation buffer (10 mM Sodium 
Phosphate pH 7.0, 140 mM NaCl, 0.05% Triton X-100). A 10% volume (input) was retrieved 
before 2ug of a 5hmC-specific antibody (Active Motif, Cat # 39791) was added for 
immunoprecipitation overnight at 4°C with rotation. Dynabeads Protein-G (Invitrogen, Cat. 
#10003D) was used to pull-down of 5hmC-enriched fragments. The 5hmC-enriched DNA 
fragments (IP) were then released from the antibody by digestion with Proteinase K (Ambion, 
Cat. #AM2548). After cleanup with AMPure XP beads (Beckman Coulter, Prod.# A63880), the 
percent input enrichment (%input) in the IP was evaluated by qPCR, using primers for spike-ins. 
Samples with high % input for the 5-hmC spike-in – typical inclusion threshold was >80% – 
were then PCR amplified for the final library production, cleaned using AMPure XP beads, and 
quantified using the Qubit assay (Invitrogen, Cat. #Q32850) and TapeStation High Sensitivity 
D1000 kit (Agilent, Cat. #G2991AA). Single-end, 50 base pair reads were obtained for each 
library by sequencing on the HiSeq 4000 system (Illumina). Each HMeDIP-seq sample was run 
on a single sequencing lane. 
Bioinformatics pipeline for differential 5-mC and 5-hmC 
Sequencing results for all three ages were compared using a number of bioinformatics 
tools (Figure 4-1). The mint pipeline was used for data quality control (FastQC and MultiQC), 
adapter trimming (trim_galore), and alignment (bismark and bowtie2) (Cavalcante et al. 2017). 
For quality and adapter trimming, we required a minimum overlap of 6bp and minimum quality 
score of 20 in conjunction with special ERRBS trimming of 2bp from the 3’ end. For bismark 
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methylation extractor, the minimum threshold to consider a CpG site in analysis was 5 reads. 
Default parameters were used for bowtie2.  
The DSS R package was used to test for differential 5-mC in ERRBS data by age (Feng et 
al. 2014; Park and Wu 2016; Wu et al. 2013, 2015). Within the DSS package, the 
DMLfit.multiFactor function was used to test for differential methylation by age using a 
multifactorial modeling approach, with matched mouse ID and sex included as covariates. As 
such, modeling was performed according to the following formula: ~age + mouseID + sex. The 
DMLtest.multiFactor function was used to test the null hypothesis that the age coefficient was 
equal to 0. Differentially methylated CpG sites (DMCs) were then sorted and filtered according 
to a false discovery rate (FDR) cutoff < 0.05. The callDMR function in DSS was for DMR 
calling. DMRs were called at a p-value < 0.05 and absolute methylation difference ≥ 5%. 
The csaw package was used to test for differential 5-hmC by age (Lun and Smyth 2016). 
Aligned HMeDIP-seq data were read into R using the windowCounts function in csaw. When 
reading in the data, extension was set to 52, window width was set to 100, and sex chromosomes 
were removed. Next, the data were filtered twice – by count (average count >5) and by local 
enrichment using the filterWindows function (type= “local”) – to remove regions of negligible 
binding. After filtering, normalization factors were calculated for each sample using the 
normOffsets function on binned data (width=10000). Normalization factors were linked to 
filtered data using the asDGEList function, and then the estimateDisp function was used to 
generate dispersion factors based on a multifactorial design matrix identical to that used for 
ERRBS data. The glmQLFit function was used to fit a model for differential 5hmC binding by 
age; an empirical Bayesian method used to stabilize the QL dispersion estimates. A contrast 
statement was used to extract modeling results for the age variable. To correct for multiple 
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testing, filtered data were clustered using a window length of 500 bp; the combineTests function 
was then used to compute a combined p-value for each cluster. The Benjamini-Hochberg method 
was then used to control the FDR in all clusters (Benjamini and Hochberg 1995, 1997). DHMRs 
were called using an FDR < 0.10.  
After testing for differential 5-mC and 5-hmC, the annotatr R package was used to 
annotate all DMCs, DMRs, and DHMRs to the mm10 genome (Cavalcante and Sartor 2017). 
The annotate_regions function was used to generate annotations, including gene IDs and 
genomic context (e.g. intron, exon, promoter, etc.). Within annotatr, the randomize_regions 
function was used to create a secondary, random distribution of annotated sites or regions from 
the complete ERRBS or HMeDIP-seq data, respectively. Distributions of DMCs and DHMRs by 
genomic annotation were plotted against the random distribution using the plot_categorical and 
plot_annotation functions, respectively. Lists of chromosomal locations were compared using the 
bedtools (version 2.26.0) intersect function to determine overlap between DMCs and DHMRs.  
Sequencing data visualization 
 5-mC levels were visualized using the RnBeads R package (Assenov et al. 2014). Within 
this package, the rnb.execute.import function was first used to import the aligned ERRBS data. 
Next, the rnb.sample.groups function was used to group samples by age. The 
rnb.plot.locus.profile function was then used to plot relative 5-mC level in a heat map output for 
defined regions of the genome. A custom set of nine red colors were chosen from RColorBrewer 
for the heat map gradient.  
 5-hmC levels were visualized using the csaw and GViz R packages (Hahne and Ivanek 
2016; Lun and Smyth 2016). Data were read into R as a GRanges object using the extractReads 
function. Next, the GeneRegionTrack in the Gviz R package was used to define regions of 
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interest for visualization. Separate blue and red genome tracks were used to represent the 
forward and reverse strand reads, respectively. The plotTracks function was then used to plot 5-
hmC levels for these regions. Reads-per-million was used for the y-axis in all graphs, and scale 
was adjusted to individual region coverage.  
Plots generated in R (R version 3.4.0) were formatted for publication in Adobe Illustrator 
CS6 (version 16.0.5). 
Real-time quantitative PCR (RT-qPCR) 
The Bio-Rad iScript cDNA Synthesis Kit (Cat. #1708890) was used to reverse transcribe 
complementary DNA (cDNA) from 250 ng of RNA for each blood sample (n=6 per age). In 
preparation for RT-qPCR, cDNA samples were diluted 1:2.5 in RNase-free water, then mixed 
with 10 µM forward/reverse primers, nuclease-free water, and Bio-Rad iQ SYBR Green 
Supermix (Cat. #1708880). RT-qPCR was then performed using a Bio-rad CFX96 Real-Time 
System C1000 Thermal Cycler (Bio-Rad; Hercules, CA). The pre-programmed 2-step PCR+melt 
curve protocol was used for all qPCR reactions – 95°C for 3 minutes, [95°C for 10 seconds, 
55°C for 30 seconds, plate read] x40, 95°C for 10 seconds. The melt curve for each plate was 
65°C-95°C; 0.5°C increment for 5 seconds, with plate read at each temperature. RT-qPCR 
analyses were performed for the Nfic and Esr1 gene in triplicate for each cDNA sample. Three 
housekeeping genes – Actb, 18S, and Gapdh – were included as internal controls in all RT-qPCR 
runs. In addition to housekeeping genes, an inter-plate calibrator control of brain cDNA was 
included for calculation of relative gene expression across multiple plates. Expression levels 
were calculated following the 2
−ΔΔCt
 method (Livak and Schmittgen 2001). RT-qPCR primers for 
the Nfic, Esr1, and Gapdh genes (Table 4-3) were designed using the online Genscript Real-time 
PCR Primer Design software (https://www.genscript.com/tools/real-time-pcr-tagman-primer-
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design-tool). The Actb and 18S gene primer pairs were sourced from the literature (Dolinoy et al. 
2010; La Salle et al. 2004). Primer pair specificity for all designed primers was checked using 
the NCBI Primer-BLAST online tool (https://www.ncbi.nlm.nih.gov/tools/ primer-blast/). 
Pathway analysis 
Pathway analyses for DMCs and DHMRs were performed using the ChIP-enrich analysis 
tool (Welch et al. 2014). In the ChIP-enrich online interface (http://chip-enrich.med.umich.edu/), 
the gene set filter was set to 2000, peak threshold was set to 1, and adjustment for mappability of 
gene locus regions was set to false. The ChIP-enrich method was used for GO term and KEGG 
pathway enrichment testing against the mm10 reference genome. Both DMCs and DHMRs were 
split into hypo- and hyper-methylated sites/regions prior to separate analyses. For DHMRs and 
DMCs, only peaks <5kb from TSS were included in ChIP-enrich analysis. Due to the large 
number of significant DMCs, DMC pathway analyses were restricted to CpGs annotated to 
promoter regions. After correcting for multiple testing, pathways with FDR<0.05 were 
considered significant. 
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4.8 Figures and Tables 
 
Δ5-mC/5-
hmC 
Age 
DMRs† DMCs* DHMRs‡ 
Hyper- 9 17460 160 
Hypo- 11 10736 8446 
Both 0 0 7 
Total 20 28196 8613 
Table 4-1: Differential 5-mC and 5-hmC in mouse blood by age. The DSS and csaw R 
packages were used to examine the effect of age on 5-mC and 5-hmC levels across the 
epigenome. For all models, effect of age was defined as 10 months old relative to 2 months old 
(baseline). Models also included a paired mouse ID variable to account for within-individual 
effects, as well as a sex variable. Directionality of DMRs, DMCs, and DHMRs are indicated in 
separate rows; direction is relative to 2 month old samples. DMR, DMC, and DHMR calling 
thresholds are indicated -- †DMRs = Δ > 0.05 and p-value < 0.05; *DMCs = Δ > 0.05 and FDR 
< 0.05; ‡DHMRs = FDR < 0.10. 
 
 
 
 
 
Chr Start End Strand Location Δ % Methylation* 
chr10 4666894 4666894 + intron -25.7% 
chr10 4709922 4709922 + promoter 10.0% 
chr10 4712221 4712221 + promoter 41.2% 
chr10 4712716 4712716 + exon -25.4% 
chr10 4932943 4932943 + 1 to 5kb 30.4% 
chr10 4971465 4971465 + intron 36.2% 
chr10 4972470 4972470 + intron -14.9% 
Table 4-2: Age-related DMCs annotated to the Esr1 locus. List of significant DSS modeling 
DMCs annotated to the Esr1 locus. *Change in % methylation is defined as 10 month old level 
relative to 2 month old level. 
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Gene Full Name 
GenBank 
Number 
Strand Primers (5' to 3') 
Tm 
(°C) 
Amplicon 
Size 
Gapdh 
Glyceraldehyde 
3-phosphate 
dehydrogenase 
NM_008084.3 
FWD GCCTGCTTCACCACCTTCTT 59.96 
98 
RVS CATGGCCTTCCGTGTTCCTA 59.07 
Nfic 
Nuclear factor 
I-C 
AF111265.1 
FWD CGAGAAGCGCATGTCCAAGG 58.83 
168 
RVS GCCTTCTTGCCAGTCACAGC 58.95 
Esr1 
Estrogen 
Receptor 1 
(Alpha) 
NM_007956  
FWD AACCGGAGGAAGAGTTGCCA 58.40 
76 
RVS TCCGTATGCCGCCTTTCATCA 59.05 
Table 4-3: RT-qPCR primers for self-designed gene assays. Forward and reverse primer 
sequences for the Gapdh, Nfic, and Esr1 RT-qPCR assays are listed, along with melting 
temperatures and amplicon sizes. All assays were designed using the online Genscript Real-time 
PCR Primer Design software (https://www.genscript.com/tools/real-time-pcr-tagman-primer-
design-tool). Additional primers for the Actb and 18S genes were adapted from (Dolinoy et al. 
2010) and (La Salle et al. 2004), respectively. 
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Figure 4-1: Sequencing data collection and analysis workflow. Genomic DNA was isolated 
from matched offspring blood samples at 2 months (n=6), 4 months (n=6), and 10 months of age 
(n=6). DNA samples were then split for separate, parallel processing steps specific to the ERRBS 
and HMeDIP-seq methods. All processed samples were amplified and sequenced on an Illumina 
HiSeq 4000 sequencer using single-end, 50 nt read length. Separate bioinformatics pipelines 
were used to analyze ERRBS and HMeDIP-seq data. Differentially methylated CpGs (DMCs) 
and regions (DMRs) were compared to differentially hydroxymethylated regions (DHMRs) for 
regions of chromosomal overlap. Regions of overlap were then annotated and visualized in the 
genome browser. The Nfic gene was validated using RT-qPCR on available RNA from the blood 
samples. 
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Figure 4-2: Distributions of age-related DMCs and DHMRs compared to random. Age-related DMCs and DHMRs were 
annotated to the mm10 genome using the annotatr package in R. Within annotatr, the randomize_regions function was used to create 
secondary, random distributions of annotated DMCs and DHMRs using the complete ERRBS and HMeDIP-seq data as background, 
respectively. Distributions of DMCs and DHMRs by genomic annotation were then plotted against the random distribution using the 
plot_annotation function. A) Compared to the random distribution, age-related DMCs (All, Hyper, and Hypo) were enriched at 
promoters, CpG islands, CpG shores, CpG shelves, promoters, 5’ UTRs, and exons, but were depleted at interCGI regions. B) 
Compared to a random distribution, age-related DHMRs showed moderate enrichment at CpG shores, CpG shelves, promoters, 3’-
UTRs, 5’-UTRs, exons, and introns, as well as mild depletion at interCGI regions and CpG islands.
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Figure 4-3: Venn diagrams of intersecting age-related DMCs and DHMRs by chromosomal 
location. The bedtools intercept function was used to test for overlap between DMCs and 
DHMRs by exact chromosomal location. Comparing age-related DMCs and DHMRs, we 
identified 65 regions that overlapped by chromosomal position. The age-related DMC and 
DHMR overlap sites annotated to 40 unique gene IDs. Of these 40 genes, three had multiple 
DMCs that overlapped a DHMR – Fbln1, Ldlrad3, and Nfic. 
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Figure 4-4: ERRBS and HMeDIP-seq data for the Nfic gene DMR and DHMR overlap 
region. (A) ERRBS and (B) HMeDIP-seq data at the identified Nfic DMC/DHMR overlap 
region (chr10: 81433551-81433800). 5-mC levels and 5-hmC peaks were visualized using the 
Gviz, csaw, and RnBeads R packages. 5-hmC and 5-mC levels at this overlap region both 
decrease with age in longitudinal mouse blood samples. 
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Figure 4-5: 5-hmC peaks across the Esr1 locus. 5-hmC coverage was visualized across the Esr1 locus (chr10: 4666850-4972500) 
using the csaw R package. Region of visualization covers all age-related DMCs annotated to Esr1. As indicated by labels on the y-
axis, data is shown for all 2 month (n=6), 4 month (n=6), and 10 month (n=6) blood samples. Data shows clear 5-hmC peaks along the 
entire Esr1 locus, a pattern that is consistent across the life course. This data shows that 5-hmC content is under tight regulation at the 
Esr1 locus. 
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Figure 4-6: RT-qPCR data for the Nfic and Esr1 loci by age. Based on DNA methylation 
results, RT-qPCR was used to investigate mRNA expression levels at the Nfic and Esr1 genes. 
Three housekeeping genes – Actb, 18S, and Gapdh – were included as internal controls in all RT-
qPCR runs. In addition to housekeeping genes, an inter-plate calibrator control of brain cDNA 
was included for calculation of relative gene expression across multiple plates; all expression 
values are shown relative to this inter-plate calibrator. Expression levels were calculated 
following the 2
−ΔΔCt
 method. There was a significant decrease in mean Nfic expression between 2 
and 10 month blood samples (p=0.04). Esr1 expression did not significantly differ by age.  
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Chapter 5  
Neonatal DNA Methylation Patterns are Associated with Childhood Weight 
Status in the Healthy Families Project 
 
Abstract 
Recent reports suggest that both cross-sectional DNA methylation and rates of age-related 
methylation are associated with obesity status, but it remains unclear whether levels of DNA 
methylation at various stages of childhood can be used to predict obesity likelihood. Using 
logistic regression, we tested whether neonatal bloodspot or childhood DNA methylation (12-24 
months old (n=40), 3-5 years of age (n=40), or 10-12 years of age (n=52)) at several target gene 
regions predicted childhood obesity likelihood, as defined by weight-for-length (WFL) z-score at 
12-14 mos. and body mass index (BMI) z-score at 3-5 and 10-12 years old. DNA methylation 
was quantified at a repetitive element (LINE-1), two imprinted genes (IGF2, H19), and four non-
imprinted genes (LEP, PPARA, ESR1, SREBF1) related to growth and adiposity in children from 
the Healthy Families study. In 3-5 year olds, neonatal bloodspot LINE-1 methylation was 
negatively associated with obesity likelihood (OR= -0.40, p=0.04). There were also suggestive 
negative associations between bloodspot IGF2 methylation and obesity likelihood in 12-24 
month olds (OR= -0.24, p=0.07), 10-12 year olds (OR= -0.14, p=0.09), and when all age groups 
were combined (OR= -0.08, p=0.09). Across childhood age in matched blood samples, DNA 
methylation levels in blood significantly decreased (p<0.05) at LINE-1, PPARA, ESR1, SREBF1, 
IGF2, and H19, and significantly increased (p<0.05) at LEP. Our results suggest that age-related 
epigenetic changes occur at growth-related genes in the first decade of life, and that gene-
specific neonatal bloodspot DNA methylation may be a useful biomarker for predicting obesity 
likelihood later in childhood. 
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5.1 Introduction 
As a field of study, epigenetics refers to heritable and potentially reversible changes in an 
organism’s gene regulation that occur independent of the DNA sequence. Epigenetic control 
mechanisms include chromatin modifications (e.g., histone tail acetylation), non-coding RNA 
interactions, and alterations to DNA (e.g., DNA methylation) (Bernal and Jirtle 2010; Egger et 
al. 2004). Previous studies have documented distinct, programmed waves of demethylation and 
de novo DNA methylation during fetal development, as well as evidence that these programmed 
events help regulate primordial germ cell proliferation and differentiation (Messerschmidt et al. 
2014; Reik et al. 2001; Smallwood and Kelsey 2012). While developmental epigenetic events are 
typically under tight regulation, 5-methylcytosine (5-mC) levels have been shown to change in 
response to environmental factors during early development (Anderson et al. 2012; Bernal and 
Jirtle 2010; Manikkam et al. 2013), adolescence (Essex et al. 2013), and even adulthood (Tellez-
Plaza et al. 2014; Wright et al. 2010). Given that DNA methylation is established during early 
development and sensitive to the environment, it has been proposed as a mechanism underlying 
the developmental origins of health and disease (DOHaD) hypothesis. DOHaD posits that 
developmental exposure to nutritional and environmental factors alters later-life susceptibility to 
chronic diseases (e.g., metabolic syndrome) by influencing developmental plasticity (Bateson et 
al. 2004; Heindel et al. 2015). This paradigm is supported by results from animal model exposure 
studies and human cohort epidemiological studies (Eriksson 2016; Hart et al. 2015; Heindel et al. 
2015; Radford et al. 2014). Despite this rich literature, however, the biological mechanisms 
supporting the apparent delay between developmental exposure and later-life disease remain 
poorly characterized. Specifically, few studies have considered whether associations between 
DNA methylation and disease likelihood change as a function of age during sensitive periods in 
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early and mid-childhood. This project aims to shed light on the contribution of longitudinal 
childhood epigenetics to obesity in a human population.  
Research suggests that prenatal nutrition can play an important role in establishment of 
the epigenome. For example, a recent intergenerational study in mice showed that in utero 
undernourishment leads to changes in the F1 adult male mouse methylome, as well as locus-
specific alterations in F2 generation metabolism-related gene expression (Radford et al. 2014). 
Other animal studies indicate that high-fat-diet-induced obesity is associated with altered 
methylation in promoters of genes related to metabolism and obesity, including Leptin (Lep) and 
Peroxisome Proliferator-activated Receptor-α (Ppara) (Ge et al. 2014; Milagro et al. 2009). 
Genome-wide studies of the methylome have also noted both nutrient- and obesity-sensitive CpG 
sites throughout the epigenome, indicating that alterations in diet or adiposity can affect DNA 
methylation at specific genomic sites (Parle-McDermott and Ozaki 2011; Xu et al. 2013). 
Supplementing the available animal research, studies in human cohorts have shown that maternal 
differences in methyl donor intake are associated with altered DNA methylation in children at 
metastable epialleles (Dominguez-Salas et al. 2014) and target genes related to growth and 
metabolism (Pauwels et al. 2017). In addition, another recent human cohort study demonstrated 
associations between lower maternal intake of vitamin D and several adverse outcomes in 
children – impaired neurocognitive function at 10 years of age, greater risk of eating disorders 
during adolescence, and lower peak bone mass at 20 years of age (Hart et al. 2015). Based on 
these results, diet represents an important mediator of methylation, in that it has the potential to 
affect the epigenome throughout the life course.  
In addition to the effects of diet, evidence also suggests that other lifestyle factors, 
including physical activity, can alter both gene expression levels (Huang et al. 2010; Lesniewski 
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et al. 2013; Lindholm et al. 2014) and site-specific DNA methylation (Barrès et al. 2012; Rönn et 
al. 2013). One recent study demonstrated that long-term endurance training is associated with 
significant changes in DNA methylation at specific enhancer regions across the genome 
(Lindholm et al. 2014), suggesting that physical activity may have long-term protective effects in 
the epigenome. Supporting this idea, a study in mice showed that induced maternal physical 
activity prevents high-fat-diet-induced offspring hypermethylation at the promoter of peroxisome 
proliferator-activated receptor γ coactivator-1α (Pgc-1α), a master regulator of metabolism 
(Laker et al. 2014). Together, the available data suggests that physical activity could be an 
important modifier of methylome establishment/upkeep. 
While many DOHaD studies have focused on the association between developmental 
environment and a snapshot of the later-life epigenome, other recent studies have shown that the 
epigenome is dynamic with age in human twins (Fraga et al. 2005; Martino et al. 2013), non-
twin human cohorts (Alisch et al. 2012; Heyn et al. 2012; Madrigano et al. 2012; Urdinguio et al. 
2016; Wang et al. 2012), and rodent models (Maegawa et al. 2014; Spiers et al. 2016). 
Furthermore, reports indicate consistent patterns of DNA methylation with age -- higher gene-
specific methylation (Teschendorff et al. 2013), lower global methylation (Issa 2014; 
Teschendorff et al. 2013), and bidirectional changes in methylation variability (Jones et al. 2015; 
Shah et al. 2014). In general, age has two types of effect on the epigenome – epigenetic drift, 
which refers to stochastic, bidirectional changes in epigenetic variability with age (Fraga et al. 
2005; Jones et al. 2015; Teschendorff et al. 2013), and age-related methylation, which is defined 
as predictable, unidirectional changes in DNA methylation levels that occur with normal aging 
(Horvath 2013; Jung and Pfeifer 2015). Despite the establishment of these well-defined concepts 
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in adult populations, the patterns of epigenetic aging during childhood remain unclear, and could 
play an important role in early development of chronic diseases.  
Expanding the literature on epigenetic aging, recent studies have suggested that rates of 
age-related methylation and epigenetic drift can be affected by environmental exposures. For 
example, mouse studies indicate that environmental exposure to lead (Pb), Western high-fat diet, 
or trichloroethylene (TCE) can modify the rates of either age-related methylation (Faulk et al. 
2014; Kochmanski et al. 2016) or epigenetic drift (Gilbert et al. 2016), respectively. In an effort 
to describe a mechanism by which the environment could shape the aging epigenome, we 
recently introduced a new term – environmental deflection – that refers to any environment- or 
toxicant-mediated shift away from the baseline rate of age-related methylation or epigenetic drift 
within an organism (Kochmanski et al. 2017). Given that alterations in longitudinal epigenetic 
marks may facilitate long-term changes in gene regulation, environmental deflection could 
underlie the apparent delay between developmental exposure and biological effects later in life. 
In other words, alterations to the rates of age-related methylation may represent a mechanism 
underlying the DOHaD hypothesis. 
Obesity is a well-documented risk factor for a number of chronic diseases, including 
heart disease, hypertension, various cancers, and type 2 diabetes
 
(Dixon 2010). Rates of obesity 
continue to rise in the United States, but models using large numbers of BMI-associated genetic 
loci show that gene variants only explain 0.66-2.70% of BMI variation (Loos et al. 2017). This 
suggests that gene-environment interactions play an important role in the growing prevalence of 
obesity. Supporting this idea, reports suggest that both cross-sectional, gene-specific DNA 
methylation and rates of age-related methylation are associated with obesity status in humans 
(Almén et al. 2014; Horvath et al. 2014; Wahl et al. 2016). However, it remains to be seen 
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whether developmental programming of the epigenome at obesity-related genes is specifically 
associated with later-life obesity development. Here, we aim to shed light on this question by 
measuring longitudinal patterns of age-related DNA methylation at a number of obesity-related 
genes throughout childhood.  
For this study, we examined DNA methylation levels at seven target gene regions – the 
LINE-1 repetitive element, IGF2, H19, PPARA, LEP, ESR1, and SREBF1. LINE-1, or long 
interspersed nuclear element 1, is a retrotransposon that comprises ~18% of the human genome 
(Rodić et al. 2013). Given its prevalence across the genome, LINE-1 can be used as a surrogate 
for global DNA methylation levels (Yang et al. 2004). Apart from LINE-1, all of the other 
interrogated genes play a role in metabolism, growth, or development. Insulin-like growth factor 
II (IGF2) and H19 are well-characterized imprinted genes, in which parent-of-origin mono-
allelic expression is involved in the regulation of body composition and growth (Huang et al. 
2012; Lui et al. 2008; Soubry et al. 2013; St-Pierre et al. 2012). PPARA is a non-imprinted gene 
that encodes the peroxisome proliferator-activated receptor alpha (PPAR-α) protein, a nuclear 
receptor that regulates fatty acid metabolism (Lillycrop et al. 2008; Rees et al. 2008; Yoon 
2009). LEP is a non-imprinted gene that encodes leptin, an adipokine involved in satiety 
signaling (Crujeiras et al. 2015; Lesseur et al. 2013). ESR1 is a non-imprinted gene that encodes 
estrogen receptor alpha (ER-α), a transcription factor involved in regulation of energy 
homeostasis (Mauvais-Jarvis 2011). Lastly, SREBF1 is a non-imprinted gene that encodes the 
Sterol regulatory element-binding transcription factor 1, a transcription factor involved in 
glucose metabolism and lipid homeostasis (Eberlé et al. 2004; Ferré and Foufelle 2007). Here, 
we test whether epigenetic modifications at these target genes are associated with obesity risk 
during childhood.  
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As described in detail elsewhere (Acharya et al. 2017), the University of Michigan 
Momentum Center Healthy Families (HF) Project is an interdisciplinary study that explores the 
obese phenotype among children in three age groups (12-24 months old (n=40), 3-5 years of age 
(n=40), or 10-12 years of age (n=52)) through measurements of weight status, biology, food 
environment, and parenting. As part of this project, longitudinal paired DNA methylation levels 
were quantified from neonatal bloodspots and capillary and venous blood draws in childhood. 
This study design allows for a comprehensive examination of associations between age, the 
epigenome, and obesity during childhood. Here, we tested three hypotheses: 1. DNA methylation 
at growth-related genes at birth and during childhood will be associated with obesity status; 2. 
growth-related genes will exhibit age-related DNA methylation in childhood; 3. rates of age-
related methylation will differ by obesity status, childhood diet, physical activity, and/or age 
group.  
In testing these hypotheses, we aim to identify early-life epigenetic biomarkers of 
childhood obesity onset, as well as determine whether age-related DNA methylation is occurring 
at obesity-related genes during the early stages of human life. Furthermore, we aim to test 
whether rates of age-related methylation vary by environmental factors throughout childhood. 
Combining these results, it is possible to assess the utility of the longitudinal methylome as a 
predictive tool for obesity risk during multiple stages of childhood.  
5.2 Results 
Summary statistics  
Mean weight-for-length (WFL) or BMI z-score and weight category distribution were not 
significantly different across the three age groups (Table 5-1). Child race/ethnicity was 
significantly different (p=0.013) in the toddler (12-24 months old) group compared to the total 
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population, but maternal education and child sex ratio were not significantly different by age 
group (Table 5-1).  
Associations between neonatal DNA methylation and childhood weight status 
First, logistic regression models were used to examine the relationship between neonatal 
bloodspot target gene DNA methylation and dichotomous obesity (Y/N). For the toddler group, 
no target genes demonstrated significant associations between bloodspot DNA methylation and 
obesity likelihood. However, in the preschool group, bloodspot LINE-1 methylation showed a 
significant negative association with obesity likelihood (log odds = -0.40, p=0.04) (Figure 5-1). 
In addition, preschool bloodspot IGF2 methylation had a marginally significant negative 
association with obesity likelihood (log odds = -0.24, p=0.07). Matching this pattern, the school-
aged group showed a marginally significant negative association between bloodspot IGF2 
methylation and obesity likelihood (log odds = -0.14, p=0.09). This negative marginal 
association between bloodspot IGF2 methylation and log odds of obesity also held when all age 
groups were combined in a single model (log odds = -0.08, p=0.09) (Figure 5-1). No other 
investigated loci showed significant associations between bloodspot DNA methylation and log 
odds of obesity in the preschool or school-aged groups. 
Separate from the logistic regression analysis, linear regression models were used to 
examine the relationship between bloodspot DNA methylation and continuous WFL or BMI z-
score. For the toddler group, bloodspot LEP methylation showed a marginal negative association 
(β= -0.08, p=0.09) with WFL z-score, but no other investigated loci showed significant 
associations between bloodspot DNA methylation and WFL or BMI z-score in the toddler, 
preschool, or school-aged groups. This lack of significance also held true in models where all 
age groups were combined. 
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Associations between childhood DNA methylation and childhood weight status 
Following up on the bloodspot DNA methylation results, simple logistic models were 
also used to determine whether childhood blood DNA methylation levels were associated with 
obesity likelihood. Just as in the bloodspot results, separate models were run for each age group. 
When combining all the age groups together into a single model, there was a marginally 
significant negative relationship between LEP methylation and obesity likelihood (log odds =  
-0.455, p=0.08) (Figure 5-2). In the preschool group alone, we also found a marginal negative 
association between blood ESR1 methylation and obesity likelihood (log odds = -1.668, p=0.08) 
(Figure 5-2). However, both of these results are difficult to interpret due to the very low sample 
size of the childhood blood draws.  
Given the difficulty in interpreting the logistic regression results, follow-up linear 
regression models were used to examine the relationship between childhood blood DNA 
methylation and continuous WFL or BMI z-score. In the preschool group, blood PPARA 
methylation showed a significant positive association with BMI z-score (β= 0.210, p=0.01) 
(Figure 5-3). While this result did not carry over to any of the other age groups, it is noteworthy 
that the preschool group had the largest childhood blood draw sample size. The remaining 
genetic loci did not demonstrate significant associations between DNA methylation and WFL or 
BMI z-score in any analysis. 
Age-related DNA methylation in matched samples 
Linear mixed effect (LME) models were used to model longitudinal patterns of age-
related methylation for each target gene. Given that each age group contained different 
individuals, separate LME models were constructed for matched data in each age group (Table 
5-2). Longitudinal changes in methylation reflect differences between neonatal bloodspot DNA 
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(birth) and blood draw (childhood). All genes were modeled using the mean of all included CpG 
sites. For all age groups, LINE-1, H19, PPARA, LEP, and SREBF1 demonstrated significant age-
related methylation (Table 5-2). In contrast, significance of age-related methylation at IGF2 and 
ESR1 differed by age, suggesting that patterns of age-related methylation are not static 
throughout childhood. 
Age-related DNA methylation by childhood age group 
 To further test whether age-related methylation varied by recruited age group, an 
age*group interaction term was included in linear mixed effect models for each target gene. For 
most of the genes, the age*group interaction term was not significant. However, both ESR1 
(β=0.364; p=0.007) and LINE-1 (β=1.021; p=0.003) showed significant age*group interaction 
terms in the mixed models. At these genes, the slope of age-related methylation varied across the 
three age groups, showing a lower intensity of effect with age (Figure 5-4). This may reflect 
region-specific, controlled attenuation of age-related methylation that occurs throughout 
childhood. 
Effects of diet and physical activity on cross-sectional DNA methylation  
Cross-sectional linear regression models were used to test for associations between 
lifestyle factors – healthy eating index (HEI) score or moderate-to-vigorous physical activity per 
day (MVPA/day) – and target gene methylation later in life (Table S3). In the preschool group, 
there was a marginally significant negative relationship between MVPA/day and LEP 
methylation (p=0.06). In contrast, there was a marginally significant positive relationship 
between MVPA/day and LEP methylation in the school-aged children (p=0.07). There were no 
significant cross-sectional relationships between MVPA/day and target gene methylation in the 
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toddler group, and there were no significant cross-sectional relationships between HEI score and 
target gene methylation in any of the three age groups. 
Environmental deflection of age-related methylation 
Linear mixed effects models were used to examine environmental deflection of age-
related methylation by obesity status (BMI/WFL z-score), physical activity (MVPA/day), and 
healthy eating index (HEI score). To test for environmental deflection by these environmental 
factors, age:environment interaction terms were added to the linear mixed effects models used to 
test for age-related methylation. To ensure model integrity, each of the included interaction terms 
– age:MVPA/day, age:HEI, and age:BMI/WFLz – were included in separate models. Overall, 
there were no consistent patterns of significant environmental deflection at any of the 
investigated genetic loci across all three time points. However, several target genes exhibited 
significant or marginally significant environmental deflection by BMI/WFL z-score, MVPA/day, 
or HEI (Table 5-3).  
For the age:BMI/WFLz interaction term, there was no significant environmental 
deflection in the toddler group. In the preschool group, PPARA showed significant positive 
deflection of age-related methylation by BMI z-score (p=0.04) (Figure 5-5), but no other 
significant results were present. In the school-aged children, SREBF1 showed significant 
negative environmental deflection of age-related methylation by BMI z-score (p=0.05), but no 
other target genes showed significant effects of BMI z-score. 
For the age:MVPA/day interaction term, it was not possible to examine environmental 
deflection in the toddler group due to a lack of physical activity data. However, in the preschool 
group, LEP showed significant (p=0.02) positive deflection of age-related methylation by 
MVPA/day (Figure 5-6). No other significant results were present in the preschool age group. In 
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the school-aged children, LEP and IGF2 showed significant (p=0.001) and marginally significant 
(p=0.09) negative environmental deflection of age-related methylation by MVPA/day. No other 
target genes showed significant environmental deflection by obesity status in the school-aged 
group. 
For the age:HEI interaction term, there was no significant environmental deflection in the 
preschool or school-aged groups. In the toddler group, LEP demonstrated marginally significant 
negative environmental deflection of age-related methylation by HEI score (p=0.094), but no 
significant results were present.  
 
5.3 Discussion 
Associations between DNA methylation and childhood weight status  
 Neonatal bloodspot DNA methylation at the LINE-1 repetitive element and IGF2 
imprinted locus demonstrated significant and marginally significant negative associations with 
obesity likelihood in preschool children, respectively. These results, while not apparent in the 
other investigated loci, suggest that neonatal epigenetic biomarkers may be associated with 
childhood obesity. While these are only preliminary results from a small number of individuals, 
to our knowledge, this is the first time that neonatal bloodspot DNA methylation status has been 
linked to obesity likelihood in matched individuals during childhood.  
The significant bloodspot locus, LINE-1, is an active retrotransposon that comprises 
~18% of the human genome (Rodić et al. 2013). DNA methylation acts as a repressive mark at 
retrotransposons, blocking these repetitive elements from either duplicating in the genome or 
generating chimeric fusion transcripts (Slotkin and Martienssen 2007; Wang et al. 2016b). As a 
result, research indicates that decreases in LINE-1 methylation can increase retrotransposon 
activity, leading to a reduction in overall genomic stability (Rodić et al. 2013). While it’s 
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possible that this mechanism could modify risk for obesity development in later childhood, 
LINE-1 is not protein-coding and has no direct involvement in human growth or development, 
making it difficult to determine the biological significance of specific changes in LINE-1 
methylation in relation to obesity risk. However, separate from its intrinsic retrotransposon 
activity, LINE-1 methylation is prevalent enough in the genome that it also serves as a useful 
surrogate for global methylation levels (Yang et al. 2004). As such, the negative association 
between LINE-1 methylation and log odds of obesity in the preschool group may reflect a global 
link between lower DNA methylation and obesity likelihood during a specific phase of 
childhood.  
Distinct from LINE-1, IGF2 is an imprinted gene that encodes insulin-like growth factor 
II, a developmental growth factor that is active throughout life in humans (Chao and D’Amore 
2008). As an imprinted gene, IGF2 demonstrates parent-of-origin-dependent mono-allelic 
expression, a pattern at least partially controlled via differentially methylated regions (DMRs) 
(Chao and D’Amore 2008; Tobi et al. 2012). Allele-specific IGF2 DMR methylation is 
established in the two waves of epigenomic reprogramming that occur during gametogenesis and 
early embryogenesis (Ishida and Moore 2013). The imprinted epigenetic marks at IGF2 are then 
propagated throughout cellular replication and differentiation, providing life-long regulation of 
gene expression (Bartolomei and Ferguson-Smith 2011). Given this distinct pattern of 
programming, developmental changes in IGF2 DMR imprinting could have long-lasting effects 
on IGF2 expression, thereby altering growth and development. Recent studies support this idea, 
demonstrating associations between developmental IGF2 DMR methylation and newborn 
growth indices; however, directionality of these effects varies by study, making interpretation 
difficult. For example, one study found a significant association between lower umbilical cord 
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blood IGF2 DMR methylation and higher plasma IGF2 protein level, as well as a positive 
association between plasma IGF2 protein levels and birth weight (Hoyo et al. 2012). On the 
other hand, another study showed that greater placental IGF2 DMR methylation was positively 
correlated with newborn length, head circumference, and weight (St-Pierre et al. 2012). Further 
complicating the issue, a third study found an association between higher cord blood IGF2 DMR 
methylation and birth weight, but also showed that lower IGF2 DMR methylation was associated 
with greater weight gain six months after birth (Bouwland-Both et al. 2013). These available 
cross-sectional data indicate that epigenetic programming of IGF2 is associated with growth and 
development of newborns, and that directionality of this association is life stage-specific. Our 
results support this hypothesis, showing a positive link between lower bloodspot IGF2 DNA 
methylation and higher obesity likelihood during specific stages of childhood. The consistency 
of this effect across multiple older age groups suggests that IGF2 bloodspot methylation may be 
a meaningful biomarker of obesity risk in later childhood. To further validate this idea, this result 
must be replicated in a larger childhood obesity study. 
In the cross-sectional blood draw DNA methylation models, PPARA promoter 
methylation showed a significant positive association with BMI z-score in the preschool children 
(Figure 5-3). PPARA encodes the peroxisome proliferator-activated receptor alpha (PPAR-α) 
protein, a nuclear receptor that regulates fatty acid metabolism (Yoon 2009). Greater expression 
of this gene leads to breakdown of fatty acids, potentially leading to reductions in dyslipidemia 
and obesity (Chung et al. 2016; Yoon 2009). As such, it is expected that higher methylation at 
the PPARA promoter would be associated with lower PPARA gene expression and an increased 
risk of obesity. The significant positive association between preschool PPARA promoter 
methylation and BMI z-score matches this expectation, suggesting that PPARA promoter 
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methylation may play a role in childhood obesity development. However, this result was not 
consistent across age groups, making interpretation of these data difficult. Future studies should 
further investigate the contribution of PPARA promoter methylation to obesity in children across 
multiple life stages.  
In addition to PPARA, the ESR1 and LEP loci each demonstrated marginally significant 
negative associations between childhood DNA methylation and log odds of obesity in a single 
age group. However, like the PPARA results, these trends were not stable across ages, making it 
difficult to interpret the data (Figure 5-2). Furthermore, childhood blood DNA methylation 
models showed greater variability in results compared to neonatal bloodspot models. This is 
likely due to the smaller sample size of the cross-sectional childhood blood draw samples 
compared to sourced bloodspots. Of particular note in the childhood DNA methylation models, 
IGF2 and LINE-1 DNA methylation did not maintain the negative association with obesity 
likelihood seen in the neonatal bloodspots. This suggests that neonate DNA methylation levels at 
these loci, not cross-sectional DNA methylation, may be better predictors of later-life obesity 
risk. Based on our results, future studies investigating links between the epigenome and obesity 
should not only ensure large samples sizes, but also consider including neonatal bloodspot 
samples.  
Age-related methylation in matched samples 
A number of human cohort studies have examined the effect of age on the epigenome, 
with most of the available literature utilizing cross-sectional samples from pediatric or elderly 
populations (Alisch et al. 2012; Heyn et al. 2012; Madrigano et al. 2012; Wang et al. 2012). 
Here, we utilized matched bloodspot and blood samples from children in multiple age groups to 
investigate the effects of aging on the epigenome throughout different phases of childhood. We 
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found significant age-related methylation in all investigated genetic loci, with the directionality 
and magnitude of age effects varying by region. This matches previous studies, which have 
shown that the childhood methylome varies with age in a gene-specific fashion (Alisch et al. 
2012; Urdinguio et al. 2016; Wang et al. 2012). The directionality of age-related methylation 
was consistent across all three age groups for six out of the seven investigated loci, suggesting 
that aging effects during childhood are generally consistent at a given gene region.  
It is noteworthy that age-related changes in DNA methylation were seen as early as 12-24 
months old. This emphasizes the importance of considering age when interpreting DNA 
methylation data, suggesting that timing of sample collection during childhood could have a 
huge impact on how a study’s results are interpreted. Supporting this idea, marginal associations 
between neonatal IGF2 methylation and obesity likelihood disappeared in the 12-24 month old 
blood draw models, indicating that sample age can alter interpretation of the link between 
childhood DNA methylation and obesity risk. Based on these considerations, future studies 
should include longitudinal measurements of the childhood epigenome when testing for 
associations between DNA methylation and early-life disease risk. 
Age-related methylation by childhood age group 
 Beyond demonstrating age-related methylation during childhood, we also showed that the 
magnitude of age-related methylation can vary by developmental stage. This is most apparent at 
LINE-1, LEP, and ESR1, where rates of age-related methylation significantly diminished with 
increasing age (Figure 5-4). These results indicate that rates of age-related methylation are not 
necessarily static during childhood, but may instead follow regulated trajectories. For example, 
the ESR1 gene showed variable directionality of age-related methylation by age group, shifting 
from significant hypomethylation with age in preschool children to non-significant 
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hypermethylation with age in the school-aged children (Figure 5-4). The school-aged data were 
not unexpected, since previous studies in adult human colon tissue have demonstrated significant 
age-related hypermethylation at the ESR1 promoter (Issa et al. 1994; Kaz et al. 2014). However, 
the shift from hypo- to hypermethylation with age indicates that childhood may be a period of 
particular epigenetic volatility at the ESR1 promoter region. This idea matches evidence from 
previous studies, which show that patterns of age-related methylation are different during 
childhood and adulthood (Alisch et al. 2012; Simpkin et al. 2015), particularly at genes related to 
development (Acevedo et al. 2015; Urdinguio et al. 2016). Building on our results, future studies 
must not only capture cross-sectional measures of the epigenome early and late in life, but also 
characterize how longitudinal epigenetic marks vary during the child-to-adult transition. This 
would allow for improved identification of potential windows of epigenetic susceptibility.  
Environmental deflection of age-related methylation 
 Continuous BMI/WFL z-score demonstrated significant environmental deflection of the 
PPARA and SREBF1 gene regions in the preschool and school-aged children, respectively. In the 
preschool group, the age:BMIz interaction term was positive for the PPARA gene region. Given 
that our data show decreased PPARA DNA methylation throughout childhood, this result 
indicates that higher BMI is associated with weakened negative slope of age-related PPARA 
methylation in preschoolers. The PPARA pyrosequencing assay used in this study covers two 
CpG sites in the 5’ promoter of the PPARA gene. PPARA encodes the peroxisome proliferator-
activated receptor alpha (PPAR-α), a nuclear receptor that regulates fatty acid metabolism (Yoon 
2009). Increased expression of this gene leads to breakdown of fatty acids, potentially leading to 
reductions in dyslipidemia and obesity (Chung et al. 2016; Yoon 2009). Given that increased 
DNA methylation in promoter regions is typically associated with decreased transcription 
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(Medvedeva et al. 2014), it is expected that decreased methylation at the PPARA promoter would 
be associated with an increase in PPARA gene expression and decreased adiposity. Working 
under this paradigm, negative age-related methylation at PPARA during childhood could reflect 
programmed, age-dependent increases in PPARA expression. When the slope of this decrease 
with age is moderated, the affected individual will have a weakened programmed response, 
potentially leading to decreased PPARA expression and obesity development later in childhood. 
Our results support this idea, showing that increased preschooler BMI z-score is associated with 
weakened negative rates of age-related methylation at the PPARA promoter. 
The SREBF1 pyrosequencing assay covers four CpG sites in the gene body of SREBF1, 
including one CpG site – Illumina 450k cg2747935 – that has shown associations with Vitamin 
B12 intake and BMI in previous epigenome-wide studies (Adaikalakoteswari et al. 2015; Wang 
et al. 2016a). In contrast to the PPARA results, SREBF1 showed significant negative 
environmental deflection of age-related methylation by BMI z-score in the school-aged group. 
This is not unexpected, since the SREBF1 gene encodes the SREBF-1c protein, an insulin-
activated transcription factor involved in fatty acid synthesis and lipogenesis (Eberlé et al. 2004). 
Given its biological function, increased expression of SREBF1 is expected to increase adiposity 
(Shimano 2009). Our data show decreased SREBF1 DNA methylation with childhood age, 
suggesting that SREBF1 expression and associated adiposity may increase with age. In addition 
to age effects, we also found a significant negative deflection of SREBF1 methylation status by 
BMI z-score in school-aged children. While this result indicates that increased BMI may 
exacerbate the negative slope of SREBF1 age-related methylation during childhood, the low 
sample size limits interpretability of deflection results.  
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For the most part, measured lifestyle factors – dietary recall and physical activity – did 
not significantly modify age-related methylation patterns. In all three age groups, HEI score 
showed no significant environmental deflection of age-related methylation, suggesting that diet 
quality may not alter the dynamics of longitudinal DNA methylation during childhood. However, 
the interpretability of this result depends largely on the inherent range of HEI scores present in 
our population. In this study population, the HEI score distributions for all ages approached 
normality, with the majority of scores falling near the mean for each age group (Figure 5-7). 
Given the small sample size of our cohort, our HEI score distributions did not adequately capture 
the far extremes of diet quality, where most effects are expected to occur. As such, an obesity 
cohort study measuring levels of specific nutrients may be more appropriate for determining 
whether diet can lead to environmental deflection of childhood age-related methylation patterns. 
Exploring this idea, a recent cross-sectional study in adult human colon tissue showed concurrent 
effects of age and specific nutrients – folate, vitamin D, and selenium – on DNA methylation 
levels at target genes (Tapp et al. 2013). However, while these results are intriguing, the study 
was non-longitudinal and failed to test for interactions between age and nutrient intake. To better 
determine the impact of specific nutrients on age-related methylation, future work in the field 
should consider matched, longitudinal study designs. 
In contrast to HEI score, MVPA/day showed some significant environmental deflection 
of age-related methylation in the preschool and school-aged children. In both of these age 
groups, LEP showed a significant interaction between age and MVPA/day. However, these LEP 
interaction terms had opposing directionality across the age groups, shifting from positive to 
negative with increasing age. Assuming these opposing results are true positive, they may reflect 
changes in the effect of MVPA/day on rates of LEP age-related methylation during different 
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phases of childhood development. Although the mechanism behind this abrupt switch in 
deflection directionality remains unclear, it may be representative of physical activity dropping 
below some effect threshold in later childhood. Supporting the idea that physical activity could 
alter age-related methylation, previous research shows that physical activity can alter the adult 
epigenetic landscape through distinct alterations in either gene-specific (Nakajima et al. 2010; 
Zhang et al. 2015) or global methylation (White et al. 2013; Zhang et al. 2011). One study 
specifically addressed the idea that shifts in activity level could alter the course of age-related 
methylation, showing that an exercise intervention increased the rates of age-related methylation 
at the ASC gene in adult peripheral blood samples (Nakajima et al. 2010). In addition, a recent 
review of the literature concluded that physical activity leads to hypermethylation on a genome-
wide scale (Yu and Irwin 2016). These findings support the positive age:MVPA interaction we 
found for LEP methylation in preschoolers, and further suggest a trend toward positive 
environmental deflection of DNA methylation by physical activity. Further investigation into 
physical activity-mediated environmental deflection at the genes related to growth and 
metabolism should be repeated in a larger cohort that includes a defined exercise regimen. 
Limitations and future directions 
Our study was unique in many ways, but the findings are limited by the small sample 
sizes in analyses with the neonatal bloodspots (n=40, n=40, n=52) and especially in analyses 
with matching blood samples at childhood (n=16, n=26, n=20). While we observed several 
significant (p<0.05) and marginally significant (p<0.1) associations between target gene DNA 
methylation and childhood obesity outcomes, none would withstand correction for multiple 
testing. Given the associations observed, we recommend future longitudinal studies with 
increased cohort size and longer follow-up across successive life stages. Follow-up studies 
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should also consider expanding beyond target gene pyrosequencing, instead measuring 
epigenome-wide DNA methylation from neonatal bloodspots. Using this approach, future studies 
could utilize the Horvath epigenetic clock algorithm to determine whether early-life exposures 
alter rates of epigenetic aging from birth to adulthood (Horvath 2013). This may lead to the 
identification of additional gene regions where bloodspot DNA methylation predicts either 
childhood or adulthood obesity likelihood, strengthening the utility of bloodspot epigenetics as a 
clinically relevant tool for chronic disease risk estimation. 
Given the variability in DNA methylation levels by tissue, it remains to be seen whether 
the documented target gene age-related methylation in blood is consistent in other human tissues 
during childhood. Tissues of biological interest – i.e. liver, fat, muscle – may demonstrate 
significantly different associations between DNA methylation and age. Additionally, we did not 
correct for cellular heterogeneity over time, and the documented age-related methylation could 
be a reflection of shifting blood cell types with age. Future work should determine white blood 
cell percentage estimates from both neonatal bloodspots and childhood blood samples, then 
adjust for bias using a normalization method. Despite this uncertainty, there were some distinct 
advantages to using blood samples. First, they provided a matched tissue to retroactively 
collected neonatal bloodspots, allowing for direct measurement of intra-individual age-related 
methylation during childhood. In addition, blood is minimally invasive to collect from a cohort 
of children and was the best available biological sample for children in the Healthy Families 
project.  
Expanding the utility of neonatal bloodspots, recent literature shows that it is possible to 
measure some exposures (e.g., lead, mercury) from dried bloodspot samples (Funk et al. 2013). 
As such, it is possible that future study designs could use neonatal bloodspots to examine the 
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effects of childhood exposure to environmental contaminants on age-related methylation and 
associated phenotypes. This type of paradigm would provide important insight into the 
temporality of exposure-mediated changes in DNA methylation, further teasing out whether 
epigenetic changes are a cause or effect of disease phenotypes. The utilization of neonatal 
bloodspots as research samples is an exciting new model for environmental epidemiology, and 
should be considered in future human cohort epigenetics studies.  
5.4 Conclusions 
We tested whether neonatal bloodspot DNA methylation and childhood DNA methylation 
(12-24 mos. old, 3-5 years of age, or 10-12 years of age) at several target gene regions was 
associated with childhood obesity status. DNA methylation was quantified at one repetitive 
element (LINE-1), two imprinted genes (IGF2, H19), and four non-imprinted genes (LEP, 
PPARA, ESR1, SREBF1) in children from the Healthy Families cohort. We demonstrated 
negative associations between bloodspot target gene DNA methylation and obesity likelihood in 
preschool children, suggesting that the neonatal methylome may be useful tool for estimating 
obesity risk in childhood. In addition, the use of both neonatal bloodspots and matched childhood 
blood samples allowed for a unique examination of early-life epigenetic patterns. During 
childhood, all seven investigated genetic loci demonstrated significant age-related methylation, 
with directionality of age effects varying by region. Environmental deflection of age-related 
methylation by BMI z-score, MVPA/day, and HEI was minimal, with only a few significant 
interactions. Associations between neonatal DNA methylation and obesity likelihood were 
diminished in later-life blood models, indicating that longitudinal studies are critical for effective 
interpretation of DNA methylation data during childhood. To improve the utility of these results, 
the dynamics of epigenome-wide bloodspot DNA methylation should be further evaluated in 
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larger cohorts that examine specific exposure to environmental chemicals or modified behaviors 
during childhood. 
5.5 Methods 
Healthy families study 
The HF project recruited 40 families with children 12-24 months old (toddlers), 40 
families with children 3-5.99 years old (preschool), and 52 families with children 10-12.99 years 
old (school-aged) within 1-hour driving distance to Ann Arbor, MI. During a home visit by a 
research assistant, families provided survey data, child and parent anthropometry measurements, 
and written, informed consent. Questionnaires were used to assess sociodemographic 
characteristics, which included measures of maternal education, child race/ethnicity, and child 
sex. Each child was weighed to the nearest 0.1 kg using a Detecto Portable Scale Model 
(Detecto, Cat. #DR550C) and measured to the nearest 0.1 cm using a Seca 214 portable 
stadiometer (Seca, Prod. #213 1821 009). For toddlers, length was measured using a Seca 417 
infantometer (Seca, Prod. # 417 1821 009). Each individual was weighed twice; if the two 
readings were inconsistent by more than 0.1 kg, the individual was weighed two more times. For 
the height and length measurement, the individual’s position and posture were checked and the 
height/length measured twice; if the measurements differed by more than 0.5 cm, two more 
measurements were performed. Weight-for-length (WFL) or Body mass index (BMI) was then 
calculated. Separately, preschool and school-aged BMI z-score and toddler WFL z-score were 
derived using age- and sex-specific references from the US Centers for Disease Control (CDC) 
growth charts (Center for Health Statistics 2000). Per CDC recommendations, for preschool and 
school-age children, obese was categorized as a BMI ≥ 95th percentile, and overweight as a BMI 
≥ 85th percentile and <95th percentile for age and sex (Defining Childhood Obesity 2016). For 
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toddlers, obese was categorized as a WFL ≥ 95th percentile and overweight ≥ 85th percentile and 
<95th percentile for age and sex. Institutional Review Board (IRB) approval was obtained for all 
research practices (HUM00079730). 
 
Neonatal bloodspots and blood collection 
Neonatal bloodspots (n=132) for each recruited child were sourced from the Michigan 
Neonatal Biobank (MNB). Consent was obtained from all recruited families prior to bloodspot 
retrieval. Michigan Department of Health and Human Services (MDHHS) and University of 
Michigan (UM) IRB approvals were obtained for the Healthy Families project (UM: 
HUM00079730), DNA isolations from neonatal bloodspots (MDHHS: 201311-04-EA), and 
DNA isolations from blood draw samples (UM: HUM00086182). Before retrieval, MNB 
neonatal bloodspots were stored at different temperatures depending upon their collection date. 
As such, the current age of each recruited child corresponded to the storage method for their 
bloodspot – toddler and preschooler bloodspots were stored at -20°C, school-aged children’s 
bloodspots were stored at 4°C.Upon receiving the bloodspots, they were stored in their shipping 
bags at 4°C.  
In addition to neonatal bloodspots, matched childhood blood samples were collected for 
recruited children by the Michigan Clinical Research Unit based on child assent (school-aged 
group)/parent consent (all ages). During this blood draw, 0.25-0.50 mL of blood (finger or heel 
poke) or 7 mL of blood (venous draw) were collected from the toddlers/preschoolers or school-
aged children, respectively. Due to lack of consent, blood draw samples were only collected for 
approximately half of the recruited children (n=65). After collection, all blood draw samples 
were stored at -80°C. 
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DNA isolation and bisulfite conversion 
DNA was isolated from neonatal bloodspots using a modified version of the Oragene 
QIAamp DNA Micro Kit (Qiagen, Cat. #56304). To maximize DNA yields from bloodspots, a 
number of changes were made to the standard QIAamp DNA Micro Kit protocol. First, isolations 
were performed on four 3mm bloodspot punches rather than the recommended three punches. 
Second, to account for the increase in sample punches, all protocol buffer volumes were scaled 
up by 33%. Third, to ensure complete digestion, the heated incubation step was increased from 1 
hour to overnight. Fourth, the two vortex mixing steps were increased to 2 minutes and 5 
minutes, respectively. Fifth, the elution buffer was heated to 56°C prior to use. Finally, the final 
elution step was repeated to maximize yield. Across all bloodspot samples, average DNA yield 
was 19.3 ng/µL (S.D. = 9.3 ng/µL) for 25 µL samples. 
For the 12-24 mo. and 3-5 yr. age groups, DNA was isolated from blood samples using 
the Qiagen DNA Blood Mini Kit (Qiagen, Cat. #51104). For the 10-12 yr. group, DNA was 
isolated from blood samples using the Qiagen Flexigene Kit (Qiagen, Cat. #51206). DNA purity 
and yield was measured using a NanoDrop spectrophotometer. All isolated DNA was stored at -
80°C prior to use. 
Genomic DNA from all samples was bisulfite converted using the Zymo Research 96-
well EZ-methylation kit (Zymo Research, Cat. #D5004). Depending on the total yield of each 
DNA sample, bisulfite conversion was carried out on 0.2-1 µg of genomic DNA. To amplify 
bisulfite converted DNA, polymerase chain reaction (PCR) was performed using HotStarTaq 
master mix (Qiagen, Cat. #203443), RNAse-free water, forward primer (9 pmol), and 
biotinylated reverse primer (9 pmol). Total PCR volume was 35 µL per sample, and gel 
electrophoresis was used to verify PCR product identity. 
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Target gene pyrosequencing 
Upon successful DNA purification, bisulfite conversion, and PCR amplification, % DNA 
methylation was quantified for a panel of target genes using quantitative DNA pyrosequencing 
assays specific to each gene (Table 5-4). Methylation levels for all genes of interest were defined 
as the mean % methylation of all CpG sites in each gene’s PCR amplicon. SREBF1, PPARA, 
LEP, ESR1, H19, and IGF2 were chosen as a panel of target genes to explore based on their 
involvement in growth/development, obesity, and energy homeostasis. Long Interspersed 
Nucleotide Element 1 (LINE-1), a repetitive element spread throughout the human genome, was 
also included as a surrogate for global methylation levels (Martín-Núñez et al. 2014; Yang et al. 
2004). 
Quantification of DNA methylation levels was performed using the Qiagen Q96 
PyroMark ID instrument (Qiagen). Percentage methylation at target CpG sites is calculated 
within the Pyromark software as the fraction of 5-methylcytosine (5-mC) among all cytosines 
(methylated and unmethylated). All samples were run in duplicate and mean methylation 
percentages were calculated as the mean of the duplicates. All pyrosequencing plates included 
0%, 25%, 50%, 75%, and 100% methylation controls to ensure proper functioning of the 
instrument, and to provide baseline measures of methylation. 
Physical activity 
Physical activity was measured in preschool and school-aged children using an Actigraph 
(GT3X+, Pensacola, FL) accelerometer. Children were instructed to wear the accelerometer on 
an elastic belt at their hip for 7 consecutive days. To improve validity of included accelerometry 
data, participants who did not complete at least 4 days of valid recording, with at least 8 hours of 
measured activity, were removed prior to analysis. The 8 hour cutoff is below the standard 10 
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hour inclusion criteria, but was chosen in an effort to maximize sample size in this small study. 
Providing additional support for this choice, other recent studies have used 8 hour cutoffs when 
characterizing accelerometer data (Cain et al. 2013; Lockwood et al. 2016). At least one recorded 
weekend day was required for inclusion (Cain et al. 2013). Using the ActiLife software, 
accelerometer output was reduced into 1 minute epochs to classify data into three groups: 
moderate- to vigorous- intensity physical activity (MVPA/day; min·d
-1
), light intensity physical 
activity (LPA, min·d
-1
), and sedentary time (ST, min·d
-1
). Accelerometer data calibration was 
performed using previously established intensity cut points for children (Freedson et al. 2005). 
Physical activity data were not collected for toddlers. 
Dietary recall and healthy eating index 
Three separate, unannounced 24-hour dietary recalls (one weekend day, two weekdays) 
were completed with the parents of each enrolled child over the phone. Dietary recalls were 
completed according to the USDA Automated Multiple Pass Method (AMPM) (Blanton et al. 
2006), and recorded using the Nutrition Data System for Research (NDSR) software (Tiro et al. 
2013). During the phone call, parents were asked to recall exactly what their child ate/drank for 
the past 24 hours, and were provided with a Food Amounts Booklet to assist in portion size 
estimation. School-aged children were also sometimes asked recall questions by the staff directly 
to help clarify exact diet. Dietary recalls were broken down into specific nutrient and food group 
intakes using the Nutrition Data System for Research (NDSR) software (Tiro et al. 2013). 
According to guidelines established in the NDSR “Guide to Creating Variables Needed to 
Calculate Scores for Each Component of the Healthy Eating Index-2010 (HEI-2010)” (NDSR 
2014), a Healthy Eating Index (HEI) score was then calculated for each meal (Guenther et al. 
2014). All calculated HEI scores were based on serving size recommendations (per 1000 kcal) 
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from the Dietary Guidelines for Americans (McGuire 2011). Calculation of HEI was performed 
using an in-house SAS code, and the average of all three meal scores for each child was used as a 
final HEI score.  
Statistical analysis 
Simple summary statistics, including number of recruited individuals, sex ratios, and 
mean WFL or BMI z-score were calculated for each age group. For sex, child race/ethnicity, 
maternal education, and weight status category, a chi-squared test of equal proportions was 
computed to assess differences in distribution of sociodemographic characteristics across the 
three age groups. Analysis of variance (ANOVA) was used to test for significant differences in 
mean WFL or BMI z-score across the three age groups. 
To test our first hypothesis, logistic regression models were used to examine the 
association between target gene bloodspot DNA methylation (% methylation) and obesity status 
(categorical outcome; obese vs. not obese) within each age group. As a secondary test of this 
association, linear regression models were used to examine the association between target gene 
bloodspot DNA methylation (% methylation) and continuous WFL or BMI z-score. This 
modeling approach was repeated to examine associations between blood draw DNA methylation 
at the same age and weight status. 
For our second hypothesis, age-related methylation was measured as the absolute change 
in average DNA methylation for each gene from birth to follow-up in each of three age groups 
(toddler, preschool, school-aged). Linear mixed effect (LME) models were used to test for an 
association between percent DNA methylation and age at each gene region. Percent DNA 
methylation for all investigated loci was defined as the mean of all included CpG sites. Age, 
WFL or BMI z-score, and sex were included as explanatory variables in LME models. Linear 
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mixed models for each target region also included a paired individual factor to account for 
matched, within-individual data. Given that each age group contained different individuals, 
separate age-related methylation models were run for each group. All models were run using the 
lme4 package in R 3.4.0 (http://www.r-project.org).  
For the third hypothesis, childhood age group was delineated as a categorical variable. 
Using this new grouping variable, an age:group interaction term was included in the LME 
models to test for differences in age-related methylation slope by recruited age group. 
Environmental deflection of age-related methylation was tested using interaction terms between 
potential environmental modifiers and age in LME models. Interaction terms for age:BMI z-
score, age:WFL z-score, age:HEI score, and age:MVPA/day were included in separate models to 
test the individual effects of each factor on age-related methylation. 
Significance levels were set at p ≤ 0.05 for all analyses. Results with p≤ 0.10 were 
considered suggestive of significance. 
5.6 Funding 
Data for this study were collected as a part of the Healthy Families Project, which was 
funded by the University of Michigan (UM) Momentum Center. The work was supported by the 
MCubed program at the University of Michigan; the Michigan Lifestage Environmental 
Exposures and Disease (M-LEEaD) NIEHS Core Center under grant P30 ES017885; and the 
UM NIEHS institutional Training Grant T32 ES007062. 
5.7 Acknowledgements 
We acknowledge the Michigan Neonatal Biobank for providing neonatal bloodspots. 
 
 
 181 
5.8 Figures and Tables 
Variables 
12-24 months 
(n=40) 
  3-5 years (n=40)   10-12 years (n=52) 
Mean (SD)   Mean (SD)   Mean (SD) 
         
WFL or BMI z-
score 
0.32 (0.94)  0.38 (1.06)  0.24 (1.28) 
         
Variables 
12-24 months 
(n=40) 
  3-5 years (n=40)   10-12 years (n=52) 
Count     
(n) 
(%)   
Count      
(n) 
(%)   
Count      
(n) 
(%) 
Child Weight 
Class         
Underweight 1 (2.5)  2 (5)  5 (9.6) 
Normal 30 (75)  28 (70)  30 (57.7) 
Overweight 6 (15)  6 (15)  10 (19.2) 
Obese 3 (7.5)  4 (10)  7 (13.5) 
         
Neonatal 
Bloodspots 
40 (100)  40 (100)  52 (100) 
         
Ancillary Blood 
Draws 
19 (47.5)  26 (65)  20 (38.5) 
         
Child Gender          
Male 20 (50)  22 (55)  28 (54) 
Female 20 (50)  18 (45)  24 (46) 
         
Child Race*          
White 24 (60)  31 (77.5)  38 (73.1) 
Black 6 (15)  7 (17.5)  9 (17.3) 
American Indian 
or Alaska Native 
0 (0)  0 (0)  1 (0) 
Asian or Pacific 
Islander 
8 (20)  1 (2.5)  1 (1.9) 
Biracial 2 (5)  1 (2.5)  3 (5.7) 
Other 0 (0)  0 (0)  0 (0) 
         
Child Ethnicity          
Hispanic or 
Latino 
4 (10)  2 (5)  2 (3.8) 
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Not hispanic or 
latino 
36 (90)  38 (95)  50 (96.2) 
         
Maternal 
education  
        
Did not complete 
High School 
6 (15)  1 (2.5)  4 (7.7) 
Graduated High 
School 
4 (10)  2 (5)  9 (17.3) 
Completed GED 1 (2.5)  0 (0)  1 (1.9) 
Have some 
college courses 
9 (22.5)  10 (25)  13 (25) 
Completed a 2-
year  degree 
7 (17.5)  6 (15)  7 (13.4) 
Completed a 4-
year degree 
13 (32.5)   21 (52.5)   18 (34.6) 
Table 5-1: Summary statistics for Healthy Families cohort. A total of n=132 bloodspots for 
children in three age groups were sourced from the Michigan Neonatal Biobank. At visits during 
childhood, anthropometry data were collected. ANOVA was used to compare mean WFL or 
BMI z-score across age groups. A chi-squared test of equal proportions was used to test for 
significant differences in categorical variable proportions by age group. WFL z-score, BMI z-
score, and distribution of weight categories were not significantly different by age; child race 
was significantly different by age group.* = p-value < 0.05. 
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Toddler Age-related Methylation 
Gene N 
Mean 
Bloodspot % 
Methylation 
(SE) 
Mean 12-24 
month old % 
Methylation 
(SE) 
Methylation by 
Age - Beta 
coefficient† 
 p-
value 
LINE-1 18 80.44 (0.89) 77.99 (0.23) -2.431   0.011* 
IGF2 18 49.10 (1.43) 47.93 (0.59) -1.147 0.310 
H19 18 58.14 (1.36) 52.37 (0.56) -5.774 <0.001* 
PPARA 18 18.29 (0.88) 14.45 (0.67) -3.852   0.001* 
LEP 18 21.9 (0.69) 26.93 (0.63) 5.020 <0.001* 
ESR1  18 4.96 (0.23) 4.40 (0.18) -0.582 0.052 
SREBF1 13 50.52 (2.47) 41.42 (2.91) -11.750   0.005* 
Preschool Age-related Methylation 
Gene N 
Mean 
Bloodspot % 
Methylation 
(SE) 
Mean 3-5 year 
old % 
Methylation 
(SE) 
Methylation by 
Age - Beta 
coefficient† 
 p-
value 
LINE-1 25 82.15 (0.66) 77.68 (0.23) -2.058 <0.001* 
IGF2 25 50.98 (0.91) 47.06 (0.50) -1.865 <0.001* 
H19 25 61.92 (1.39) 52.36 (0.45) -4.652 <0.001* 
PPARA 23 21.62 (0.74) 12.58 (0.49) -4.890 <0.001* 
LEP 23 22.05 (1/19) 28.59 (0.65) 3.297 <0.001* 
ESR1 23 5.42 (0.28) 4.54 (0.18) -0.430   0.008* 
SREBF1 22 47.85 (1.49) 37.89 (1.65) -5.306 <0.001* 
School-Aged Age-related Methylation 
Gene N 
Mean 
Bloodspot % 
Methylation 
(SE) 
Mean 10-12 
year old % 
Methylation 
(SE) 
Methylation by 
Age - Beta 
coefficient† 
 p-
value 
LINE-1 17 81.95 (0.73) 79.69 (0.49) -0.843   0.018* 
IGF2 16 49.34 (1.71) 45.30 (0.48) -1.779   0.013* 
H19 16 63.23 (3.51) 52.81 (0.59) -4.683   0.002* 
PPARA 16 19.98 (2.04) 10.06 (0.47) -3.607   0.002* 
LEP 13 19.52 (2.27) 27.68 (0.74) 2.184   0.047* 
ESR1  15 4.71 (0.29) 5.08 (0.17) 0.120 0.337 
SREBF1 12 51.11 (2.08) 36.38 (1.55) -5.305 <0.001* 
Table 5-2: Age-related methylation separated by gene region and age group. The three 
sections of the table show target gene age-related methylation for the separate age groups. WFL 
or BMI z-score and sex were included as covariates in all models. Linear mixed models included 
a paired factor to account for matched, within-individual effects. Separate models were run for 
each gene; beta coefficients and associated p-values for age from each model are reported. † = 
Beta coefficient for age predictor in linear mixed model; * = p<0.05. 
 184 
Toddler Environmental Deflection 
Gene N 
Age:BMIz - 
Beta 
coefficient† 
 p-
value 
Age:MVPA - 
Beta 
coefficient† 
 p-
value 
Age:HEI - 
Beta 
coefficient† 
 p-
value 
LINE-1 36 -0.457 0.551 N/A N/A 0.036 0.671 
IGF2 36 -0.369 0.708 N/A N/A -0.110 0.335 
H19 37 0.434 0.726 N/A N/A -0.037 0.786 
PPARA 36 0.500 0.591 N/A N/A -0.041 0.694 
LEP 36 0.764 0.353 N/A N/A -0.151 0.094^ 
ESR1 36 -0.113 0.683 N/A N/A 0.015 0.596 
SREBF1 26 -1.198 0.687 N/A N/A 0.084 0.793 
Preschool Environmental Deflection 
Gene N 
Age:BMIz - 
Beta 
coefficient† 
 p-
value 
Age:MVPA - 
Beta 
coefficient† 
 p-
value 
Age:HEI - 
Beta 
coefficient† 
 p-
value 
LINE-1 50 0.277 0.456 -0.005 0.739 0.044 0.123 
IGF2 50 0.293 0.528 -0.005 0.782 0.007 0.854 
H19 50 -0.202 0.807 -0.019 0.565 0.059 0.352 
PPARA 47 0.771 0.042* -0.008 0.606 0.025 0.423 
LEP 46 -0.176 0.639 0.033 0.016* 0.024 0.402 
ESR1 46 0.006 0.970 0.005 0.480 -0.007 0.548 
SREBF1 44 0.867 0.367 -0.006 0.896 0.030 0.738 
School-Aged 
Children  
Environmental Deflection 
Gene N 
Age:BMIz - 
Beta 
coefficient† 
 p-
value 
Age:MVPA - 
Beta 
coefficient† 
 p-
value 
Age:HEI - 
Beta 
coefficient† 
 p-
value 
LINE-1 35 0.040 0.863 -0.002 0.905 0.040 0.331 
IGF2 33 0.026 0.950 -0.047 0.093^ 0.107 0.209 
H19 33 0.020 0.977 -0.056 0.363 0.012 0.919 
PPARA 32 -0.437 0.517 -0.080 0.510 -0.080 0.510 
LEP 27 -0.231 0.733 -0.180 0.001* 0.186 0.125 
ESR1 31 -0.076 0.470 -0.011 0.202 -0.009 0.637 
SREBF1 25 -1.248 0.050* -0.031 0.576 -0.036 0.768 
Table 5-3: Environmental deflection of age-related DNA methylation. Environmental 
deflection was investigated for each separate age group using interaction terms between age and 
environmental predictors of interest. Linear mixed models included a paired factor to account for 
matched, within-individual effects, and sex was included as a covariate in all models. Separate 
models were run for each gene; beta coefficients and associated p-values for interaction terms 
from separate models are reported. † = Beta coefficient for age:environment interaction terms in 
LME models that control for gender and id random effect; * = p<0.05; ^ = p<0.10. 
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Assay LINE-1 IGF2
1
 H19
1
 PPARA LEP
2
 ESR1 SREBF1
3
 
Location 
(hg19) 
Repetitive 
Element 
chr11: 2169499; 
chr11: 2169515; 
chr11: 2169518  
chr11: 
2024254; 
chr11: 
2024257; 
chr11: 
2024259; 
chr11: 
2024261 
chr22: 46545064; 
chr22: 46545083 
chr7: 
127881127; 
chr7: 
127881129; 
chr7:1278811
3 
chr6: 
152128834
; chr6: 
152128841
; chr6: 
152128845
; chr6: 
152128868 
chr17: 
17723203; 
chr17: 
17723288; 
chr17: 
17723297; 
chr17: 
17723305 
Forward 
PCR 
Primer 
5'- 
TTGAGTTAGGT
GTGGGATATA
GTT-3' 
5'-
GGAGGGGGTTTA
TTTTTTTAGGAAG-
3' 
5'-
TTTGTTGATTT
TATTAAGGGA
G-3'  
5'-
GGAGGTTTTTATG
AGGATGTAGTT-3'  
5'-
GAGTTTTTGG
AGGGATATTA
AGGAT-3' 
5'-
GTTGGAG
GTTAGGGA
GTTTAGGA
-3' 
5'-
TTTGTTTGG
GTTTTGATG
TAAATGTA-
3' 
Reverse 
PCR 
Primer 
5'-[Biotin]-
CAAAAAATCAA
AAAATTCCCTT
TCC-3' 
5'-[Biotin]-
AACCCCAACAAAA
ACCACTAAACAC-
3' 
5'-[Biotin]-
CTATAAATAA
ACCCCAACCA
AAC-3' 
5'-[Biotin]-
ACACATATTAACC
AACAATAACTATC
AT-3' 
5'-[Biotin]-
CAAAATTATA
TAAAACCCTA
TAACCTACCA-
3' 
5'-[Biotin]-
CTAACCCC
CACCCTAC
CCC-3' 
5'-[Biotin]-
ATTCAACTC
CACCCCTAT
ATTAAACTA
C-3' 
Sequencin
g Primer 
5'-
AGGTGTGGAT
ATAGT-3' 
5'-
GGGGTTTATTTTT
TTAGGA-3' 
5'-
GTGTGGAATT
AGAAGT-3' 
5'-
GGATGTGGTTGTT
TG-3' 
5'-
GGGAGGTAT
TTAAGGG-3'; 
5'-
GGGAGGGGA
GGGAGTTGG-
3' 
5'-
GGTTAGG
GAGTTTAG
GAG-3'  
5'-
GTATTGGTT
TTAAGTTAG
GTT-3' 
Sequence 
to Analyze 
TTYGTGGTGYG
TYGTTTTTTAAG
TYGGTTTGAAA
AG 
AGTATAGTTAYGT
YGTTTTTTATTGGT
TTYGTTAAGTAGA 
GGTYGYGYGG
YGGTAGTGTA
GGTTTATATA 
TTATAGTT 
TATATTTTAYGAGA
TATGTAGGATATT
AYGTGTATAGGTT 
ATTTTATAAATTTT
GAAATAA  
TGYGYGYGTG
GTTTTTGGHG 
TTGGYGGA
GGGYGTTY
GTTT 
TGGGATTG
TATTTGTTT
TYGT 
TTTAGTGYG
AGGTTGYGT
TT 
ATTTYGGTA
ATAAGTATA
TT 
AGGATTGTT
AGTAATAGG
GT 
ATTTTAAGT
AGTYGAGTG
GA 
GTTTTAGTTT
TTAAAGTTT
G 
Amplicon 
Length 
(bp) 
~150 bp 93 145 198 383 119 293 
Annealing 
Temperat
ure (°C) 
55 55 51 54.5 52 58/56* 56 
Number 
of Cycles 
48 50 50 48 50 15/29* 44 
Number 
of CpG 
Sites 
4 3 4 2 3 4 4 
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Table 5-4: Pyrosequencing primer sequences and PCR conditions. Pyrosequencing primer 
sequences and PCR conditions. Information for each assay, including genomic location 
(individual CpGs analyzed), primer sequences (5’-3’), sequence to analyze, amplicon length, 
annealing temperature, number of cycles, and number of CpG sites measured. Touchdown PCR 
was used for ESR1 assay, as indicated by the multiple temperatures and cycle numbers. 
1
Assay 
adapted from Hoyo et al., 2012; 
2
Assay adapted from Lesseur et al., 2013; 
3
Assay adapted from 
Adaikalakoteswari et al., 2016. 
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Figure 5-1: Associations between bloodspot DNA methylation and log odds of obesity 
(Y/N). Forest plot of logistic regression models examining associations between neonatal 
bloodspot DNA methylation at investigated target genes and log odds of obesity. Logistic 
regression coefficients are represented as log odds of obesity in the right column. The left 
column shows how the obesity outcome was grouped by age in the regression models. It also 
lists all target genes included in analyses. Associations that approach significance (p<0.10) are 
indicated in blue, and significant (p<0.05) associations are indicated in red. Arrows indicate that 
confidence interval extends beyond the scale of the plot. 
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Figure 5-2: Associations between childhood blood DNA methylation and log odds obesity 
(Y/N). Forest plot of obesity likelihood by childhood blood draw DNA methylation at 
investigated target genes. Logistic regression coefficients are represented as log odds of obesity 
in the right column. The left column shows how the obesity likelihood outcome was grouped by 
age in the regression models. It also lists all of the target gene methylation predictors included in 
bloodspot logistic regression models. For the 10-12 year old age group, no LEP methylation data 
was available for obese individuals. Trends that approach significance (p<0.10) are indicated in 
blue. 
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Figure 5-3: Associations between childhood blood DNA methylation and WFL or BMI z-
score. Forest plot of continuous WFL or BMI z-score by childhood blood draw DNA 
methylation at investigated target genes. Linear regression coefficients are shown in the right 
column. The left column shows how the regression models were grouped by age. It also lists all 
of the target gene methylation predictors included in blood logistic regression models. 
Significant positive association between PPARA blood DNA methylation and WFL or BMI z-
score (p<0.05) is indicated in red. 
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Figure 5-4: Age-related methylation at seven target loci by age group. Spaghetti plots are 
used to visualize age-related methylation for all individuals at each gene region. The three 
separate age groups are represented in different boxes, as well as by different colors. Thick black 
lines correspond to linear regression lines for association between age and mean methylation at 
each gene region. Age groups are indicated as 0, 1, 2, and 3, which correspond to bloodspot 
(time=0) and follow-up at one of three age groups – 12-24 months old (time=1), 3-5 years old 
(time=2), and 10-12 years old (time=3). All seven target genes demonstrated significant (p<0.05) 
age-related methylation between birth and at least one follow-up age. 
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Figure 5-5: Environmental deflection of preschool PPARA age-related DNA methylation by 
BMI z-score. Line plot of longitudinal PPARA DNA methylation from neonatal bloodspot (age 
group = 0) to preschool (age group = 2). BMI z-score is indicated on a colored scale, with blue 
representing higher z-score and red representing lower z-score. In the preschool group, PPARA 
showed significant positive deflection of age-related methylation by BMI z-score (p=0.04). The 
thick black line is the best-fit regression slope of DNA methylation over time for all individuals 
combined. Going from low BMI z-score (red) to high BMI z-score (blue), individuals had 
increased slopes of age-related methylation at the PPARA gene. This result was only present in 
the preschool age group. 
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Figure 5-6: Environmental deflection of preschool LEP age-related DNA methylation by 
MVPA/day. Line plot of longitudinal LEP DNA methylation from neonatal bloodspot (age 
group = 0) to preschool (age group = 2). MVPA/day is indicated on a colored scale, with blue 
representing higher activity counts and red representing lower activity counts. In the preschool 
group, LEP showed significant positive deflection of age-related methylation by MVPA/day 
(p=0.02). The thick black line is the best-fit regression slope of DNA methylation over time for 
all individuals combined. Going from low MVPA/day (red) to high MVPA/day (blue), 
individuals had increased slopes of age-related methylation at the LEP gene. This result was only 
present in the preschool age group. 
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Figure 5-7: Histograms and Q-Q plots of HEI score distributions. Histograms and Q-Q plots demonstrate general normality of 
HEI score data for each separate age group. Low sample size was available at the high and low end of HEI score range, meaning HEI 
score distributions did not adequately capture the far extremes of diet quality.  
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Chapter 6 
Conclusion 
 
6.1 Dissertation Objectives 
The overall goal of this dissertation was to improve understanding of the epigenetic 
mechanisms driving the developmental origins of health and disease (DOHaD) hypothesis 
(Bateson et al. 2004; Heindel et al. 2015). Specifically, we aimed to determine whether 
epigenetic aging, the changes that occur in the epigenome with age, contribute to later-life 
disease development. In an effort to answer this question, we tested whether early-life exposure 
to specific environmental factors alters long-term regulation of the epigenome, as had been 
suggested in previous human (Horvath et al. 2014; Shah et al. 2014; van Dongen et al. 2016; 
Zannas et al. 2015) and animal model (Faulk et al. 2014; Gilbert et al. 2016; Kochmanski et al. 
2016) studies. To examine the effects of perinatal environmental exposures on longitudinal 
epigenetic patterns, we exposed mice to bishenol A (BPA) and/or Western high-fat diet (WHFD) 
throughout the perinatal period, then measured longitudinal DNA methylation from blood and 
tail tissues. Both BPA and HFD have shown cross-sectional effects on the epigenome (Anderson 
et al. 2012; Yoon et al. 2017), but their effects on epigenetic aging were unclear prior to this 
dissertation. 
To describe the effects of the perinatal environment on epigenetic aging, we first 
developed a formal conceptual framework – environmental deflection (Kochmanski et al. 2017). 
This concept, which refers to environment-mediated shifts in the aging epigenome, was tested in 
each part of this dissertation. In the first chapter, we hypothesized that early-life exposure to the 
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endocrine-disrupting chemical BPA would result in altered epigenetic aging in a mouse model, 
as measured via longitudinal DNA methylation levels across multiple mouse tissues. 
Secondarily, it was hypothesized that the effects of BPA on murine epigenetic aging would be 
mitigated by increased physical activity and exacerbated by co-exposure to WHFD. In the fifth 
chapter, utilizing samples from a children’s cohort, it was hypothesized that physical activity and 
diet would also modify rates of epigenetic aging in a human population, and that long-term 
changes in age-related methylation would be associated with obesity status. Human results were 
used in an attempt to improve the clinical significance of our animal model data. 
  While the concept of environmental deflection cut through all aspects of this dissertation, 
there were also several experimental questions unique to each chapter. For example, in chapter 1, 
we compared the aging epigenome between two tissues – tail and blood – testing for tissue-
specific differences in the effects of perinatal exposures. In chapter 2, we examined epigenome-
wide 5-mC and 5-hmC levels based on BPA exposure, testing whether exposure modified 
establishment and long-term regulation of multiple epigenetic marks. Finally, in chapter 3, we 
included a disease outcome of interest – obesity. Recent research indicates that obesity is 
associated with cross-sectional measures of the epigenome (Almén et al. 2014; Wahl et al. 2016), 
but little has done to test whether obesity modifies rates of epigenetic aging during childhood. In 
the third chapter, matched neonatal bloodspots and blood draw samples were used to test 
whether obesity was associated with changes in the aging epigenome during the early phases of 
life. Despite these chapter-specific questions, all of the additional experiments fed into a single 
goal – to determine the contribution of epigenetic aging to the DOHaD paradigm. 
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6.2 Summary of Dissertation Findings 
Contrary to our initial hypothesis, we did not find any significant effects of BPA 
exposure on age-related methylation at target genes in mice. These results suggest that BPA may 
not deflect epigenetic aging in mice. Despite the negative findings for BPA, we demonstrated 
significant effects of WHFD on age-related methylation at target genes related to growth and 
development in mouse tail and blood tissues. These data support the environmental deflection 
paradigm, showing that perinatal exposure to an altered diet can alter epigenetic aging across 
multiple murine tissues.  
On a genome-wide scale, we found some evidence for environmental deflection of 5-mC 
levels in mouse blood by BPA exposure, but no evidence for BPA-induced deflection of 5-hmC. 
These inconsistent results may be the byproduct of differences in data structure and analysis 
methods for 5-hmC and 5-mC, but they could also reflect differences in the effects of 
environmental factors on these separate epigenetic marks. Despite the unclear environmental 
epigenome-wide deflection results, we did identify twelve BPA-related DHMRs annotated to 
murine imprinted genes. While this result was not predicted, it fits with previous data showing 
that developmental BPA exposure can alter the epigenome (Anderson et al. 2012; Susiarjo et al. 
2013). Providing support for the functional relevance of these 5-hmC findings, we showed BPA-
related gene expression across the life-course at the imprinted Gnas locus. The exact mechanism 
of action for BPA’s effect on 5-hmC remains unclear, but we hypothesize that it may be a 
byproduct of oxidative stress induction by BPA, as has been shown in previous research 
(Gassman 2017). In addition to the effects of BPA exposure, we also identified a region 
upstream of the Nfic gene that showed simultaneous age-related decreases in 5-mC and 5-hmC 
levels. Following up on these results, we showed that Nfic expression significantly decreased 
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with age, suggesting that epigenetic aging may have functional effects. Further investigation into 
the biological outcomes of epigenetic aging will require additional measurements of longitudinal 
gene expression. 
In humans, we found some evidence for environmental deflection of age-related 
methylation by physical activity-related energy expenditure, but no environmental deflection by 
healthy eating index, a measure of diet quality. This latter result was unexpected given the clear 
effects of WHFD on age-related methylation in the mouse exposure study. This inconsistency 
between species could reflect difficulties in accurately measuring human diet, differences in 
follow-up time-scale used for the two species, or the fact that humans have a number of 
uncharacterized environmental factors that were not considered in our analyses. Examining the 
mouse and human results as a whole, the target genes analyzed in both mice and humans – 
IGF2/Igf2, H19, ESR1/Esr1, and LINE-1 did not display any consistent, cross-species patterns of 
environmental deflection by environmental factors. This lack of consistency may be a byproduct 
of biological differences in humans and mice, species that show clear divergences in both genetic 
sequence and regulatory control (Yue et al. 2014). However, interpretation of our human 
findings is also limited by a small sample size; a larger cohort may show effects of environment 
on epigenetic aging that better correspond to the mouse data. Despite these inter-species 
inconsistencies, we did show evidence for environmental deflection by environmental factors in 
both species, suggesting that this is a shared epigenetic phenomenon in multiple mammal 
species. 
While the mouse exposure study results differed from our human cohort, longitudinal 
mouse model studies still provide a number of experimental benefits for investigating the aging 
epigenome. For one, mice advance to adulthood at a rapid pace, reaching full maturation at 
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approximately postnatal day 60 (Brust et al. 2015); this allows for a relatively fast examination 
of the entire life-course. Second, in addition to their short lifespan, mice also have closed 
environments with controlled diets and chemical exposures. Third, our mouse colony is a 
genetically invariant in-bred strain, which eliminates genetic heterogeneity. Combines, these 
benefits remove much of the variability and confounding present in human cohort studies, 
allowing for longitudinal experimental designs that examine the effects of an isolated exposure 
early in life. This would be difficult, if not impossible, to achieve in human cohorts, even using 
large samples sizes and sophisticated statistical models. 
   
6.3 Significance of Findings 
Despite multiple public health initiatives aimed at improving metabolic health in the 
U.S., obesity rates have continued to climb over the past few decades, reaching 39.8% in 2015-
2016 (Hales et al. 2017). Of particular concern, obesity is associated with a number of chronic 
diseases, including heart disease, hypertension, some cancers, and type 2 diabetes (Dixon 2010). 
Based on these negative health effects, the estimated annual medical cost of obesity in the U.S. is 
$149.4 billion in 2014 U.S. dollars (Kim and Basu 2016). Previous research has shown that the 
best predictors of adult obesity are obesity during childhood or a family history of obesity (Loos 
and Janssens 2017), results that seem to suggest a critical role for genetics in determining obesity 
status. However, reviews of this subject have shown that BMI-associated genetic variants only 
explain 0.66-2.70% of BMI variation , concluding that the available genetic information does not 
accurately predict risk of obesity (Loos and Janssens 2017). Genetics-based models fail to 
capture the essential role of the environment – including diet, behavior, and chemical exposures 
– in shaping obesity risk. As such, biomarkers of the developmental environment, including the 
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neonatal epigenome, have the potential to provide important information about chronic disease 
risk through adulthood.  
In the last two decades, Bisphenol A has been the subject of a vast amount of research, as 
well as significant public concern. Exposure to BPA is near ubiquitous in the U.S. population 
(Calafat et al. 2008), and it is found in a number of consumer goods, including plastic bottles, 
canned food liners, and some paper products (Cooper et al. 2011). Worries about the safety of 
BPA are largely based on evidence indicating that it is an endocrine disrupting chemical, 
meaning BPA can interfere with normal hormone synthesis, metabolism, or function (Diamanti-
Kandarakis et al. 2009). Specifically, research has shown that BPA is an estrogen-mimicking 
chemical that can activate growth-related transcription factors and bind to nuclear receptors 
involved in cell growth/maturation (Krüger et al. 2008; Sui et al. 2012). In addition to its activity 
as an EDC, previous work has reported BPA-induced oxidative stress (Gassman 2017), as well 
as associations between BPA exposure and metabolic disorders (Alonso-Magdalena et al. 2015; 
Carwile and Michels 2011; Ko et al. 2014). However, as a result of contradictory results showing 
sex-specific links between BPA exposure and a lean phenotype in mice (Anderson et al. 2013; 
van Esterik et al. 2014), the exact human health effects of BPA exposure remain controversial. In 
an effort to better determine the mechanism of action for BPA, recent studies have investigated 
the epigenetic effects of BPA exposure, showing that developmental BPA exposure can alter 
global, genome-wide, and gene promoter-specific methylation in mouse models (Anderson et al. 
2012; Singh and Li 2012; Susiarjo et al. 2013). However, these studies failed to distinguish the 
effects of BPA exposure on 5-mC and 5-hmC, separate epigenetic marks that can have opposing 
associations with gene transcription (Hahn et al. 2014; Wu et al. 2011). Here, we followed up on 
previous studies, showing that genome-wide 5-hmC was altered by BPA exposure, with specific 
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effects taking place at a number of imprinted genes. Given their tight regulation during 
development and involvement in growth-related biological pathways (Bartolomei and Ferguson-
Smith 2011), modified regulation of imprinted genes has the potential to adversely impact long-
term health. As such, our results showing longitudinal BPA-related differential 
hydroxymethylation at imprinted genes may represent a epigenetic mechanism by which BPA 
impacts health throughout the life-course. 
Typical toxicology studies examine the effects of a single chemical exposure at multiple 
doses in an animal model. While these types of studies are useful for identifying specific 
functional outcomes of exposure, they do not consider whether diet and/or behavioral factors 
modify the effects of exposure. Normal human environments are a mélange of behaviors, diet, 
and chemical exposures, so examining the effect of an isolated chemical exposure has only 
limited applicability to the human condition. Here, in an effort to determine how chemical 
exposures interact with other environmental variables, we integrated changes in diet quality and 
physical activity into our longitudinal models. This is particularly important in the field of 
toxicoepigenetics since previous studies have demonstrated significant associations between the 
epigenome and developmental high-fat diet or physical activity (Dudley et al. 2011; Laker et al. 
2014; Marco et al. 2013; Xu et al. 2017). Results from this dissertation showed that diet and/or 
physical activity modified rates of age-related methylation at specific genes related growth and 
development, but failed to show an interaction between diet/physical activity and BPA exposure. 
In addition, the effects of WHFD were greater than BPA in all measures of target gene DNA 
methylation in our mouse model, suggesting that developmental diet may have a larger effect on 
the methylome than perinatal BPA exposure. These data suggest that the epigenetic effects of 
WHFD and BPA are separate phenomena, and may work through separate biological pathways. 
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However, it is also possible that the effects of BPA were simply washed out by WHFD in the 
combined exposure group, and that these two exposures could still interact with one another in a 
“two-hit” exposure design. That is, early life exposure to BPA could set the epigenome in a 
poised state, making it more vulnerable to later-life environmental challenges, including WHFD. 
This paradigm of epigenetic dormancy is supported by recent research (Chamorro-Garcia et al. 
2017), suggesting that future studies should focus on dietary and chemical exposures that are 
staggered throughout life, not necessarily simultaneous during development. 
 
6.4 Strengths and Limitations 
This dissertation has a number of strengths that set it apart from traditional toxicology 
research. First, it utilizes the toxicoepigenetics framework, examining the effects of 
environmental exposures on epigenetic marks, a biological mechanism thought to play an 
important role in the developmental origins of disease. Second, we integrated data from modern 
sequencing technologies, allowing for a wide examination of the effects of environmental factors 
on the epigenome. Third, from the dissertation’s inception, we planned to include both mouse 
and human data in an effort to increase translatability of results. To ensure comparability of data 
across species, we used the same data collection and analysis methods for mouse and human 
DNA methylation results. 
Older toxicoepigenetics studies followed a simple, two-step experimental design: 1. 
maternal exposure to toxicant; 2. cross-sectional measure of offspring epigenome at sacrifice. 
This study design is effective at identifying dichotomous effects of exposure on the epigenome 
compared to control, but fails to consider how exposure alters long-term regulation of the 
genome. Eschewing the typical cross-sectional approach used in previous toxicoepigenetics 
studies, we used longitudinal data to examine the effects of developmental dietary exposures on 
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the aging epigenome. As a result, this dissertation aims to expand on a growing question in the 
field: can early-life toxicant exposures alter rates of epigenetic aging? 
Although very similar statistical methods were applied to both mouse and human data in 
this dissertation, several differences in study design and scope between the animal and human 
projects make the results difficult to compare between species. First, the human data was only 
collected during childhood, meaning measures of age-related methylation from our human cohort 
only represented the early phases of life. In contrast, our mouse studies followed the animals 
throughout life – PND21 to 10 months of age – thereby capturing the early phases of adulthood 
when chronic disease is expected to develop. Second, the environment of the recruited human 
cohort was not controlled, meaning background exposures to various environmental factors may 
be confounding the human methylation data. In contrast, the murine environment was carefully 
controlled, with dietary exposures representing the only difference between groups of mice. This 
allows for a reduction in background noise from environmental factors, and may explain the 
increased significance found in our mouse data. Third, the mice used in this study come from an 
in-bred, genetically invariant colony, while the recruited humans come from a heterogeneous 
population. This means that the mouse data, while less variable, may not be representative of a 
real-world population. As such, the mouse experiments should be repeated in different strains of 
mice to determine whether exposure effects are specific to our mouse colony. 
Sample sizes were limited in both the mouse and human portions of this dissertation. For 
the mouse exposure study, group sizes were selected based on power calculations performed for 
previous longitudinal mouse studies performed in the Dolinoy Lab. Nevertheless, larger group 
sizes would have improved analyses, particularly the environmental deflection interaction terms 
in linear mixed models. Due to increased environmental variability and population heterogeneity, 
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small sample size is an even greater concern in the human cohort. Fitting with this idea, 
interaction term fidelity broke down in the smallest batches of childhood human pyrosequencing 
data. Increasing the sample size of recruited human cohorts would improve statistical modeling 
of environmental deflection. 
Given how recently epigenetic aging has emerged as a topic of research interest, precise 
differences in how aging alters the epigenome in mice and humans remain unclear. Despite 
similarities in the underlying mechanisms of aging, research shows that mice and humans have 
marked differences in their metabolic stability throughout life (Demetrius 2006). Metabolic 
stability, which refers to the ability of an organism’s metabolic network to maintain normal 
redox balances in response to changes in enzymatic processes, is essential for maintaining 
homeostasis, thereby slowing the aging process. Mice have lower metabolic stability than 
humans, and are therefore expected to show decreased ability to offset the effects of aging 
(Demetrius 2006). As such, it is also possible that both epigenetic aging and environmental 
deflection are distinct in mice and humans. Additional cross-species comparisons are needed to 
test this idea.  
 
6.5 Future Directions 
 This dissertation attempted to integrate data from a mouse exposure study and a human 
cohort to investigate the contribution of toxicant-mediated environmental deflection to the obese 
phenotype. Unfortunately, while we found a number of significant results, interpretation of the 
data was limited by a number of experimental limitations. As a result, we did not definitively 
determine whether environmental deflection is a mechanism underlying chronic disease 
development. Despite this, the available data are suggestive in many ways, and pave the way for 
additional studies.  
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While it is difficult to directly compare the human and mouse data generated in this 
dissertation project, the available analyses suggest that the environment plays a role in shaping 
the aging epigenome in both species. Following up on these results, future studies should 
investigate whether specific environmental exposures – i.e. endocrine disrupting chemicals, 
pesticides, metals – have consistent effects on epigenetic aging in both humans and animal 
models. Studies should also examine the effects of exposure on long-term phenotype. This could 
be achieved through longitudinal measurements of body composition, RT-qPCR for gene 
expression, or physical analysis of additional tissues for pathological responses to exposure. 
Only with this type of combined approach will it be possible to determine the phenotypic 
consequences of environmental deflection. 
In this dissertation, we showed that BPA exposure modified establishment of 5-hmC at a 
number of imprinted genes in a mouse blood. As a result of epigenetic control mechanisms, 
imprinted genes exhibit monoallelic, parent-of-origin-specific gene expression during 
development (Bartolomei and Ferguson-Smith 2011; Das et al. 2009). Research shows that 
imprinting control regions (ICRs) are not demethylated during post-fertilization reprogramming 
(Arnaud 2010; Kelsey and Feil 2012; Kim et al. 2017; Pidsley et al. 2012; Smallwood and 
Kelsey 2012), making imprinted genes important potential targets of developmental exposures 
(Haycock and Ramsay 2009; Heijmans et al. 2008; Nye et al. 2015; Susiarjo et al. 2013). While a 
number of studies have examined 5-mC levels at murine imprinted genes, this is the first report 
of differential 5-hmC levels at imprinted genes in mouse blood. Given the novelty of this 
finding, this result should be tested in additional murine tissues, as well as human cohorts.  
For the human cohort, we isolated DNA from neonatal bloodspots and used DNA 
methylation levels from these samples as a baseline epigenome. The goal of this project was to 
 214 
determine whether or not the measured neonatal DNA methylation was associated with obesity. 
However, the sample size of obese children from our cohort was quite small, making this 
relationship difficult to model. Additionally, we only measured DNA methylation at a few target 
genes related to growth and development. Moving forward, cohort size should be increased and 
data should be expanded to an epigenome-wide scale using sequencing technologies. In this way, 
it would be possible to determine whether the obesity phenotype is associated with neonatal 
DNA methylation. As an ultimate goal, future studies should examine whether it is possible to 
predict obesity risk from epigenetic biomarkers measured at birth. This would be a valuable 
clinical tool for identifying at-risk individuals prior to disease development. 
 
6.6 Conclusion 
In this dissertation, we showed that diet and physical activity have the potential to alter 
rates of age-related methylation throughout the life-course. These data support the environmental 
deflection paradigm that was described during the course of this project, showing that the 
environment can alter not only the cross-sectional measures of the epigenome, but also 
epigenetic aging. Separately, we showed that both age and BPA exposure can alter murine DNA 
hydroxymethylation, a secondary regulatory mark in the epigenome. The findings from this 
dissertation are relevant to the growing field of toxicoepigenetics, and help shed light on the 
mechanisms underpinning the developmental origins of health and disease hypothesis (Figure 6-
1). In an attempt to increase the clinical relevance of the mouse results, environmental deflection 
by physical activity and diet quality was also tested in a human cohort. While exact directionality 
of results varied by organism, our data support the idea that the aging epigenome is sensitive to 
environmental cues. These results emphasize the importance of longitudinal study design in 
toxicoepigenetics research, and suggest that environmental factors play a key role in the 
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developmental origins of adult disease. This idea has important implications for public health 
policies related to chronic disease prevention, including chemical regulations, dietary 
suggestions, and exercise recommendations. 
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6.7 Figures and Tables 
 
Figure 6-1: Synthesis of dissertation findings as they relate to the DOHaD hypothesis. Age-
related methylation was documented in both the mouse exposure study and the human cohort 
study. In mice, Western high-fat diet (WHFD) and activity-related energy expenditure (AEE) 
altered rates of epigenetic aging. Also in mice, BPA exposure had a long-term effect on 5-hmC 
levels at imprinted loci. In humans, moderate-to-vigorous physical activity (MVPA) levels 
altered gene-specific epigenetic aging, Childhood age group also altered rates of age-related 
methylation at several gene regions, indicating that epigenetic aging is dynamic throughout the 
life course. Also in humans, gene-specific neonatal bloodspot DNA methylation was associated 
with obesity likelihood in childhood. Combined, our data support the idea that the aging 
epigenome is sensitive to environmental cues, and that environmental deflection may play a role 
in the developmental origins of health and disease. 
  
 217 
6.8 References 
Almén MS, Nilsson EK, Jacobsson JA, Kalnina I, Klovins J, Fredriksson R, et al. 2014. 
Genome-wide analysis reveals DNA methylation markers that vary with both age and 
obesity. Gene 548:61–67; doi:10.1016/j.gene.2014.07.009. 
 
Alonso-Magdalena P, Quesada I, Nadal Á. 2015. Prenatal Exposure to BPA and Offspring 
Outcomes: The Diabesogenic Behavior of BPA. Dose. Response. 13:1559325815590395; 
doi:10.1177/1559325815590395. 
 
Anderson OS, Nahar MS, Faulk C, Jones TR, Liao C, Kannan K, et al. 2012. Epigenetic 
responses following maternal dietary exposure to physiologically relevant levels of 
bisphenol A. Environ. Mol. Mutagen. 53:334–342; doi:10.1002/em.21692. 
 
Anderson OS, Peterson KE, Sanchez BN, Zhang Z, Mancuso P, Dolinoy DC. 2013. Perinatal 
bisphenol A exposure promotes hyperactivity, lean body composition, and hormonal 
responses across the murine life course. FASEB J 27:1784–1792; doi:10.1096/fj.12-223545. 
 
Arnaud P. 2010. Genomic imprinting in germ cells: imprints are under control. Reproduction 
140:411–423; doi:10.1530/REP-10-0173. 
 
Bartolomei MS, Ferguson-Smith AC. 2011. Mammalian genomic imprinting. Cold Spring Harb. 
Perspect. Biol. 3; doi:10.1101/cshperspect.a002592. 
 
Bateson P, Barker D, Clutton-Brock T, Deb D, D’Udine B, Foley RA, et al. 2004. 
Developmental plasticity and human health. Nature 430:419–421; doi:10.1038/nature02725. 
 
Brust V, Schindler PM, Lewejohann L. 2015. Lifetime development of behavioural phenotype in 
the house mouse (Mus musculus). Front. Zool. 12 Suppl 1:S17; doi:10.1186/1742-9994-12-
S1-S17. 
 
Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008. Exposure of the U.S. population to 
bisphenol A and 4-tertiary-octylphenol: 2003-2004. Env. Heal. Perspect 116:39–44; 
doi:10.1289/ehp.10753. 
 
Carwile JL, Michels KB. 2011. Urinary bisphenol A and obesity: NHANES 2003–2006. 
Environ. Res. 111:825–830; doi:10.1016/j.envres.2011.05.014. 
 
Chamorro-Garcia R, Diaz-Castillo C, Shoucri BM, Käch H, Leavitt R, Shioda T, et al. 2017. 
Ancestral perinatal obesogen exposure results in a transgenerational thrifty phenotype in 
mice. Nat. Commun. 8:2012; doi:10.1038/s41467-017-01944-z. 
 
Cooper JE, Kendig EL, Belcher SM. 2011. Assessment of bisphenol A released from reusable 
plastic, aluminium and stainless steel water bottles. Chemosphere 85:943–7; 
doi:10.1016/j.chemosphere.2011.06.060. 
 
 218 
Das R, Hampton DD, Jirtle RL. 2009. Imprinting evolution and human health. Mamm. Genome 
20:563–572; doi:10.1007/s00335-009-9229-y. 
 
Demetrius L. 2006. Aging in Mouse and Human Systems: A Comparative Study. Ann. N. Y. 
Acad. Sci. 1067:66–82; doi:10.1196/annals.1354.010. 
 
Diamanti-Kandarakis E, Bourguignon J-P, Giudice LC, Hauser R, Prins GS, Soto AM, et al. 
2009. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. 
Rev. 30:293–342; doi:10.1210/er.2009-0002. 
 
Dixon JB. 2010. The effect of obesity on health outcomes. Mol. Cell. Endocrinol. 316:104–108; 
doi:10.1016/j.mce.2009.07.008. 
 
Dudley KJ, Sloboda DM, Connor KL, Beltrand J, Vickers MH. 2011. Offspring of Mothers Fed 
a High Fat Diet Display Hepatic Cell Cycle Inhibition and Associated Changes in Gene 
Expression and DNA Methylation. A. Wutz, ed PLoS One 6:e21662; 
doi:10.1371/journal.pone.0021662. 
 
Faulk C, Liu K, Barks A, Goodrich JM, Dolinoy DC. 2014. Longitudinal epigenetic drift in mice 
perinatally exposed to lead. Epigenetics 9:934–941; doi:10.4161/epi.29024. 
 
Gassman NR. 2017. Induction of oxidative stress by bisphenol A and its pleiotropic effects. 
Environ. Mol. Mutagen. 58:60–71; doi:10.1002/em.22072. 
 
Gilbert KM, Blossom SJ, Erickson SW, Reisfeld B, Zurlinden TJ, Broadfoot B, et al. 2016. 
Chronic exposure to water pollutant trichloroethylene increased epigenetic drift in CD4(+) 
T cells. Epigenomics 8:633–649; doi:10.2217/epi-2015-0018. 
 
Hahn MA, Szabo PE, Pfeifer GP. 2014. 5-Hydroxymethylcytosine: a stable or transient DNA 
modification? Genomics 104:314–323; doi:10.1016/j.ygeno.2014.08.015. 
 
Hales CM, Carroll MD, Fryar CD, Ogden CL. 2017. Prevalence of Obesity Among Adults and 
Youth: United States, 2015–2016 Key findings Data from the National Health and Nutrition 
Examination Survey. NCHS Data Brief. 
 
Haycock PC, Ramsay M. 2009. Exposure of Mouse Embryos to Ethanol During Preimplantation 
Development: Effect on DNA Methylation in the H19 Imprinting Control Region1. Biol. 
Reprod. 81:618–627; doi:10.1095/biolreprod.108.074682. 
 
Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. 2008. Persistent 
epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. 
Acad. Sci. U. S. A. 105:17046–9; doi:10.1073/pnas.0806560105. 
 
Heindel JJ, Balbus J, Birnbaum L, Brune-Drisse MN, Grandjean P, Gray K, et al. 2015. 
Developmental Origins of Health and Disease: Integrating Environmental Influences. 
Endocrinology 156:3416–3421; doi:10.1210/EN.2015-1394. 
 219 
 
Horvath S, Erhart W, Brosch M, Ammerpohl O, von Schönfels W, Ahrens M, et al. 2014. 
Obesity accelerates epigenetic aging of human liver. Proc. Natl. Acad. Sci. U. S. A. 
111:15538–43; doi:10.1073/pnas.1412759111. 
 
Kelsey G, Feil R. 2012. New insights into establishment and maintenance of DNA methylation 
imprints in mammals. Philos. Trans. R. Soc. B Biol. Sci. 368:20110336–20110336; 
doi:10.1098/rstb.2011.0336. 
 
Kim DD, Basu A. 2016. Estimating the Medical Care Costs of Obesity in the United States: 
Systematic Review, Meta-Analysis, and Empirical Analysis. Value Heal. 19:602–613; 
doi:10.1016/j.jval.2016.02.008. 
 
Kim J, He H, Kim H. 2017. Inversion of the imprinting control region of the Peg3 domain. Y. 
Yu, ed PLoS One 12:e0181591; doi:10.1371/journal.pone.0181591. 
 
Ko A, Hwang M-S, Park J-H, Kang H-S, Lee H-S, Hong J-H. 2014. Association between 
Urinary Bisphenol A and Waist Circumference in Korean Adults. Toxicol. Res. 30:39–44; 
doi:10.5487/TR.2014.30.1.039. 
 
Kochmanski J, Marchlewicz EH, Savidge M, Montrose L, Faulk C, Dolinoy DC. 2016. 
Longitudinal effects of developmental bisphenol A and variable diet exposures on 
epigenetic drift in mice. Reprod. Toxicol.; doi:10.1016/j.reprotox.2016.07.021. 
 
Kochmanski J, Montrose L, Goodrich JM, Dolinoy DC. 2017. Environmental Deflection: The 
Impact of Toxicant Exposures on the Aging Epigenome. Toxicol. Sci. 156:kfx005; 
doi:10.1093/toxsci/kfx005. 
 
Krüger T, Long M, Bonefeld-Jørgensen EC. 2008. Plastic components affect the activation of the 
aryl hydrocarbon and the androgen receptor. Toxicology 246:112–123; 
doi:10.1016/j.tox.2007.12.028. 
 
Laker RC, Lillard TS, Okutsu M, Zhang M, Hoehn KL, Connelly JJ, et al. 2014. Exercise 
prevents maternal high-fat diet-induced hypermethylation of the Pgc-1α gene and age-
dependent metabolic dysfunction in the offspring. Diabetes 63:1605–1611; 
doi:10.2337/db13-1614. 
 
Loos RJF, Janssens ACJW. 2017. Predicting Polygenic Obesity Using Genetic Information. Cell 
Metab. 25:535–543; doi:10.1016/j.cmet.2017.02.013. 
 
Marco A, Kisliouk T, Weller A, Meiri N. 2013. High fat diet induces hypermethylation of the 
hypothalamic Pomc promoter and obesity in post-weaning rats. Psychoneuroendocrinology 
38:2844–2853; doi:10.1016/j.psyneuen.2013.07.011. 
 
Nye MD, Hoyo C, Murphy SK. 2015. In vitro lead exposure changes DNA methylation and 
expression of IGF2 and PEG1/MEST. Toxicol. In Vitro 29:544–50; 
 220 
doi:10.1016/j.tiv.2015.01.002. 
 
Pidsley R, Fernandes C, Viana J, Paya-Cano JL, Liu L, Smith RG, et al. 2012. DNA methylation 
at the Igf2/H19 imprinting control region is associated with cerebellum mass in outbred 
mice. Mol. Brain 5:42; doi:10.1186/1756-6606-5-42. 
 
Shah S, McRae AF, Marioni RE, Harris SE, Gibson J, Henders AK, et al. 2014. Genetic and 
environmental exposures constrain epigenetic drift over the human life course. Genome Res 
24:1725–1733; doi:10.1101/gr.176933.114. 
 
Singh S, Li SS. 2012. Epigenetic effects of environmental chemicals bisphenol a and phthalates. 
Int J Mol Sci 13:10143–10153; doi:10.3390/ijms130810143. 
 
Smallwood SA, Kelsey G. 2012. De novo DNA methylation: a germ cell perspective. Trends 
Genet 28:33–42; doi:10.1016/j.tig.2011.09.004. 
 
Sui Y, Ai N, Park SH, Rios-Pilier J, Perkins JT, Welsh WJ, et al. 2012. Bisphenol A and its 
analogues activate human pregnane X receptor. Env. Heal. Perspect 120:399–405; 
doi:10.1289/ehp.1104426. 
 
Susiarjo M, Sasson I, Mesaros C, Bartolomei MS. 2013. Bisphenol A Exposure Disrupts 
Genomic Imprinting in the Mouse. G. Kelsey, ed PLoS Genet. 9:e1003401; 
doi:10.1371/journal.pgen.1003401. 
 
van Dongen J, Nivard MG, Willemsen G, Hottenga JJ, Helmer Q, Dolan C V, et al. 2016. 
Genetic and environmental influences interact with age and sex in shaping the human 
methylome. Nat Commun 7:11115; doi:10.1038/ncomms11115. 
 
van Esterik JCJ, Dollé MET, Lamoree MH, van Leeuwen SPJ, Hamers T, Legler J, et al. 2014. 
Programming of metabolic effects in C57BL/6JxFVB mice by exposure to bisphenol A 
during gestation and lactation. Toxicology 321:40–52; doi:10.1016/j.tox.2014.04.001. 
 
Wahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, et al. 2016. Epigenome-wide 
association study of body mass index, and the adverse outcomes of adiposity. Nature 
541:81–86; doi:10.1038/nature20784. 
 
Wu H, D’Alessio AC, Ito S, Wang Z, Cui K, Zhao K, et al. 2011. Genome-wide analysis of 5-
hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in 
mouse embryonic stem cells. Genes Dev 25:679–684; doi:10.1101/gad.2036011. 
 
Xu WH, Wu H, Xia WL, Lan H, Wang Y, Zhang Y, et al. 2017. Physical exercise before 
pregnancy helps the development of mouse embryos produced in vitro. Mitochondrion 
34:36–42; doi:10.1016/j.mito.2016.12.004. 
 
Yoon A, Tammen SA, Park S, Han SN, Choi S-W. 2017. Genome-wide hepatic DNA 
methylation changes in high-fat diet-induced obese mice. Nutr. Res. Pract. 11:105–113; 
 221 
doi:10.4162/nrp.2017.11.2.105. 
 
Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, et al. 2014. A comparative encyclopedia 
of DNA elements in the mouse genome. Nature 515:355–64; doi:10.1038/nature13992. 
 
Zannas AS, Arloth J, Carrillo-Roa T, Iurato S, Rӧh S, Ressler KJ, et al. 2015. Lifetime stress 
accelerates epigenetic aging in an urban, African American cohort: relevance of 
glucocorticoid signaling. Genome Biol 16:266; doi:10.1186/s13059-015-0828-5. 
 
